Disease ID,Disorder name,Gene symbols,OMIM ID,Chromosome,Class
1,"17,20-lyase deficiency, isolated, 202110 (3)","CYP17A1, CYP17, P450C17",609300,10q24.3,Endocrine
1,"17-alpha-hydroxylase/17,20-lyase deficiency, 202110 (3)","CYP17A1, CYP17, P450C17",609300,10q24.3,Endocrine
3,"2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency, 300438 (3)","HADH2, ERAB",300256,Xp11.2,Metabolic
4,2-methylbutyrylglycinuria (3),ACADSB,600301,10q25-q26,Metabolic
5,"3-beta-hydroxysteroid dehydrogenase, type II, deficiency (3)",HSD3B2,201810,1p13.1,Metabolic
6,"3-hydroxyacyl-CoA dehydrogenase deficiency, 609609 (3)","HADHSC, SCHAD",601609,4q22-q26,Metabolic
7,"3-Methylcrotonyl-CoA carboxylase 1 deficiency, 210200 (3)","MCCC1, MCCA",609010,3q25-q27,Metabolic
7,"3-Methylcrotonyl-CoA carboxylase 2 deficiency, 210210 (3)","MCCC2, MCCB",609014,5q12-q13,Metabolic
8,"3-methylglutaconic aciduria, type I, 250950 (3)",AUH,600529,Chr.9,Metabolic
9,"3-methylglutaconicaciduria, type III, 258501 (3)","OPA3, MGA3",606580,19q13.2-q13.3,Metabolic
10,"3-M syndrome, 273750 (3)",CUL7,609577,6p21.1,multiple
12,6-mercaptopurine sensitivity (3),TPMT,187680,6p22.3,Metabolic
13,Aarskog-Scott syndrome (3),"FGD1, FGDY, AAS",305400,Xp11.21,multiple
14,"Abacavir hypersensitivity, susceptibility to (3)",HLA-B,142830,6p21.3,Immunological
15,"ABCD syndrome, 600501 (3)","EDNRB, HSCR2, ABCDS",131244,13q22,multiple
17,"Abetalipoproteinemia, 200100 (3)",MTP,157147,4q22-q24,Metabolic
17,Abetalipoproteinemia (3),"APOB, FLDB",107730,2p24,Metabolic
18,"Acampomelic campolelic dysplasia, 114290 (3)","SOX9, CMD1, SRA1",608160,17q24.3-q25.1,Skeletal
21,Acatalasemia (3),CAT,115500,11p13,Hematological
22,"Accelerated tumor formation, susceptibility to (3)",MDM2,164785,12q14.3-q15,Cancer
24,"Achalasia-addisonianism-alacrimia syndrome, 231550 (3)","AAAS, AAA",605378,12q13,multiple
25,"Acheiropody, 200500 (3)","C7orf2, ACHP, LMBR1",605522,7q36,Skeletal
26,"Achondrogenesis-hypochondrogenesis, type II, 200610 (3)",COL2A1,120140,12q13.11-q13.2,Bone
27,"Achondrogenesis Ib, 600972 (3)","SLC26A2, DTD, DTDST, D5S1708,
EDM4",606718,5q32-q33.1,Bone
28,"Achondroplasia, 100800 (3)","FGFR3, ACH",134934,4p16.3,Skeletal
29,"Achromatopsia-2, 216900 (3)","CNGA3, CNG3, ACHM2",600053,2q11,Ophthamological
29,"Achromatopsia-3, 262300 (3)","CNGB3, ACHM3",605080,8q21-q22,Ophthamological
29,Achromatopsia-4 (3),"GNAT2, ACHM4",139340,1p13,Ophthamological
30,"Acid-labile subunit, deficiency of (3)","IGFALS, ALS",601489,16p13.3,Endocrine
31,"Acquired long QT syndrome, susceptibility to (3)","KCNH2, LQT2, HERG",152427,7q35-q36,Cardiovascular
32,"Acrocallosal syndrome, 200990 (3)","GLI3, PAPA, PAPB, ACLS",165240,7p13,multiple
33,"Acrocapitofemoral dysplasia, 607778 (3)","IHH, BDA1",600726,2q33-q35,Skeletal
34,"Acrodermatitis enteropathica, 201100 (3)","SLC39A4, ZIP4",607059,8q24.3,Dermatological
36,"Acrokeratosis verruciformis, 101900 (3)","ATP2A2, ATP2B, DAR",108740,12q23-q24.1,Dermatological
38,"Acromegaly, 102200 (3)","GNAS, GNAS1, GPSA, POH, PHP1B,
PHP1A, AHO",139320,20q13.2,Endocrine
38,"Acromegaly, 102200 (3)",SSTR5,182455,16p13.3,Endocrine
39,"Acromesomelic dysplasia, Hunter-Thompson type, 201250 (3)","GDF5, CDMP1",601146,20q11.2,Skeletal
39,"Acromesomelic dysplasia, Maroteaux type, 602875 (3)","NPR2, ANPRB, AMDM",108961,9p21-p12,Skeletal
44,"Acyl-CoA dehydrogenase, long chain, deficiency of (3)","ACADL, LCAD",201460,2q34-q35,Metabolic
44,"Acyl-CoA dehydrogenase, medium chain, deficiency of, 201450 (3)","ACADM, MCAD",607008,1p31,Metabolic
44,"Acyl-CoA dehydrogenase, short-chain, deficiency of, 201470 (3)","ACADS, SCAD",606885,12q22-qter,Metabolic
45,"Adenocarcinoma of lung, response to tyrosine kinase inhibitor in, 211980 (3)",EGFR,131550,7p12.3-p12.1,Cancer
45,"Adenocarcinoma of lung, somatic, 211980 (3)",BRAF,164757,7q34,Cancer
45,"Adenocarcinoma of lung, somatic, 211980 (3)","ERBB2, NGL, NEU, HER2",164870,17q21.1,Cancer
45,"Adenocarcinoma of lung, somatic, 211980 (3)","PRKN, PARK2, PDJ",602544,6q25.2-q27,Cancer
45,"Adenocarcinoma, ovarian, somatic (3)","PRKN, PARK2, PDJ",602544,6q25.2-q27,Cancer
46,"Adenoma, periampullary (3)","APC, GS, FPC",175100,5q21-q22,Cancer
47,"Adenomas, multiple colorectal, 608456 (3)",MUTYH,604933,1p34.3-p32.1,Cancer
47,"Adenomas, salivary gland pleomorphic, 181030 (3)","PLAG1, SGPA, PSA",603026,8q12,Cancer
47,Adenomatous polyposis coli (3),"APC, GS, FPC",175100,5q21-q22,Cancer
47,"Adenomatous polyposis coli, attenuated (3)","APC, GS, FPC",175100,5q21-q22,Cancer
49,"Adenosine deaminase deficiency, partial, 102700 (3)",ADA,608958,20q13.11,Immunological
50,"Adenylosuccinase deficiency, 103050 (3)",ADSL,608222,22q13.1,Metabolic
52,Adiponectin deficiency (3),"APM1, GBP28",605441,3q27,Endocrine
2053,"Adrenal adenoma, sporadic (3)",MEN1,131100,11q13,Cancer
2054,"Adrenal cortical carcinoma, 202300 (3)","TP53, P53, LFS1",191170,17p13.1,Cancer
53,"Adrenal hyperplasia, congenital, due to 11-beta-hydroxylase deficiency (3)","CYP11B1, P450C11, FHI",202010,8q21,Endocrine
53,"Adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency (3)","CYP21A2, CYP21, CA21H",201910,6p21.3,Endocrine
53,"Adrenal hyperplasia, congenital, due to combined P450C17 and P450C21 deficiency,
201750 (3)",POR,124015,7q11.2,Endocrine
53,"Adrenal hypoplasia, congenital, with hypogonadotropic hypogonadism, 300200 (3)","DAX1, AHC, AHX, NROB1",300473,Xp21.3-p21.2,Endocrine
2055,Adrenocortical insufficiency without ovarian defect (3),"FTZF1, FTZ1, SF1",184757,9q33,Endocrine
54,"Adrenocortical tumor, somatic (3)","PRKAR1A, TSE1, CNC1, CAR",188830,17q23-q24,Cancer
55,"Adrenocorticotropic hormone deficiency, 201400 (3)",TBS19,604614,1q23-q24,Endocrine
56,"Adrenoleukodystrophy, 300100 (3)","ABCD1, ALD, AMN",300371,Xq28,Neurological
56,"Adrenoleukodystrophy, neonatal, 202370 (3)","PEX10, NALD",602859,Chr.1,Neurological
56,"Adrenoleukodystrophy, neonatal, 202370 (3)","PEX13, ZWS, NALD",601789,2p15,Neurological
56,"Adrenoleukodystrophy, neonatal, 202370 (3)","PEX1, ZWS1",602136,7q21-q22,Neurological
56,"Adrenoleukodystrophy, neonatal, 202370 (3)",PEX26,608666,22q11.21,Neurological
56,"Adrenoleukodystrophy, neonatal, 202370 (3)","PXR1, PEX5, PTS1R",600414,12p13.3,Neurological
57,"Adrenomyeloneuropathy, 300100 (3)","ABCD1, ALD, AMN",300371,Xq28,Metabolic
58,"Adult i phenotype with congenital cataract, 110800 (3)",GCNT2,600429,6p24-p23,Hematological
58,"Adult i phenotype without cataract, 110800 (3)",GCNT2,600429,6p24-p23,Hematological
59,"ADULT syndrome, 103285 (3)","TP73L, TP63, KET, EEC3, SHFM4, LMS,
RHS",603273,3q27,multiple
60,"Advanced sleep phase syndrome, familial, 604348 (3)","PER2, FASPS, KIAA0347",603426,2q37.3,Neurological
61,"Afibrinogenemia, 202400 (3)",FGA,134820,4q28,Hematological
61,"Afibrinogenemia, congenital, 202400 (3)",FGB,134830,4q28,Hematological
63,"Agammaglobulinemia, 601495 (3)","IGHM, MU",147020,14q32.33,Hematological
63,"Agammaglobulinemia, autosomal recessive (3)","IGLL1, IGO, IGL5, VPREB2",146770,22q11.21,Hematological
63,"Agammaglobulinemia, non-Bruton type, 601495 (3)","LRRC8, KIAA1437",608360,9q34.13,Hematological
63,"Agammaglobulinemia, type 1, X-linked (3)","BTK, AGMX1, IMD1, XLA, AT",300300,Xq21.3-q22,Hematological
64,AGAT deficiency (3),"GATM, AGAT",602360,15q15.3,Metabolic
65,"Agenesis of the corpus callosum with peripheral neuropathy, 218000 (3)","SLC12A6, KCC3A, KCC3B, KCC3,
ACCPN",604878,15q13-q14,Neurological
69,"AICA-ribosiduria due to ATIC deficiency, 608688 (3)","ATIC, PURH, AICAR",601731,2q35,Metabolic
70,"AIDS, delayed/rapid progression to (3)","KIR3DL1, NKAT3, NKB1, AMB11,
KIR3DS1",604946,19q13.4,Immunological
70,"AIDS, rapid progression to, 609423 (3)",IFNG,147570,12q14,Immunological
70,"AIDS, resistance to (3)","CXCL12, SDF1",600835,10q11.1,Immunological
71,"Alagille syndrome, 118450 (3)","JAG1, AGS, AHD",601920,20p12,multiple
72,"Albinism, brown oculocutaneous, (3)","OCA2, P, PED, D15S12, BOCA",203200,15q11.2-q12,Dermatological
72,"Albinism, ocular, autosomal recessive (3)","OCA2, P, PED, D15S12, BOCA",203200,15q11.2-q12,Dermatological
72,"Albinism, oculocutaneous, type IA, 203100 (3)",TYR,606933,11q14-q21,Dermatological
72,"Albinism, oculocutaneous, type IB, 606952 (3)",TYR,606933,11q14-q21,Dermatological
72,"Albinism, oculocutaneous, type II (3)","OCA2, P, PED, D15S12, BOCA",203200,15q11.2-q12,Dermatological
72,"Albinism, rufous, 278400 (3)","TYRP1, CAS2, GP75",115501,9p23,Dermatological
74,"Alcohol dependence, susceptibility to, 103780 (3)",HTR2A,182135,13q14-q21,Unclassified
2074,"Alcohol intolerance, acute (3)",ALDH2,100650,12q24.2,Metabolic
75,"Alcoholism, susceptibility to, 103780 (3)",GABRA2,137140,4p13-p12,Unclassified
76,Aldolase A deficiency (3),ALDOA,103850,16q22-q24,Metabolic
77,Aldosterone to renin ratio raised (3),CYP11B2,124080,8q21,Endocrine
78,"Aldosteronism, glucocorticoid-remediable, 103900 (3)","CYP11B1, P450C11, FHI",202010,8q21,Endocrine
79,"Alexander disease, 203450 (3)",GFAP,137780,17q21,multiple
79,"Alexander disease, 203450 (3)","NDUFV1, UQOR1",161015,11q13,multiple
80,"Alkaptonuria, 203500 (3)","HGD, AKU",607474,3q21-q23,Metabolic
82,"Allan-Herndon-Dudley syndrome, 300523 (3)","SLC16A2, DXS128, XPCT",300095,Xq13.2,Neurological
83,"Allergic rhinitis, susceptibility to, 607154 (3)","IL13, ALRH",147683,5q31,Immunological
85,"Alopecia universalis, 203655 (3)","HR, AU",602302,8p21.2,Dermatological
86,"Alpers syndrome, 203700 (3)","POLG, POLG1, POLGA, PEO",174763,15q25,Neurological
87,Alpha-1-antichymotrypsin deficiency (3),"SERPINA3, AACT, ACT",107280,14q32.1,Respiratory
88,Alpha-actinin-3 deficiency (3),ACTN3,102574,11q13-q14,Muscular
90,"Alpha-methylacetoacetic aciduria, 203750 (3)",ACAT1,607809,11q22.3-q23.1,Metabolic
91,Alpha-methylacyl-CoA racemase deficiency (3),AMACR,604489,5p13.2-q11.1,Metabolic
92,"Alpha-thalassemia/mental retardation syndrome, 301040 (3)","ATRX, XH2, XNP, MRXS3, SHS",300032,Xq13,Hematological
92,"Alpha-thalassemia myelodysplasia syndrome, somatic, 300448 (3)","ATRX, XH2, XNP, MRXS3, SHS",300032,Xq13,Hematological
94,"Alport syndrome, 301050 (3)","COL4A5, ATS, ASLN",303630,Xq22.3,Renal
94,"Alport syndrome, autosomal recessive, 203780 (3)",COL4A3,120070,2q36-q37,Renal
94,"Alport syndrome, autosomal recessive, 203780 (3)",COL4A4,120131,2q36-q37,Renal
95,"Alstrom syndrome, 203800 (3)","ALMS1, ALSS, KIAA0328",606844,2p13,Neurological
96,"Alternating hemiplegia of childhood, 104290 (3)","ATP1A2, FHM2, MHP2",182340,1q21-q23,Neurological
97,"Alveolar soft-part sarcoma, 606243 (3)","ASPCR1, RCC17, ASPL, ASPS",606236,17q25,Cancer
98,"Alzheimer disease-1, APP-related (3)","APP, AAA, CVAP, AD1",104760,21q21,Neurological
98,"Alzheimer disease-2, 104310 (3)","APOE, AD2",107741,19q13.2,Neurological
98,"Alzheimer disease-4, 606889 (3)","PSEN2, AD4, STM2",600759,1q31-q42,Neurological
98,"Alzheimer disease, late-onset, 104300 (3)","APBB2, FE65L1",602710,4p14,Neurological
98,"Alzheimer disease, late-onset, susceptibility to, 104300 (3)",NOS3,163729,7q36,Neurological
98,"Alzheimer disease, late-onset, susceptibility to, 104300 (3)","PLAU, URK",191840,10q24,Neurological
98,"Alzheimer disease, susceptibility to, 104300 (3)","ACE, DCP1, ACE1",106180,17q23,Neurological
98,"Alzheimer disease, susceptibility to, 104300 (3)",MPO,606989,17q23.1,Neurological
98,"Alzheimer disease, susceptibility to, 104300 (3)","PACIP1, PAXIP1L, PTIP",608254,7q36,Neurological
98,"Alzheimer disease, susceptibility to (3)",A2M,103950,12p13.3-p12.3,Neurological
98,"Alzheimer disease, susceptibility to (3)","BLMH, BMH",602403,17q11.2,Neurological
98,"Alzheimer disease, type 3, 607822 (3)","PSEN1, AD3",104311,14q24.3,Neurological
98,"Alzheimer disease, type 3, with spastic paraparesis and apraxia, 607822 (3)","PSEN1, AD3",104311,14q24.3,Neurological
98,"Alzheimer disease, type 3, with spastic paraparesis and unusual plaques, 607822 (3)","PSEN1, AD3",104311,14q24.3,Neurological
99,"Amelogenesis imperfecta 2, hypoplastic local, 104500 (3)",ENAM,606585,4q21,Bone
99,"Amelogenesis imperfecta, 301200 (3)","AMELX, AMG, AIH1, AMGX",300391,Xp22.3-p22.1,Bone
99,"Amelogenesis imperfecta, hypomaturation-hypoplastic type, with taurodontism, 104510
(3)","DLX3, TDO",600525,17q21.3-q22,Bone
99,"Amelogenesis imperfecta, hypoplastic, and openbite malocclusion, 608563 (3)",ENAM,606585,4q21,Bone
99,"Amelogenesis imperfecta, pigmented hypomaturation type, 204700 (3)","KLK4, EMSP1, PRSS17",603767,19q13.3-q13.4,Bone
100,"Amish infantile epilepsy syndrome, 609056 (3)","SIAT9, ST3GALV",604402,2p11.2,Neurological
101,"AMP deaminase deficiency, erythrocytic (3)",AMPD3,102772,11pter-p13,Hematological
102,"Amyloid neuropathy, familial, several allelic types (3)","TTR, PALB",176300,18q11.2-q12.1,Neurological
103,"Amyloidosis, 3 or more types (3)",APOA1,107680,11q23,Neurological
103,"Amyloidosis, cerebroarterial, Dutch type (3)","APP, AAA, CVAP, AD1",104760,21q21,Neurological
103,"Amyloidosis, Finnish type, 105120 (3)",GSN,137350,9q34,Neurological
103,"Amyloidosis, hereditary renal, 105200 (3)",FGA,134820,4q28,Neurological
103,"Amyloidosis, renal, 105200 (3)",LYZ,153450,Chr.12,Neurological
103,"Amyloidosis, senile systemic (3)","TTR, PALB",176300,18q11.2-q12.1,Neurological
104,"Amyotrophic lateral sclerosis 8, 608627 (3)","VAPB, VAPC, ALS8",605704,20q13.3,Neurological
104,"Amyotrophic lateral sclerosis, due to SOD1 deficiency, 105400 (3)","SOD1, ALS1",147450,21q22.1,Neurological
104,"Amyotrophic lateral sclerosis, juvenile, 205100 (3)","ALS2, ALSJ, PLSJ, IAHSP",606352,2q33,Neurological
104,"Amyotrophic lateral sclerosis, susceptibility to, 105400 (3)",DCTN1,601143,2p13,Neurological
104,"Amyotrophic lateral sclerosis, susceptibility to, 105400 (3)",NEFH,162230,22q12.2,Neurological
104,"Amyotrophic lateral sclerosis, susceptibility to, 105400 (3)",PRPH,170710,12q12-q13,Neurological
105,Analbuminemia (3),ALB,103600,4q11-q13,Hematological
107,"Analgesia from kappa-opioid receptor agonist, female-specific (3)",MC1R,155555,16q24.3,Unclassified
108,"Anderson disease, 607689 (3)","SARA2, SAR1B, CMRD",607690,5q31.1,Gastrointestinal
109,"Androgen insensitivity, 300068 (3)","AR, DHTR, TFM, SBMA, KD, SMAX1",313700,Xq11-q12,Endocrine
110,"Anemia, congenital dyserythropoietic, type I, 224120 (3)","CDAN1, CDA1",607465,15q15,Hematological
110,"Anemia, Diamond-Blackfan, 105650 (3)","RPS19, DBA",603474,19q13.2,Hematological
110,"Anemia, hemolytic, due to PK deficiency (3)","PKLR, PK1",266200,1q21,Hematological
110,"Anemia, hemolytic, due to UMPH1 deficiency, 266120 (3)","NT5C3, UMPH1, PSN1",606224,7p15-p14,Hematological
110,"Anemia, hemolytic, Rh-null, regulator type, 268150 (3)","RHAG, RH50A",180297,6p21.1-p11,Hematological
110,"Anemia, hypochromic microcytic, 206100 (3)",NRAMP2,600523,12q13,Hematological
110,"Anemia, neonatal hemolytic, fatal and near-fatal (3)",SPTB,182870,14q22-q23.2,Hematological
110,"Anemia, sideroblastic/hypochromic (3)","ALAS2, ANH1, ASB",301300,Xp11.21,Hematological
110,"Anemia, sideroblastic, with ataxia, 301310 (3)","ABCB7, ABC7, ASAT",300135,Xq13.1-q13.3,Hematological
2112,"Aneurysm, familial arterial (3)",COL3A1,120180,2q31,Unclassified
113,"Angelman syndrome, 105830 (3)","MECP2, RTT, PPMX, MRX16, MRX79",300005,Xq28,Developmental
113,"Angelman syndrome, 105830 (3)","UBE3A, ANCR",601623,15q11-q13,Developmental
114,"Angioedema, hereditary, 106100 (3)","C1NH, HAE1, HAE2, SERPING1",606860,11q11-q13.1,Immunological
114,"Angioedema induced by ACE inhibitors, susceptibility to (3)",XPNPEP2,300145,Xq25,Immunological
115,"Angiofibroma, sporadic (3)",MEN1,131100,11q13,Endocrine
117,"Angiotensin I-converting enzyme, benign serum increase (3)","ACE, DCP1, ACE1",106180,17q23,Endocrine
118,Anhaptoglobinemia (3),HP,140100,16q22.1,Hematological
119,"Aniridia, type II, 106210 (3)","PAX6, AN2, MGDA",607108,11p13,Ophthamological
121,"Ankylosing spoldylitis, susceptibility to, 106300 (3)",HLA-B,142830,6p21.3,Connective tissue
122,"Anophthalmia 3, 206900 (3)","SOX2, ANOP3",184429,3q26.3-q27,Ophthamological
124,"Anorexia nervosa, susceptibility to, 606788 (3)",HTR2A,182135,13q14-q21,Nutritional
126,Anterior segment anomalies and cataract (3),"EYA1, BOR",601653,8q13.3,Ophthamological
126,"Anterior segment mesenchymal dysgenesis, 107250 (3)","FOXE3, FKHL12, ASMD",601094,1p32,Ophthamological
126,Anterior segment mesenchymal dysgenesis (3),"FOXC1, FKHL7, FREAC3",601090,6p25,Ophthamological
126,"Anterior segment mesenchymal dysgenesis and cataract, 107250 (3)",PITX3,602669,10q25,Ophthamological
127,Antithrombin III deficiency (3),AT3,107300,1q23-q25,Hematological
128,"Antley-Bixler syndrome, 207410 (3)",POR,124015,7q11.2,Unclassified
129,Anxiety-related personality traits (3),"SLC6A4, HTT, OCD1",182138,17q11.1-q12,Psychiatric
130,"Aortic aneurysm, ascending, and dissection (3)","FBN1, MFS1, WMS",134797,15q21.1,Cardiovascular
131,"Apert syndrome, 101200 (3)","FGFR2, BEK, CFD1, JWS",176943,10q26,Connective tissue
132,"Aplasia of lacrimal and salivary glands, 180920 (3)",FGF10,602115,5p13-p12,Gastrointestinal
133,"Aplastic anemia, 609135 (3)",IFNG,147570,12q14,Hematological
133,"Aplastic anemia, 609135 (3)","TERC, TRC3, TR",602322,3q21-q28,Hematological
133,"Aplastic anemia, susceptibility to, 609135 (3)","TERT, TCS1, EST2",187270,5p15.33,Hematological
134,"Apnea, postanesthetic (3)","BCHE, CHE1",177400,3q26.1-q26.2,Unclassified
136,"ApoA-I and apoC-III deficiency, combined (3)",APOA1,107680,11q23,Metabolic
136,Apolipoprotein A-II deficiency (3),APOA2,107670,1q21-q23,Metabolic
136,Apolipoprotein C3 deficiency (3),APOC3,107720,11q23,Metabolic
136,Apolipoprotein H deficiency (3),APOH,138700,17q23-qter,Metabolic
137,"Apparent mineralocorticoid excess, hypertension due to (3)","HSD11B2, HSD11K",218030,16q22,Bone
138,Aquaporin-1 deficiency (3),"AQP1, CHIP28, CO",107776,7p14,Unclassified
139,"ARC syndrome, 208085 (3)",VPS33B,608552,15q26.1,Gastrointestinal
140,"Argininemia, 207800 (3)",ARG1,608313,6q23,Metabolic
140,"Argininosuccinic aciduria, 207900 (3)",ASL,608310,7cen-q11.2,Metabolic
142,Aromatase deficiency (3),"CYP19A1, CYP19, ARO",107910,15q21.1,Metabolic
143,"Aromatic L-amino acid decarboxylase deficiency, 608643 (3)",DDC,107930,7p11,Metabolic
144,"Arrhythmogenic right ventricular dysplasia 2, 600996 (3)","RYR2, VTSIP",180902,1q42.1-q43,Cardiovascular
144,"Arrhythmogenic right ventricular dysplasia 8, 607450 (3)","DSP, KPPS2, PPKS2",125647,6p24,Cardiovascular
144,"Arrhythmogenic right ventricular dysplasia, familial, 9, 609040 (3)","PKP2, ARVD9",602861,12p11,Cardiovascular
146,"Arthrogryposis multiplex congenita, distal, type 1, 108120 (3)","TPM2, TMSB, AMCD1, DA1",190990,9p13.2-p13.1,Developmental
146,"Arthrogryposis multiplex congenita, distal, type 2B, 601680 (3)","TNNI2, AMCD2B, DA2B, FSSV",191043,11p15.5,Developmental
147,"Arthropathy, progressive pseudorheumatoid, of childhood, 208230 (3)","WISP3, PPAC, PPD",603400,6q22-q23,Bone
146,"Arthyrgryposis multiplex congenita, distal, type 2B, 601680 (3)","TNNT3, AMCD2B, DA2B, FSSV",600692,11p15.5,Developmental
150,Aspartylglucosaminuria (3),AGA,208400,4q32-q33,Metabolic
151,"Asperger syndrome, 300494 (3)",NLGN3,300336,Xq13,Psychiatric
151,"Asperger syndrome, 300497 (3)","NLGN4, KIAA1260, AUTSX2",300427,Xp22.33,Psychiatric
153,"Asthma, 600807 (3)","PHF11, NYREN34",607796,13q14.1,Respiratory
153,"Asthma, atopic, susceptibility to (3)","MS4A2, FCER1B",147138,11q13,Respiratory
153,"Asthma, dimished response to antileukotriene treatment in, 600807 (3)",ALOX5,152390,10q11.2,Respiratory
153,"Asthma, nocturnal, susceptibility to (3)",ADRB2,109690,5q32-q34,Respiratory
153,"Asthma, susceptibility to, 1, 607277 (3)","PTGDR, AS1",604687,14q22.1,Respiratory
153,"Asthma, susceptibility to, 2, 608584 (3)","GPR154, GPRA, VRR1, PGR14",608595,7p15-p14,Respiratory
153,"Asthma, susceptibility to (3)",HNMT,605238,1p32,Respiratory
153,"Asthma, susceptibility to, 600807 (3)","IL12B, NKSF2",161561,5q31.1-q33.1,Respiratory
153,"Asthma, susceptibility to, 600807 (3)","IL13, ALRH",147683,5q31,Respiratory
153,"Asthma, susceptibility to, 600807 (3)","PLA2G7, PAFAH",601690,6p21.2-p12,Respiratory
153,"Asthma, susceptibility to, 600807 (3)","SCGB3A2, UGRP1",606531,5q31-q34,Respiratory
153,"Asthma, susceptibility to, 600807 (3)","TNF, TNFA",191160,6p21.3,Respiratory
153,"Asthma, susceptibility to, 600807 (3)","UGB, CC10, CCSP, SCGB1A1",192020,11q12.3-q13.1,Respiratory
154,"Ataxia, cerebellar, Cayman type, 601238 (3)","ATCAY, CLAC, KIAA1872",608179,19p13.3,Neurological
154,"Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia, 208920 (3)","APTX, AOA, AOA1",606350,9p13.3,Neurological
154,"Ataxia, episodic (3)","CACNB4, EJM",601949,2q22-q23,Neurological
154,"Ataxia-ocular apraxia-2, 606002 (3)","SETX, SCAR1, AOA2",608465,9q34,Neurological
157,"Ataxia-telangiectasia, 208900 (3)","ATM, ATA, AT1",607585,11q22.3,Immunological
157,"Ataxia-telangiectasia-like disorder, 604391 (3)","MRE11A, MRE11, ATLD",600814,11q21,Immunological
154,"Ataxia with isolated vitamin E deficiency, 277460 (3)","TTPA, TTP1, AVED",600415,8q13.1-q13.3,Neurological
160,"Atelosteogenesis II, 256050 (3)","SLC26A2, DTD, DTDST, D5S1708,
EDM4",606718,5q32-q33.1,Connective tissue
160,"Atelostogenesis, type I, 108720 (3)","FLNB, SCT, AOI",603381,3p14.3,Connective tissue
162,"Athabaskan brainstem dysgenesis syndrome, 601536 (3)","HOXA1, HOX1F, BSAS",142955,7p15.3,Neurological
163,"Atherosclerosis, susceptibility to (3)",ALOX5,152390,10q11.2,Cardiovascular
164,"Atopy, 147050 (3)","SPINK5, LEKTI",605010,5q32,Immunological
164,"Atopy, resistance to, 147050 (3)","HAVCR1, HAVCR",606518,5q33.2,Immunological
164,"Atopy, susceptibility to, 147050 (3)","PLA2G7, PAFAH",601690,6p21.2-p12,Immunological
164,"Atopy, susceptibility to, 147050 (3)","SELP, GRMP",173610,1q23-q25,Immunological
164,"Atopy, susceptibility to (3)","IL4R, IL4RA",147781,16p12.1-p11.2,Immunological
165,"Atransferrinemia, 209300 (3)",TF,190000,3q21,Hematological
166,"Atrial fibrillation, familial, 607554 (3)","KCNE2, MIRP1, LQT6",603796,21q22.1,Cardiovascular
166,"Atrial fibrillation, familial, 607554 (3)","KCNQ1, KCNA9, LQT1, KVLQT1,
ATFB1",607542,11p15.5,Cardiovascular
166,"Atrial septal defect-2, 607941 (3)",GATA4,600576,8p23.1-p22,Cardiovascular
166,Atrial septal defect 3 (3),"MYH6, ASD3, MYHCA",160710,14q12,Cardiovascular
166,"Atrial septal defect with atrioventricular conduction defects, 108900 (3)","NKX2E, CSX",600584,5q34,Cardiovascular
167,"Atrichia with papular lesions, 209500 (3)","HR, AU",602302,8p21.2,Dermatological
168,"Atrioventricular block, idiopathic second-degree (3)","NKX2E, CSX",600584,5q34,Cardiovascular
168,"Atrioventricular septal defect, 600309 (3)","GJA1, CX43, ODDD, SDTY3, ODOD",121014,6q21-q23.2,Cardiovascular
168,"Atrioventricular septal defect, partial, with heterotaxy syndrome, 606217 (3)","CRELD1, AVSD2",607170,3p25.3,Cardiovascular
168,"Atrioventricular septal defect, susceptibility to, 2, 606217 (3)","CRELD1, AVSD2",607170,3p25.3,Cardiovascular
171,"Attention deficit-hyperactivity disorder, susceptibility to, 143465 (3)","DRD5, DRD1B, DRD1L2",126453,4p16.1-p15.3,Psychiatric
173,"Autism, susceptibility to, 209850 (3)",GLO1,138750,6p21.3-p21.2,Psychiatric
173,"Autism, X-linked, 300425 (3)","MECP2, RTT, PPMX, MRX16, MRX79",300005,Xq28,Psychiatric
173,"Autism, X-linked, 300425 (3)",NLGN3,300336,Xq13,Psychiatric
173,"Autism, X-linked, 300495 (3)","NLGN4, KIAA1260, AUTSX2",300427,Xp22.33,Psychiatric
174,"Autoimmune lymphoproliferative syndrome, 601859 (3)","TNFRSF6, APT1, FAS, CD95, ALPS1A",134637,10q24.1,Immunological
174,"Autoimmune lymphoproliferative syndrome, type IA, 601859 (3)","TNFRSF6, APT1, FAS, CD95, ALPS1A",134637,10q24.1,Immunological
174,"Autoimmune lymphoproliferative syndrome, type II, 603909 (3)","CASP10, MCH4, ALPS2",601762,2q33-q34,Immunological
174,"Autoimmune lymphoproliferative syndrome, type IIB, 607271 (3)","CASP8, MCH5",601763,2q33-q34,Immunological
174,"Autoimmune polyglandular disease, type I, 240300 (3)","AIRE, APECED",607358,21q22.3,Immunological
2174,"Autoimmune thyroid disease, susceptibility to 3, 608175 (3)","TG, AITD3",188450,8q24.2-q24.3,Endocrine
175,Autonomic nervous system dysfunction (3),DRD4,126452,11p15.5,Psychiatric
177,Axenfeld anomaly (3),"FOXC1, FKHL7, FREAC3",601090,6p25,Ophthamological
178,Azoospermia (3),"USP9Y, DFFRY",400005,Yq11.2,Endocrine
178,"Azoospermia due to perturbations of meiosis, 270960 (3)","SYCP3, SCP3, COR1",604759,12q23,Endocrine
180,"Bamforth-Lazarus syndrome, 241850 (3)","FOXE1, FKHL15, TITF2, TTF2",602617,9q22,Endocrine
182,"Bannayan-Riley-Ruvalcaba syndrome, 153480 (3)","PTEN, MMAC1",601728,10q23.31,Unclassified
182,"Bannayan-Zonana syndrome, 153480 (3)","PTEN, MMAC1",601728,10q23.31,Unclassified
183,"Bardet-Biedl syndrome 1, 209900 (3)",BBS1,209901,11q13,multiple
183,"Bardet-Biedl syndrome 1, modifier of, 209900 (3)","ARL6, BBS3",608845,3p12-q13,multiple
183,"Bardet-Biedl syndrome, 209900 (3)",BBS7,607590,4q27,multiple
183,"Bardet-Biedl syndrome 2, 209900 (3)",BBS2,606151,16q21,multiple
183,"Bardet-Biedl syndrome 3, 600151 (3)","ARL6, BBS3",608845,3p12-q13,multiple
183,"Bardet-Biedl syndrome 4, 209900 (3)",BBS4,600374,15q22.3-q23,multiple
183,"Bardet-Biedl syndrome 5, 209900 (3)",BBS5,603650,2q31,multiple
183,"Bardet-Biedl syndrome 6, 209900 (3)","MKKS, HMCS, KMS, MKS, BBS6",604896,20p12,multiple
183,"Bardet-Biedl syndrome 8, 209900 (3)","TTC8, BBS8",608132,14q32.1,multiple
184,"Bare lymphocyte syndrome, type I, 604571 (3)","TAPBP, TPSN",601962,6p21.3,Immunological
184,"Bare lymphocyte syndrome, type I, due to TAP2 deficiency, 604571 (3)","TAP2, ABCB3, PSF2, RING11",170261,6p21.3,Immunological
184,"Bare lymphocyte syndrome, type II, complementation group A, 209920 (3)","MHC2TA, C2TA",600005,16p13,Immunological
184,"Bare lymphocyte syndrome, type II, complementation group C, 209920 (3)",RFX5,601863,1q21.1-q21.3,Immunological
184,"Bare lymphocyte syndrome, type II, complementation group D, 209920 (3)",RFXAP,601861,13q14,Immunological
184,"Bare lymphocyte syndrome, type II, complementation group E, 209920 (3)",RFX5,601863,1q21.1-q21.3,Immunological
185,"Barth syndrome, 302060 (3)","TAZ, EFE2, BTHS, CMD3A, LVNCX",300394,Xq28,multiple
186,"Bart-Pumphrey syndrome, 149200 (3)","GJB2, CX26, DFNB1, PPK, DFNA3, KID,
HID",121011,13q11-q12,multiple
187,"Bartter syndrome, type 1, 601678 (3)","SLC12A1, NKCC2",600839,15q15-q21.1,multiple
187,"Bartter syndrome, type 2, 241200 (3)","KCNJ1, ROMK1",600359,11q24,multiple
187,"Bartter syndrome, type 3, 607364 (3)",CLCNKB,602023,1p36,multiple
187,"Bartter syndrome, type 4, 602522 (3)",BSND,606412,1p31,multiple
187,"Bartter syndrome, type 4, digenic, 602522 (3)",CLCNKA,602024,1p36,multiple
187,"Bartter syndrome, type 4, digenic, 602522 (3)",CLCNKB,602023,1p36,multiple
188,Basal cell carcinoma (3),"RASA1, GAP, CMAVM, PKWS",139150,5q13.3,Cancer
188,"Basal cell carcinoma, somatic, 605462 (3)",PTCH2,603673,1p32,Cancer
188,"Basal cell carcinoma, somatic, 605462 (3)","PTCH, NBCCS, BCNS, HPE7",601309,9q22.3,Cancer
188,"Basal cell carcinoma, sporadic (3)","SMOH, SMO",601500,7q31-q32,Cancer
2188,"Basal cell nevus syndrome, 109400 (3)","PTCH, NBCCS, BCNS, HPE7",601309,9q22.3,multiple
4188,"Basal ganglia disease, adult-onset, 606159 (3)",FTL,134790,19q13.3-q13.4,Neurological
4188,"Basal ganglia disease, biotin-responsive, 607483 (3)",SLC19A3,606152,2q36.3,Neurological
190,"B-cell non-Hodgkin lymphoma, high-grade (3)","BCL7A, BCL7",601406,12q24.1,Cancer
191,"BCG infection, generalized familial (3)",IFNGR1,107470,6q23-q24,Immunological
192,"Beare-Stevenson cutis gyrata syndrome, 123790 (3)","FGFR2, BEK, CFD1, JWS",176943,10q26,multiple
193,"Becker muscular dystrophy, 300376 (3)","DMD, BMD",300377,Xp21.2,Muscular
193,"Becker muscular dystrophy modifier, 310200 (3)",MYF6,159991,12q21,Muscular
194,"Beckwith-Wiedemann syndrome, 130650 (3)","CDKN1C, KIP2, BWS",600856,11p15.5,multiple
194,"Beckwith-Wiedemann syndrome, 130650 (3)","H19, D11S813E, ASM1, BWS",103280,11p15.5,multiple
194,"Beckwith-Wiedemann syndrome, 130650 (3)","KCNQ10T1, LIT1",604115,11p15.5,multiple
194,"Beckwith-Wiedemann syndrome, 130650 (3)","NSD1, ARA267, STO",606681,5q35,multiple
195,"Benzene toxicity, susceptibility to (3)","NQO1, DIA4, NMOR1",125860,16q22.1,Unclassified
196,"Bernard-Soulier syndrome, 231200 (3)",GP1BA,606672,17pter-p12,Hematological
196,"Bernard-Soulier syndrome, type B, 231200 (3)",GP1BB,138720,22q11.2,Hematological
196,"Bernard-Soulier syndrome, type C (3)",GP9,173515,Chr.3,Hematological
197,"Beryllium disease, chronic, susceptibility to (3)",HLA-DPB1,142858,6p21.3,Unclassified
198,"Beta-2-adrenoreceptor agonist, reduced response to (3)",ADRB2,109690,5q32-q34,Unclassified
199,Beta-ureidopropionase deficiency (3),"UPB1, BUP1",606673,22q11.2,Metabolic
200,"Bethlem myopathy, 158810 (3)","COL6A1, OPLL",120220,21q22.3,Muscular
200,"Bethlem myopathy, 158810 (3)",COL6A2,120240,21q22.3,Muscular
200,"Bethlem myopathy, 158810 (3)",COL6A3,120250,2q37,Muscular
201,"Bietti crystalline corneoretinal dystrophy, 210370 (3)","CYP4V2, BCD",608614,4q35.1,Ophthamological
202,"Bile acid malabsorption, primary (3)","SLC10A2, NTCP2",601295,13q33,Gastrointestinal
203,"Biotinidase deficiency, 253260 (3)",BTD,609019,3p25,Metabolic
204,"Bipolar disorder, susceptibility to, 125480 (3)","XBP1, XBP2",194355,22q12,Psychiatric
205,"Birt-Hogg-Dube syndrome, 135150 (3)","FLCN, BHD",607273,17p11.2,Dermatological
207,"Bladder cancer, 109800 (3)","FGFR3, ACH",134934,4p16.3,Cancer
207,"Bladder cancer, 109800 (3)","KRAS2, RASK2",190070,12p12.1,Cancer
207,"Bladder cancer, 109800 (3)",RB1,180200,13q14.1-q14.2,Cancer
207,"Bladder cancer, somatic, 109800 (3)",HRAS,190020,11p15.5,Cancer
208,"Blau syndrome, 186580 (3)","CARD15, NOD2, IBD1, CD, ACUG,
PSORAS1",605956,16q12,multiple
209,Bleeding disorder due to defective thromboxane A2 receptor (3),TBXA2R,188070,19p13.3,Hematological
209,"Bleeding due to platelet ADP receptor defect, 600515 (3)","P2RX1, P2X1",600845,17p13.3,Hematological
210,"Blepharophimosis, epicanthus inversus, and ptosis, type 1, 110100 (3)","FOXL2, BPES, BPES1, PFRK, POF3",605597,3q23,multiple
210,"Blepharophimosis, epicanthus inversus, and ptosis, type 2, 110100 (3)","FOXL2, BPES, BPES1, PFRK, POF3",605597,3q23,multiple
211,"Blepharospasm, primary benign, 606798 (3)","DRD5, DRD1B, DRD1L2",126453,4p16.1-p15.3,Ophthamological
212,"Blood group, ABO system (3)",ABO,110300,9q34,Hematological
212,"Blood group, Auberger system (3)","LU, AU, BCAM",111200,19q13.2,Hematological
212,"Blood group, Colton, 110450 (3)","AQP1, CHIP28, CO",107776,7p14,Hematological
212,Blood group Cromer (3),DAF,125240,1q32,Hematological
212,"Blood group, Diego, 110500 (3)","SLC4A1, AE1, EPB3",109270,17q21-q22,Hematological
212,"Blood group, Dombrock (3)","ART4, DO",110600,12p13-p12,Hematological
212,"Blood group, Gerbich (3)","GYPC, GE, GPC",110750,2q14-q21,Hematological
212,"Blood group GIL, 607457 (3)",AQP3,600170,9p13,Hematological
212,"Blood group, Ii, 110800 (3)",GCNT2,600429,6p24-p23,Hematological
212,"Blood group, Indian system (3)","CD44, MDU2, MDU3, MIC4",107269,11pter-p13,Hematological
212,"Blood group, Kell (3)",KEL,110900,7q33,Hematological
212,"Blood group, Kidd (3)","SLC14A1, JK, UTE, UT1",111000,18q11-q12,Hematological
212,"Blood group, Knops system, 607486 (3)","CR1, C3BR",120620,1q32,Hematological
212,"Blood group, Landsteiner-Wiener (3)",LW,111250,19p13.3,Hematological
212,"Blood group, Lewis (3)","FUT3, LE",111100,19p13.3,Hematological
212,"Blood group, Lutheran system (3)","LU, AU, BCAM",111200,19q13.2,Hematological
212,"Blood group, MN (3)","GYPA, MN, GPA",111300,4q28.2-q31.1,Hematological
212,"Blood group, OK, 111380 (3)",BSG,109480,19p13.3,Hematological
212,"Blood group, P system, 111400 (3)","A4GALT, PK",607922,22q13.2,Hematological
212,"Blood group, P system, 111400 (3)","B3GALT3, GLCT3, P",603094,3q25,Hematological
212,"Blood group, Rhesus (3)",RHCE,111700,1p36.2-p34,Hematological
212,"Blood group, Ss (3)","GYPB, SS, MNS",111740,4q28-q31,Hematological
212,"Blood group, Waldner, 112010 (3)","SLC4A1, AE1, EPB3",109270,17q21-q22,Hematological
212,"Blood group, Wright, 112050 (3)","SLC4A1, AE1, EPB3",109270,17q21-q22,Hematological
212,"Blood group, XG system (3)",XG,314700,Xpter-p22.32,Hematological
212,"Blood group, Yt system, 112100 (3)","ACHE, YT",100740,7q22,Hematological
213,"Bloom syndrome, 210900 (3)","RECQL3, RECQ2, BLM, BS",604610,15q26.1,Cancer
214,"Blue-cone monochromacy, 303700 (3)","OPN1LW, RCP, CBP, CBBM",303900,Xq28,Ophthamological
214,"Blue-cone monochromacy, 303700 (3)","OPN1MW, GCP, CBD, CBBM",303800,Xq28,Ophthamological
216,Bombay phenotype (3),"FUT1, H, HH",211100,19q13.3,Hematological
216,Bombay phenotype (3),"FUT2, SE",182100,19q13.3,Hematological
217,"Bone mineral density variability 1, 601884 (3)","LRP5, BMND1, LRP7, LR3, OPPG,
VBCH2",603506,11q13.4,Bone
218,"Borjeson-Forssman-Lehmann syndrome, 301900 (3)","PHF6, BFLS",300414,Xq26.3,multiple
220,"Bosley-Salih-Alorainy syndrome, 601536 (3)","HOXA1, HOX1F, BSAS",142955,7p15.3,Neurological
221,"Bothnia retinal dystrophy, 607475 (3)",RLBP1,180090,15q26,Ophthamological
224,"Brachydactyly, type A1, 112500 (3)","IHH, BDA1",600726,2q33-q35,Skeletal
224,"Brachydactyly, type A2, 112600 (3)","BMPR1B, ALK6",603248,4q23-q24,Skeletal
224,"Brachydactyly, type B1, 113000 (3)","ROR2, BDB1, BDB, NTRKR2",602337,9q22,Skeletal
224,"Brachydactyly, type C, 113100 (3)","GDF5, CDMP1",601146,20q11.2,Skeletal
224,"Brachydactyly, type D, 113200 (3)","HOXD13, HOX4I, SPD",142989,2q31-q32,Skeletal
224,"Brachydactyly, type E, 113300 (3)","HOXD13, HOX4I, SPD",142989,2q31-q32,Skeletal
225,"Bradyopsia, 608415 (3)","R9AP, RGS9, PERRS",607814,19q13.11,Ophthamological
225,"Bradyopsia, 608415 (3)","RGS9, PERRS",604067,17q23-q24,Ophthamological
226,Branchiootic syndrome (3),"EYA1, BOR",601653,8q13.3,Neurological
226,"Branchiootorenal syndrome, 113650 (3)","EYA1, BOR",601653,8q13.3,Neurological
226,"Branchiootorenal syndrome with cataract, 113650 (3)","EYA1, BOR",601653,8q13.3,Neurological
228,"Breast and colorectal cancer, susceptibility to (3)","CHEK2, RAD53, CHK2, CDS1, LFS2",604373,22q12.1,Cancer
228,"Breast cancer, 114480 (3)",PIK3CA,171834,3q26.3,Cancer
228,"Breast cancer, 114480 (3)","PPM1D, WIP1",605100,17q22-q23,Cancer
228,"Breast cancer, 114480 (3)","SLC22A1L, BWSCR1A, IMPT1",602631,11p15.5,Cancer
228,"Breast cancer, 114480 (3)","TP53, P53, LFS1",191170,17p13.1,Cancer
228,Breast cancer-1 (3),"BRCA1, PSCP",113705,17q21,Cancer
228,"Breast cancer 2, early onset (3)","BRCA2, FANCD1",600185,13q12.3,Cancer
228,Breast cancer (3),TSG101,601387,11p15.2-p15.1,Cancer
228,"Breast cancer, early-onset, 114480 (3)","BRIP1, BACH1, FANCJ",605882,17q22,Cancer
228,"Breast cancer, invasive intraductal (3)","RAD54L, HR54, HRAD54",603615,1p32,Cancer
228,"Breast cancer, lobular (3)","CDH1, UVO",192090,16q22.1,Cancer
228,"Breast cancer, male, susceptibility to, 114480 (3)","BRCA2, FANCD1",600185,13q12.3,Cancer
228,"Breast cancer, male, with Reifenstein syndrome (3)","AR, DHTR, TFM, SBMA, KD, SMAX1",313700,Xq11-q12,Cancer
228,"Breast cancer, somatic, 114480 (3)","KRAS2, RASK2",190070,12p12.1,Cancer
228,"Breast cancer, somatic, 114480 (3)","RB1CC1, CC1, KIAA0203",606837,8q11,Cancer
228,"Breast cancer, sporadic (3)",PHB,176705,17q21,Cancer
228,"Breast cancer, susceptibility to, 114480 (3)","ATM, ATA, AT1",607585,11q22.3,Cancer
228,"Breast cancer, susceptibility to, 114480 (3)",BARD1,601593,2q34-q35,Cancer
228,"Breast cancer, susceptibility to, 114480 (3)","CHEK2, RAD53, CHK2, CDS1, LFS2",604373,22q12.1,Cancer
228,"Breast cancer, susceptibility to, 114480 (3)","RAD51A, RECA",179617,15q15.1,Cancer
228,"Breast cancer, susceptibility to (3)",XRCC3,600675,14q32.3,Cancer
228,Breast-ovarian cancer (3),"BRCA1, PSCP",113705,17q21,Cancer
231,"Brody myopathy, 601003 (3)","ATP2A1, SERCA1",108730,16p12,Muscular
233,"Bruck syndrome 2, 609220 (3)",PLOD2,601865,3q23-q24,Unclassified
234,"Brugada syndrome, 601144 (3)","SCN5A, LQT3, IVF, HB1, SSS1",600163,3p21,Cardiovascular
235,Brunner syndrome (3),MAOA,309850,Xp11.23,Unclassified
237,"Burkitt lymphoma, 113970 (3)",MYC,190080,8q24.12-q24.13,Cancer
238,"Buschke-Ollendorff syndrome, 166700 (3)","LEMD3, MAN1",607844,12q14,multiple
239,"Butterfly dystrophy, retinal, 169150 (3)","RDS, RP7, PRPH2, PRPH, AVMD,
AOFMD",179605,6p21.1-cen,Ophthamological
240,"C1q deficiency, type A (3)",C1QA,120550,1p36.3-p34.1,Immunological
240,"C1q deficiency, type B (3)",C1QB,120570,1p36.3-p34.1,Immunological
240,"C1q deficiency, type C (3)",C1QG,120575,1p36.3-p34.1,Immunological
240,"C1s deficiency, isolated (3)",C1S,120580,12p13,Immunological
240,C2 deficiency (3),C2,217000,6p21.3,Immunological
240,C3b inactivator deficiency (3),IF,217030,4q25,Immunological
240,C3 deficiency (3),C3,120700,19p13.3-p13.2,Immunological
240,C4 deficiency (3),"C4A, C4S",120810,6p21.3,Immunological
240,C4 deficiency (3),"C4B, C4F",120820,6p21.3,Immunological
240,C6 deficiency (3),C6,217050,5p13,Immunological
240,C7 deficiency (3),C7,217070,5p13,Immunological
240,"C8 deficiency, type II (3)",C8B,120960,1p32,Immunological
240,C9 deficiency (3),C9,120940,5p13,Immunological
240,C9 deficiency with dermatomyositis (3),C9,120940,5p13,Immunological
252,"Cafe-au-lait spots, multiple, with leukemia, 114030 (3)","MSH2, COCA1, FCC1, HNPCC1",609309,2p22-p21,Cancer
252,"Cafe-au-lait spots with glioma or leukemia, 114030 (3)","MLH1, COCA2, HNPCC2",120436,3p21.3,Cancer
253,"Caffey disease, 114000 (3)",COL1A1,120150,17q21.31-q22,Connective tissue
254,"Calcinosis, tumoral, 211900 (3)","FGF23, ADHR, HPDR2, PHPTC",605380,12p13.3,Bone
254,"Calcinosis, tumoral, 211900 (3)",GALNT3,601756,2q24-q31,Bone
255,"Campomelic dysplasia, 114290 (3)","SOX9, CMD1, SRA1",608160,17q24.3-q25.1,Skeletal
255,"Campomelic dysplasia with autosomal sex reversal, 114290 (3)","SOX9, CMD1, SRA1",608160,17q24.3-q25.1,Skeletal
256,"Camptodactyly-arthropathy-coxa vara-pericarditis syndrome, 208250 (3)","PRG4, CACP, MSF, SZP, HAPO",604283,1q24-q25,Skeletal
257,"Camurati-Engelmann disease, 131300 (3)","TGFB1, DPD1, CED",190180,19q13.1,Skeletal
258,"Canavan disease, 271900 (3)",ASPA,608034,17pter-p13,Metabolic
259,Cancer progression/metastasis (3),FGFR4,134935,5q35.1-qter,Cancer
259,Cancer susceptibility (3),"MSH6, GTBP, HNPCC5",600678,2p16,Cancer
261,"Capillary malformation-arteriovenous malformation, 608354 (3)","RASA1, GAP, CMAVM, PKWS",139150,5q13.3,Cardiovascular
262,"Carbamoylphosphate synthetase I deficiency, 237300 (3)",CPS1,608307,2q35,Metabolic
263,"Carbohydrate-deficient glycoprotein syndrome, type I, 212065 (3)","PMM2, CDG1",601785,16p13.3-p13.2,Metabolic
263,"Carbohydrate-deficient glycoprotein syndrome, type Ib, 602579 (3)","MPI, PMI1",154550,15q22-qter,Metabolic
263,"Carbohydrate-deficient glycoprotein syndrome, type II, 212066 (3)","MGAT2, CDGS2",602616,14q21,Metabolic
264,"Carboxypeptidase N deficiency, 212070 (3)","CPN1, SCPN, CPN",603103,10q24.2,Hematological
2265,Carcinoid tumor of lung (3),MEN1,131100,11q13,Cancer
265,"Carcinoid tumors, intestinal, 114900 (3)","SDHD, PGL1",602690,11q23,Cancer
267,"Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency,
604377 (3)",SCO2,604272,22q13,Cardiovascular
268,"Cardiomyopathy, Familial hypertrophic, 8, 608751 (3)","MYL3, CMH8",160790,3p,Cardiovascular
268,"Cardiomyopathy, dilated, 115200 (3)",ACTC,102540,15q14,Cardiovascular
268,"Cardiomyopathy, dilated, 115200 (3)","MYH7, CMH1, MPD1",160760,14q12,Cardiovascular
268,"Cardiomyopathy, dilated, 1A, 115200 (3)","LMNA, LMN1, EMD2, FPLD, CMD1A,
HGPS, LGMD1B",150330,1q21.2,Cardiovascular
268,"Cardiomyopathy, dilated, 1D, 601494 (3)","TNNT2, CMH2, CMD1D",191045,1q32,Cardiovascular
268,"Cardiomyopathy, dilated, 1G, 604145 (3), Tibial muscular dystrophy, tardive, 600334 (3) TTN, CMD1G, TMD, LGMD2J",,188840,2q24.3,Cardiovascular
268,"Cardiomyopathy, dilated, 1I, 604765 (3)","DES, CMD1I",125660,2q35,Cardiovascular
268,"Cardiomyopathy, dilated, 1J, 605362 (3)","EYA4, DFNA10, CMD1J",603550,6q23,Cardiovascular
268,"Cardiomyopathy, dilated, 1L, 606685 (3)","SGCD, SGD, LGMD2F, CMD1L",601411,5q33,Cardiovascular
268,"Cardiomyopathy, dilated, 1M, 607482 (3)","CSRP3, CRP3, CLP, CMD1M",600824,11p15.1,Cardiovascular
268,"Cardiomyopathy, dilated, 1N, 607487 (3)","TCAP, LGMD2G, CMD1N",604488,17q12,Cardiovascular
268,"Cardiomyopathy, dilated, with ventricular tachycardia, 608569 (3)","ABCC9, SUR2",601439,12p12.1,Cardiovascular
268,"Cardiomyopathy, dilated, X-linked, 302045 (3)","DMD, BMD",300377,Xp21.2,Cardiovascular
268,"Cardiomyopathy, familial hypertrophic, 10, 608758 (3)","MYL2, CMH10",160781,12q23-q24.3,Cardiovascular
268,"Cardiomyopathy, familial hypertrophic, 1, 192600 (3)","MYH7, CMH1, MPD1",160760,14q12,Cardiovascular
268,"Cardiomyopathy, familial hypertrophic, 192600 (3)",ACTC,102540,15q14,Cardiovascular
268,"Cardiomyopathy, familial hypertrophic, 192600 (3)","CAV3, LGMD1C",601253,3p25,Cardiovascular
268,"Cardiomyopathy, familial hypertrophic, 192600 (3)","MYH6, ASD3, MYHCA",160710,14q12,Cardiovascular
268,"Cardiomyopathy, familial hypertrophic, 192600 (3) ()",TNNC1,191040,3p21.3-p14.3,Cardiovascular
268,"Cardiomyopathy, familial hypertrophic, 2, 115195 (3)","TNNT2, CMH2, CMD1D",191045,1q32,Cardiovascular
268,"Cardiomyopathy, familial hypertrophic, 3, 115196 (3)","TPM1, CMH3",191010,15q22.1,Cardiovascular
268,"Cardiomyopathy, familial hypertrophic (3)",TNNI3,191044,19q13.4,Cardiovascular
268,"Cardiomyopathy, familial hypertrophic, 4, 115197 (3)","MYBPC3, CMH4",600958,11p11.2,Cardiovascular
268,"Cardiomyopathy, familial hypertrophic, 9 (3)","TTN, CMD1G, TMD, LGMD2J",188840,2q24.3,Cardiovascular
268,"Cardiomyopathy, familial restrictive, 115210 (3)",TNNI3,191044,19q13.4,Cardiovascular
268,"Cardiomyopathy, hypertrophic, early-onset fatal (3)",COX15,603646,10q24,Cardiovascular
268,"Cardiomyopathy, hypertrophic, mid-left ventricular chamber type, 608758 (3)","MYL2, CMH10",160781,12q23-q24.3,Cardiovascular
268,"Cardiomyopathy, hypertrophic, midventricular, digenic, 192600 (3)","MYLK2, MLCK",606566,20q13.3,Cardiovascular
268,"Cardiomyopathy, hypertrophic, with WPW, 600858 (3)","PRKAG2, WPWS",602743,7q36,Cardiovascular
268,"Cardiomyopathy, idiopathic dilated, 115200 (3)","PLN, PLB",172405,6q22.1,Cardiovascular
268,"Cardiomyopathy, X-linked dilated, 300069 (3)","TAZ, EFE2, BTHS, CMD3A, LVNCX",300394,Xq28,Cardiovascular
269,"Carney complex, type 1, 160980 (3)","PRKAR1A, TSE1, CNC1, CAR",188830,17q23-q24,multiple
269,"Carney complex variant, 608837 (3)",MYH8,160741,17p13.1,multiple
271,Carnitine-acylcarnitine translocase deficiency (3),"SLC25A20, CACT, CAC",212138,3p21.31,Metabolic
272,"Carnitine deficiency, systemic primary, 212140 (3)","SLC22A5, OCTN2, CDSP, SCD",603377,5q31.1,Metabolic
275,"Carpal tunnel syndrome, familial (3)","TTR, PALB",176300,18q11.2-q12.1,Unclassified
276,"Cartilage-hair hypoplasia, 250250 (3)","RMRP, RMRPR, CHH",157660,9p21-p12,Skeletal
277,"Cataract, autosomal dominant nuclear (3)","CRYAA, CRYA1",123580,21q22.3,Ophthamological
277,"Cataract, cerulean, type 2, 601547 (3)","CRYBB2, CRYB2",123620,22q11.2-q12.2,Ophthamological
277,"Cataract, congenital (3)",PITX3,602669,10q25,Ophthamological
277,"Cataract, congenital, 604219 (3)","BFSP2, CP49, CP47",603212,3q21-q25,Ophthamological
277,"Cataract, congenital progressive, autosomal recessive (3)","CRYAA, CRYA1",123580,21q22.3,Ophthamological
277,"Cataract, congenital, with late-onset corneal dystrophy (3)","PAX6, AN2, MGDA",607108,11p13,Ophthamological
277,"Cataract, congenital zonular, with sutural opacities, 600881 (3)","CRYBA1, CRYB1",123610,17q11.1-q12,Ophthamological
277,"Cataract, Coppock-like, 604307 (3)","CRYGC, CRYG3, CCL",123680,2q33-q35,Ophthamological
277,"Cataract, cortical pulverulent, late-onset (3)","LIM2, MP19",154045,19q13.4,Ophthamological
277,"Cataract, crystalline aculeiform, 115700 (3)","CRYGD, CRYG4",123690,2q33-q35,Ophthamological
277,"Cataract, juvenile-onset, 604219 (3)","BFSP2, CP49, CP47",603212,3q21-q25,Ophthamological
277,"Cataract, lamellar, 116800 (3)","HSF4, CTM",602438,16q21-q22.1,Ophthamological
277,"Cataract, Marner type, 116800 (3)","HSF4, CTM",602438,16q21-q22.1,Ophthamological
277,"Cataract, polymorphic and lamellar, 604219 (3)","MIP, AQP0",154050,12q13,Ophthamological
277,"Cataract, posterior polar 2 (3)","CRYAB, CRYA2, CTPP2",123590,11q22.3-q23.1,Ophthamological
277,"Cataract, pulverulent (3)",CRYBB1,600929,22q11.2-q12.1,Ophthamological
277,"Cataracts, punctate, progressive juvenile-onset (3)","CRYGD, CRYG4",123690,2q33-q35,Ophthamological
277,"Cataract, sutural, with punctate and cerulean opacities, 607133 (3)","CRYBB2, CRYB2",123620,22q11.2-q12.2,Ophthamological
277,"Cataract, variable zonular pulverulent (3)","CRYGC, CRYG3, CCL",123680,2q33-q35,Ophthamological
277,"Cataract, zonular central nuclear, autosomal dominant (3)","CRYAA, CRYA1",123580,21q22.3,Ophthamological
277,"Cataract, zonular pulverulent-1, 116200 (3)","GJA8, CX50, CAE1",600897,1q21.1,Ophthamological
277,"Cataract, zonular pulverulent-3, 601885 (3)","GJA3, CX46, CZP3, CAE3",121015,13q11,Ophthamological
279,"Cavernous malformations of CNS and retina, 116860 (3)","CCM1, CAM, KRIT1",604214,7q11.2-q21,Cardiovascular
283,CD59 deficiency (3),"CD59, MIC11",107271,11p13,Immunological
284,"CD8 deficiency, familial, 608957 (3)",CD8A,186910,2p12,Immunological
2287,"Central core disease, 117000 (3)","RYR1, MHS, CCO",180901,19q13.1,Muscular
2287,"Central core disease, one form (3) ()","MYH7, CMH1, MPD1",160760,14q12,Muscular
287,"Central hypoventilation syndrome, 209880 (3)",GDNF,600837,5p13.1-p12,Respiratory
287,"Central hypoventilation syndrome, congenital, 209880 (3)",BDNF,113505,11p13,Respiratory
287,"Central hypoventilation syndrome, congenital, 209880 (3)",EDN3,131242,20q13.2-q13.3,Respiratory
287,"Central hypoventilation syndrome, congenital, 209880 (3)","PMX2B, NBPHOX, PHOX2B",603851,4p12,Respiratory
287,"Central hypoventilation syndrome, congenital, 209880 (3)","RET, MEN2A",164761,10q11.2,Respiratory
289,"Cerebellar ataxia, 604290 (3)",CP,117700,3q23-q24,Neurological
289,"Cerebellar ataxia, pure (3)","CACNA1A, CACNL1A4, SCA6",601011,19p13,Neurological
4289,"Cerebellar hypoplasia, VLDLR-associated, 224050 (3)","VLDLR, VLDLRCH",192977,9p24,Neurological
291,"Cerebral amyloid angiopathy, 105150 (3)","ABCA1, ABC1, HDLDT1, TGD",600046,9q22-q31,Neurological
291,"Cerebral amyloid angiopathy, 105150 (3)",CST3,604312,20p11.2,Neurological
2291,"Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy, 125310 (3)","NOTCH3, CADASIL, CASIL",600276,19p13.2-p13.1,Cardiovascular
4291,"Cerebral cavernous malformations-1, 116860 (3)","CCM1, CAM, KRIT1",604214,7q11.2-q21,Neurological
4291,"Cerebral cavernous malformations-2, 603284 (3)","C7orf22, CCM2, MGC4067",607929,7p13,Neurological
4291,"Cerebral cavernous malformations 3, 603285 (3)","PDCD10, TFAR15, CCM3",609118,3q26.1,Neurological
6291,"Cerebral dysgenesis, neuropathy, ichthyosis, and palmoplantar keratoderma syndrome,
609528 (3)","SNAP29, CEDNIK",604202,22q11.2,Neurological
292,"Cerebrooculofacioskeletal syndrome, 214150 (3)","ERCC2, EM9",126340,19q13.2-q13.3,multiple
292,"Cerebrooculofacioskeletal syndrome, 214150 (3)","ERCC5, XPG",133530,13q33,multiple
292,Cerebrooculofacioskeletal syndrome 214150 (3),"ERCC6, CKN2, COFS, CSB",609413,10q11,multiple
293,"Cerebrotendinous xanthomatosis, 213700 (3)","CYP27A1, CYP27, CTX",606530,2q33-qter,Metabolic
294,"Cerebrovascular disease, occlusive (3)","SERPINA3, AACT, ACT",107280,14q32.1,Unclassified
295,"Ceroid lipofuscinosis, neuronal-1, infantile, 256730 (3)","PPT1, CLN1",600722,1p32,Neurological
296,"Ceroid-lipofuscinosis, neuronal 2, classic late infantile, 204500 (3)",CLN2,607998,11p15.5,Neurological
296,"Ceroid-lipofuscinosis, neuronal-3, juvenile, 204200 (3)","CLN3, BTS",607042,16p12.1,Neurological
296,"Ceroid-lipofuscinosis, neuronal-5, variant late infantile, 256731 (3)",CLN5,608102,13q21.1-q32,Neurological
296,"Ceroid-lipofuscinosis, neuronal-6, variant late infantile, 601780 (3)",CLN6,606725,15q21-q23,Neurological
296,"Ceroid lipofuscinosis, neuronal 8, 600143 (3)","CLN8, EPMR",607837,8pter-p22,Neurological
296,"Ceroid lipofuscinosis, neuronal, variant juvenile type, with granular osmiophilic deposits
(3)","PPT1, CLN1",600722,1p32,Neurological
298,"Cervical cancer, somatic, 603956 (3)","FGFR3, ACH",134934,4p16.3,Cancer
299,"CETP deficiency, 607322 (3)",CETP,118470,16q21,Metabolic
300,"Chanarin-Dorfman syndrome, 275630 (3)","ABHD5, CGI58, IECN2, NCIE2",604780,3p21,Metabolic
301,"Charcot-Marie-Tooth disease, axonal, type 2F, 606595 (3)","HSPB1, HSP27, CMT2F",602195,7q11.23,Neurological
301,"Charcot-Marie-Tooth disease, dominant intermediate 3, 607791 (3)","MPZ, CMT1B, CMTDI3, CHM, DSS",159440,1q22,Neurological
301,"Charcot-Marie-Tooth disease, dominant intermediate B, 606482 (3)",DNM2,602378,19p13.2,Neurological
301,"Charcot-Marie-Tooth disease, foot deformity of (3)","HOXD10, HOX4D",142984,2q31-q32,Neurological
301,"Charcot-Marie-Tooth disease, mixed axonal and demyelinating type, 214400 (3)","GDAP1, CMT4A, CMT2K, CMT2G",606598,8q13-q21.1,Neurological
301,"Charcot-Marie-Tooth disease, type 1A, 118220 (3)","PMP22, CMT1A, CMT1E, DSS",601097,17p11.2,Neurological
301,"Charcot-Marie-Tooth disease, type 1B, 118200 (3)","MPZ, CMT1B, CMTDI3, CHM, DSS",159440,1q22,Neurological
301,"Charcot-Marie-Tooth disease, type 1C, 601098 (3)","LITAF, CMT1C",603795,16p13.3-p12,Neurological
301,"Charcot-Marie-Tooth disease, type 1D, 607678 (3)","EGR2, KROX20",129010,10q21.1-q22.1,Neurological
301,"Charcot-Marie-Tooth disease, type 1E, 118300 (3)","PMP22, CMT1A, CMT1E, DSS",601097,17p11.2,Neurological
301,"Charcot-Marie-Tooth disease, type 1F, 607734 (3)","NEFL, CMT2E, CMT1F",162280,8p21,Neurological
301,"Charcot-Marie-Tooth disease, type 2A1, 118210 (3)","KIF1B, CMT2A, CMT2A1",605995,1p36.2,Neurological
301,"Charcot-Marie-Tooth disease, type 2A2, 609260 (3)","MFN2, KIAA0214, CMT2A2",608507,1p36.2,Neurological
301,"Charcot-Marie-Tooth disease, type 2B, 600882 (3)","RAB7, CMT2B, PSN",602298,3q21,Neurological
301,"Charcot-Marie-Tooth disease, type 2D, 601472 (3)","GARS, SMAD1, CMT2D",600287,7p15,Neurological
301,"Charcot-Marie-Tooth disease, type 2E, 607684 (3)","NEFL, CMT2E, CMT1F",162280,8p21,Neurological
301,"Charcot-Marie-Tooth disease, type 2G, 607706 (3)","GDAP1, CMT4A, CMT2K, CMT2G",606598,8q13-q21.1,Neurological
301,"Charcot-Marie-Tooth disease, type 2I, 607677 (3)","MPZ, CMT1B, CMTDI3, CHM, DSS",159440,1q22,Neurological
301,"Charcot-Marie-Tooth disease, type 2J, 607736 (3)","MPZ, CMT1B, CMTDI3, CHM, DSS",159440,1q22,Neurological
301,"Charcot-Marie-Tooth disease, type 2K, 607831 (3)","GDAP1, CMT4A, CMT2K, CMT2G",606598,8q13-q21.1,Neurological
301,"Charcot-Marie-Tooth disease, type 4A, 214400 (3)","GDAP1, CMT4A, CMT2K, CMT2G",606598,8q13-q21.1,Neurological
301,"Charcot-Marie-Tooth disease, type 4B1, 601382 (3)","MTMR2, CMT4B1",603557,11q22,Neurological
301,"Charcot-Marie-Tooth disease, type 4B2, 604563 (3)","SBF2, MTMR13, CMT4B2",607697,11p15,Neurological
301,"Charcot-Marie-Tooth disease, type 4B2, with early-onset glaucoma, 607739 (3)","SBF2, MTMR13, CMT4B2",607697,11p15,Neurological
301,"Charcot-Marie-Tooth disease, type 4C, 601596 (3)",KIAA1985,608206,5q32,Neurological
301,"Charcot-Marie-Tooth disease, type 4D, 601455 (3)","NDRG1, HMSNL, CMT4D",605262,8q24.3,Neurological
301,"Charcot-Marie-Tooth neuropathy, X-linked dominant, 1, 302800 (3)","GJB1, CX32, CMTX1",304040,Xq13.1,Neurological
302,"CHARGE syndrome, 214800 (3)",CHD7,608892,8q12.1,multiple
303,"Char syndrome, 169100 (3)","TFAP2B, CHAR",601601,6p12,multiple
304,"Chediak-Higashi syndrome, 214500 (3)","CHS1, LYST",606897,1q42.1-q42.2,multiple
305,"Cherubism, 118400 (3)","SH3BP2, CRPM",602104,4p16.3,Unclassified
306,"CHILD syndrome, 308050 (3)",NSDHL,300275,Xq28,Developmental
307,Chitotriosidase deficiency (3),CHIT,600031,1q31-q32,Metabolic
308,"Chloride diarrhea, congenital, Finnish type, 214700 (3)","SLC26A3, DRA, CLD",126650,7q22-q31.1,Gastrointestinal
309,"Cholelithiasis, 600803 (3)","ABCB4, PGY3, MDR3",171060,7q21.1,Gastrointestinal
310,"Cholestasis, benign recurrent intrahepatic, 243300 (3)","ATP8B1, FIC1, BRIC, PFIC1",602397,18q21,Gastrointestinal
310,"Cholestasis, familial intrahepatic, of pregnancy, 147480 (3)","ABCB4, PGY3, MDR3",171060,7q21.1,Gastrointestinal
310,"Cholestasis, progressive familial intrahepatic 1, 211600 (3)","ATP8B1, FIC1, BRIC, PFIC1",602397,18q21,Gastrointestinal
310,"Cholestasis, progressive familial intrahepatic 2, 601847 (3)","ABCB11, BSEP, SPGP, PFIC2",603201,2q24,Gastrointestinal
310,"Cholestasis, progressive familial intrahepatic 3, 602347 (3)","ABCB4, PGY3, MDR3",171060,7q21.1,Gastrointestinal
310,"Cholestasis, progressive familial intrahepatic 4, 607765 (3)","HSD3B7, PFIC4",607764,16p12-p11.2,Gastrointestinal
313,Cholesteryl ester storage disease (3),LIPA,278000,10q24-q25,Metabolic
314,"Chondrocalcinosis 2, 118600 (3)","ANKH, HANK, ANK, CMDJ, CCAL2,
CPPDD",605145,5p15.2-p14.1,"Connective tissue
disorder"
2315,"Chondrodysplasia, Grebe type, 200700 (3)","GDF5, CDMP1",601146,20q11.2,Skeletal
315,"Chondrodysplasia punctata, rhizomelic, type 2, 222765 (3)","GNPAT, DHAPAT",602744,1q42,Connective tissue
315,"Chondrodysplasia punctata, X-linked dominant, 302960 (3)","EBP, CDPX2, CPXD, CPX",300205,Xp11.23-p11.22,Connective tissue
315,"Chondrodysplasia punctata, X-linked recessive, 302950 (3)","ARSE, CDPX1, CDPXR",300180,Xp22.3,Connective tissue
316,"Chondrosarcoma, 215300 (3)",EXT1,608177,8q24.11-q24.13,Cancer
316,"Chondrosarcoma, extraskeletal myxoid (3)",CSMF,600542,9q22,Cancer
316,"Chondrosarcoma, extraskeletal myxoid (3)","EWSR1, EWS",133450,22q12,Cancer
318,"Chorea, hereditary benign, 118700 (3)","TITF1, NKX2A, TTF1",600635,14q13,Neurological
319,"Choreoacanthocytosis, 200150 (3)","VPS13A, CHAC",605978,9q21,Neurological
320,"Choreoathetosis, hypothyroidism, and respiratory distress (3)","TITF1, NKX2A, TTF1",600635,14q13,multiple
323,"Choroideremia, 303100 (3)","CHM, TCD",300390,Xq21.2,Ophthamological
326,"Chromosome 22q13.3 deletion syndrome, 606232 (3)","PSAP2, PROSAP2, KIAA1650",606230,22q13.3,multiple
327,"Chronic granulomatous disease, autosomal, due to deficiency of CYBA, 233690 (3)",CYBA,608508,16q24,Immunological
327,"Chronic granulomatous disease due to deficiency of NCF-1, 233700 (3)",NCF1,608512,7q11.23,Immunological
327,"Chronic granulomatous disease due to deficiency of NCF-2, 233710 (3)",NCF2,608515,1q25,Immunological
327,"Chronic granulomatous disease, X-linked, 306400 (3)","CYBB, CGD",300481,Xp21.1,Immunological
2327,"Chronic infections, due to opsonin defect (3)","MBL2, MBL, MBP1",154545,10q11.2-q21,Immunological
328,"Chudley-Lowry syndrome, 309490 (3)","ATRX, XH2, XNP, MRXS3, SHS",300032,Xq13,multiple
329,"Chylomicronemia syndrome, familial (3)","LPL, LIPD",238600,8p22,Metabolic
330,"Chylomicron retention disease, 246700 (3)","SARA2, SAR1B, CMRD",607690,5q31.1,Gastrointestinal
330,"Chylomicron retention disease with Marinesco-Sjogren syndrome, 607692 (3)","SARA2, SAR1B, CMRD",607690,5q31.1,Gastrointestinal
331,"Ciliary dyskinesia, primary, 1, 242650 (3)","DNAI1, CILD1, ICS, PCD",604366,9p21-p13,Respiratory
331,"Ciliary dyskinesia, primary, 3 608644 (3)","DNAH5, HL1, PCD, CILD3",603335,5p15-p14,Respiratory
332,"CINCA syndrome, 607115 (3)","CIAS1, C1orf7, FCU, FCAS",606416,1q44,multiple
334,"Cirrhosis, cryptogenic (3)",KRT18,148070,12q13,Gastrointestinal
334,"Cirrhosis, cryptogenic (3)",KRT8,148060,12q13,Gastrointestinal
334,"Cirrhosis, noncryptogenic, susceptibility to, 215600 (3)",KRT18,148070,12q13,Gastrointestinal
334,"Cirrhosis, noncryptogenic, susceptibility to, 215600 (3)",KRT8,148060,12q13,Gastrointestinal
334,"Cirrhosis, North American Indian childhood type, 604901 (3)","CIRH1A, NAIC, TEX292, KIAA1988",607456,16q22,Gastrointestinal
335,"Citrullinemia, 215700 (3)",ASS,603470,9q34,Metabolic
335,"Citrullinemia, adult-onset type II, 603471 (3)","SLC25A13, CTLN2",603859,7q21.3,Metabolic
335,"Citrullinemia, type II, neonatal-onset, 605814 (3)","SLC25A13, CTLN2",603859,7q21.3,Metabolic
336,"Cleft lip/palate ectodermal dysplasia syndrome, 225000 (3)","HVEC, PVRL1, PVRR1, PRR1",600644,11q23-q24,Developmental
336,"Cleft lip/palate, nonsyndromic, 608874 (3)","MSX1, HOX7, HYD1, OFC5",142983,4p16.1,Developmental
336,"Cleft palate with ankyloglossia, 303400 (3)","TBX22, CPX",300307,Xq12-q21,Developmental
337,"Cleidocranial dysplasia, 119600 (3)","RUNX2, CBFA1, PEBP2A1, AML3",600211,6p21,Skeletal
338,"Coats disease, 300216 (3)","NDP, ND",310600,Xp11.4,Ophthamological
339,"Cockayne syndrome, type A, 216400 (3)","ERCC8, CKN1, CSA",609412,5q12,multiple
339,"Cockayne syndrome, type B, 133540 (3)","ERCC6, CKN2, COFS, CSB",609413,10q11,multiple
340,Codeine sensitivity (3),"CYP2D@, CYP2D, P450C2D",124030,22q13.1,Metabolic
341,"Coffin-Lowry syndrome, 303600 (3)","RPS6KA3, RSK2, MRX19",300075,Xp22.2-p22.1,multiple
342,"Cohen syndrome, 216550 (3)",COH1,607817,8q22-q23,multiple
343,Colchicine resistance (3),"ABCB1, PGY1, MDR1",171050,7q21.1,Unclassified
344,"Cold-induced autoinflammatory syndrome, familial, 120100 (3)","CIAS1, C1orf7, FCU, FCAS",606416,1q44,Immunological
2344,"Cold-induced sweating syndrome, 272430 (3)","CRLF1, CISS",604237,19p12,multiple
345,"Coloboma, ocular, 120200 (3)","PAX6, AN2, MGDA",607108,11p13,Ophthamological
345,"Coloboma, ocular, 120200 (3)","SHH, HPE3, HLP3, SMMCI",600725,7q36,Ophthamological
346,Colon adenocarcinoma (3),RAD54B,604289,8q21.3-q22,Cancer
346,Colon adenocarcinoma (3),"RAD54L, HR54, HRAD54",603615,1p32,Cancer
346,Colon cancer (3),BCL10,603517,1p22,Cancer
346,Colon cancer (3),"PTPN12, PTPG1",600079,7q11.23,Cancer
346,Colon cancer (3),"TGFBR2, HNPCC6",190182,3p22,Cancer
346,"Colon cancer, advanced (3)","SRC, ASV, SRC1",190090,20q12-q13,Cancer
346,"Colon cancer, hereditary nonpolypopsis, type 7 (3)","MLH3, HNPCC7",604395,14q24.3,Cancer
346,"Colon cancer, somatic, 114500 (3)","PTPRJ, DEP1",600925,11p11.2,Cancer
346,"Colonic adenoma recurrence, reduced risk of, 114500 (3)",ODC1,165640,2p25,Cancer
347,"Colonic aganglionosis, total, with small bowel involvement (3)","RET, MEN2A",164761,10q11.2,Gastrointestinal
348,"Colorblindness, deutan (3)","OPN1MW, GCP, CBD, CBBM",303800,Xq28,Ophthamological
348,"Colorblindness, protan (3)","OPN1LW, RCP, CBP, CBBM",303900,Xq28,Ophthamological
348,"Colorblindness, tritan (3)","OPN1SW, BCP, CBT",190900,7q31.3-q32,Ophthamological
346,"Colorectal adenomatous polyposis, autosomal recessive, with pilomatricomas, 132600
(3)",MUTYH,604933,1p34.3-p32.1,Cancer
346,"Colorectal cancer, 114500 (3)",AXIN2,604025,17q24,Cancer
346,"Colorectal cancer, 114500 (3)","BUB1B, BUBR1",602860,15q15,Cancer
346,"Colorectal cancer, 114500 (3)",EP300,602700,22q13,Cancer
346,"Colorectal cancer, 114500 (3)","PDGFRL, PDGRL, PRLTS",604584,8p22-p21.3,Cancer
346,"Colorectal cancer, 114500 (3)",PIK3CA,171834,3q26.3,Cancer
346,"Colorectal cancer, 114500 (3)","TP53, P53, LFS1",191170,17p13.1,Cancer
346,Colorectal cancer (3),"APC, GS, FPC",175100,5q21-q22,Cancer
346,Colorectal cancer (3),BAX,600040,19q13.3-q13.4,Cancer
346,Colorectal cancer (3),CTNNB1,116806,3p22-p21.3,Cancer
346,Colorectal cancer (3),DCC,120470,18q21.3,Cancer
346,Colorectal cancer (3),MCC,159350,5q21,Cancer
346,Colorectal cancer (3),NRAS,164790,1p13.2,Cancer
346,"Colorectal cancer, hereditary nonpolyposis, type 1, 120435 (3)","MSH2, COCA1, FCC1, HNPCC1",609309,2p22-p21,Cancer
346,"Colorectal cancer, hereditary nonpolyposis, type 2, 609310 (3)","MLH1, COCA2, HNPCC2",120436,3p21.3,Cancer
346,"Colorectal cancer, hereditary nonpolyposis, type 3 (3)","PMS1, PMSL1, HNPCC3",600258,2q31-q33,Cancer
346,"Colorectal cancer, hereditary nonpolyposis, type 4 (3)","PMS2, PMSL2, HNPCC4",600259,7p22,Cancer
346,"Colorectal cancer, hereditary nonpolyposis, type 5 (3)","MSH6, GTBP, HNPCC5",600678,2p16,Cancer
346,"Colorectal cancer, hereditary nonpolyposis, type 6 (3)","TGFBR2, HNPCC6",190182,3p22,Cancer
346,"Colorectal cancer, somatic, 109800 (3)","FGFR3, ACH",134934,4p16.3,Cancer
346,"Colorectal cancer, somatic, 114500 (3)","FLCN, BHD",607273,17p11.2,Cancer
346,"Colorectal cancer, somatic, 114500 (3)","MLH3, HNPCC7",604395,14q24.3,Cancer
346,"Colorectal cancer, somatic (3)",BRAF,164757,7q34,Cancer
346,"Colorectal cancer, somatic (3)",DLC1,604258,8p22-p21.3,Cancer
346,"Colorectal cancer, sporadic, 114500 (3)","PLA2G2A, PLA2B, PLA2L, MOM1",172411,1p35,Cancer
346,"Colorectal cancer, susceptibility to (3)","CCND1, PRAD1, BCL1",168461,11q13,Cancer
346,Colorectal cancer with chromosomal instability (3),BUB1,602452,2q14,Cancer
4350,Combined C6/C7 deficiency (3),C6,217050,5p13,Immunological
350,"Combined factor V and VIII deficiency, 227300 (3)","LMAN1, ERGIC53, F5F8D, MCFD1",601567,18q21.3-q22,Hematological
2350,"Combined hyperlipemia, familial (3)","LPL, LIPD",238600,8p22,Metabolic
4350,"Combined immunodeficiency, X-linked, moderate, 312863 (3)","IL2RG, SCIDX1, SCIDX, IMD4",308380,Xq13,Immunological
6350,"Combined oxidative phosphorylation deficiency, 609060 (3)","GFM1, EFG1, GFM",606639,3q25.1-q26.2,multiple
8350,Combined SAP deficiency (3),"PSAP, SAP1",176801,10q22.1,Metabolic
351,"Complex I, mitochondrial respiratory chain, deficiency of, 252010 (3)",NDUFS6,603848,5pter-p15.33,multiple
351,"Complex V, mitochondrial respiratory chain, deficiency of, 604273 (3)","ATPAF2, ATP12",608918,17p11.2,multiple
352,"Cone dystrophy-1, 304020 (3)","RPGR, RP3, CRD, RP15, COD1",312610,Xp21.1,Ophthamological
352,"Cone dystrophy-3, 602093 (3)","GUCA1A, GCAP",600364,6p21.1,Ophthamological
352,"Cone-rod dystrophy, 300029 (3)","RPGR, RP3, CRD, RP15, COD1",312610,Xp21.1,Ophthamological
352,Cone-rod dystrophy 3 (3),"ABCA4, ABCR, STGD1, FFM, RP19",601691,1p21-p13,Ophthamological
352,Cone-rod dystrophy (3),"AIPL1, LCA4",604392,17p13.1,Ophthamological
352,"Cone-rod dystrophy 6, 601777(3)","GUCY2D, GUC2D, LCA1, CORD6",600179,17p13.1,Ophthamological
352,"Cone-rod dystrophy 9, 608194 (3)","RPGRIP1, LCA6, CORD9",605446,14q11,Ophthamological
352,"Cone-rod retinal dystrophy-2, 120970 (3)","CRX, CORD2, CRD",602225,19q13.3,Ophthamological
2354,"Congenital bilateral absence of vas deferens, 277180 (3)","CFTR, ABCC7, CF, MRP7",602421,7q31.2,Unclassified
4354,"Congenital cataracts, facial dysmorphism, and neuropathy, 604168 (3)","CTDP1, FCP1, CCFDN",604927,18q23,Ophthamological
354,"Congenital disorder of glycosylation, type Ic, 603147 (3)",ALG6,604566,1p22.3,Metabolic
354,"Congenital disorder of glycosylation, type Id, 601110 (3)","ALG3, NOT56L, CDGS4",608750,3q27,Metabolic
354,"Congenital disorder of glycosylation, type Ie, 608799 (3)","DPM1, MPDS, CDGIE",603503,20q13.13,Metabolic
354,"Congenital disorder of glycosylation, type If, 609180 (3)","MPDU1, SL15, CDGIF",604041,17p13.1-p12,Metabolic
354,"Congenital disorder of glycosylation, type Ig, 607143 (3)",ALG12,607144,Chr.22,Metabolic
354,"Congenital disorder of glycosylation, type Ih, 608104 (3)",ALG8,608103,11pter-p15.5,Metabolic
354,"Congenital disorder of glycosylation, type Ii, 607906 (3)","ALG2, CDGII",607905,9q22,Metabolic
354,"Congenital disorder of glycosylation, type II, 608776 (3)","DIBD1, ALG9",606941,11q23,Metabolic
354,"Congenital disorder of glycosylation, type IIc, 266265 (3)","SLC35C1, FUCT1",605881,11p11.2,Metabolic
354,"Congenital disorder of glycosylation, type IId, 607091 (3)","B4GALT1, GGTB2, GT1, GTB",137060,9p13,Metabolic
354,"Congenital disorder of glycosylation, type IIe, 608779 (3)","COG7, CDG2E",606978,16p,Metabolic
354,"Congenital disorder of glycosylation, type Ij, 608093 (3)","DPAGT2, DGPT",191350,11q23.3,Metabolic
354,"Congenital disorder of glycosylation, type Ik, 608540 (3)","ALG1, HMAT1, HMT1",605907,16p13.3,Metabolic
355,"Congestive heart failure, susceptibility to (3)","ADRA2C, ADRA2L2",104250,4p16.1,Cardiovascular
355,"Congestive heart failure, susceptibility to (3)","ADRB1, ADRB1R, RHR",109630,10q24-q26,Cardiovascular
356,"Conjunctivitis, ligneous, 217090 (3)",PLG,173350,6q26,Ophthamological
357,"Conotruncal anomaly face syndrome, 217095 (3)","TBX1, DGS, CTHM, CAFS, TGA, DORV,
VCFS, DGCR",602054,22q11.2,Cardiovascular
358,"Contractural arachnodactyly, congenital (3)","FBN2, CCA",121050,5q23-q31,Connective tissue
359,"Convulsions, familial febrile, 4, 604352 (3)","MASS1, VLGR1, KIAA0686, FEB4,
USH2C",602851,5q14,Neurological
360,"COPD, rate of decline of lung function in, 606963 (3)","MMP1, CLG",120353,11q22-q23,Respiratory
361,Coproporphyria (3),CPO,121300,3q12,Metabolic
362,"Corneal clouding, autosomal recessive (3)",APOA1,107680,11q23,Ophthamological
362,"Corneal dystrophy, Avellino type, 607541 (3)","TGFBI, CSD2, CDGG1, CSD, BIGH3,
CDG2",601692,5q31,Ophthamological
362,"Corneal dystrophy, gelatinous drop-like, 204870 (3)","TACSTD2, TROP2, M1S1",137290,1p32,Ophthamological
362,"Corneal dystrophy, Groenouw type I, 121900 (3)","TGFBI, CSD2, CDGG1, CSD, BIGH3,
CDG2",601692,5q31,Ophthamological
362,"Corneal dystrophy, hereditary polymorphous posterior, 122000 (3)","VSX1, RINX, PPCD, PPD, KTCN",605020,20p11.2,Ophthamological
362,"Corneal dystrophy, hereditary polymorphous posterior, 2, 122000 (3)","COL8A2, FECD, PPCD2",120252,1p34.3-p32.3,Ophthamological
362,"Corneal dystrophy, lattice type I, 122200 (3)","TGFBI, CSD2, CDGG1, CSD, BIGH3,
CDG2",601692,5q31,Ophthamological
362,"Corneal dystrophy, lattice type IIIA, 608471 (3)","TGFBI, CSD2, CDGG1, CSD, BIGH3,
CDG2",601692,5q31,Ophthamological
362,"Corneal dystrophy, Reis-Bucklers type, 608470 (3)","TGFBI, CSD2, CDGG1, CSD, BIGH3,
CDG2",601692,5q31,Ophthamological
362,"Corneal dystrophy, Thiel-Behnke type, 602082 (3)","TGFBI, CSD2, CDGG1, CSD, BIGH3,
CDG2",601692,5q31,Ophthamological
362,"Corneal fleck dystrophy, 121850 (3)","PIP5K3, CFD",609414,2q35,Ophthamological
362,"Cornea plana congenita, recessive, 217300 (3)","KERA, CNA2",603288,12q22,Ophthamological
364,"Cornelia de Lange syndrome, 122470 (3)","NIPBL, CDLS",608667,5p13.1,Developmental
365,"Coronary artery disease, autosomal dominant, 1, 608320 (3)","MEF2A, ADCAD1",600660,15q26,Cardiovascular
365,"Coronary artery disease in familial hypercholesterolemia, protection against, 143890 (3)","ABCA1, ABC1, HDLDT1, TGD",600046,9q22-q31,Cardiovascular
365,"Coronary artery disease, susceptibility to (3)",KL,604824,13q12,Cardiovascular
365,"Coronary artery disease, susceptibility to (3)","PON1, PON, ESA",168820,7q21.3,Cardiovascular
365,"Coronary artery disease, susceptibility to (3)",PON2,602447,7q21.3,Cardiovascular
365,"Coronary artery spasm, susceptibility to (3)","PON1, PON, ESA",168820,7q21.3,Cardiovascular
365,"Coronary heart disease, susceptibility to (3)","MMP3, STMY1",185250,11q23,Cardiovascular
2365,"Coronary spasms, susceptibility to (3)",NOS3,163729,7q36,Cardiovascular
366,"Corpus callosum, agenesis of, with mental retardation, ocular coloboma and
micrognathia, 300472 (3)",IGBP1,300139,Xq13.1-q13.3,Neurological
367,Cortisol resistance (3),"NR3C1, GCR, GRL",138040,5q31,Endocrine
368,"Cortisone reductase deficiency, 604931 (3)",GDH,138090,1pter-p36.13,Metabolic
368,"Cortisone reductase deficiency, 604931 (3)","HSD11B1, HSD11, HSD11L",600713,1q32-q41,Metabolic
369,"Costello syndrome, 218040 (3)",HRAS,190020,11p15.5,multiple
370,"Coumarin resistance, 122700 (3)","CYP2A6, CYP2A3, CYP2A, P450C2A",122720,19q13.2,Hematological
372,"Cowden disease, 158350 (3)","PTEN, MMAC1",601728,10q23.31,Cancer
372,"Cowden-like syndrome, 158350 (3)","BMPR1A, ACVRLK3, ALK3",601299,10q22.3,Cancer
374,"CPT deficiency, hepatic, type IA, 255120 (3)",CPT1A,600528,11q13,Metabolic
374,"CPT deficiency, hepatic, type II, 600649 (3)",CPT2,600650,1p32,Metabolic
374,"CPT II deficiency, lethal neonatal, 608836 (3)",CPT2,600650,1p32,Metabolic
376,"Cramps, familial, potassium-aggravated (3)","SCN4A, HYPP, NAC1A",603967,17q23.1-q25.3,Muscular
377,"Craniofacial anomalies, empty sella turcica, corneal endothelial changes, and abnormal
retinal and auditory bipolar cells (3)","VSX1, RINX, PPCD, PPD, KTCN",605020,20p11.2,multiple
378,"Craniofacial-deafness-hand syndrome, 122880 (3)","PAX3, WS1, HUP2, CDHS",606597,2q35,multiple
379,Craniofacial-skeletal-dermatologic dysplasia (3),"FGFR2, BEK, CFD1, JWS",176943,10q26,multiple
380,"Craniofrontonasal dysplasia, 304110 (3)","EFNB1, EPLG2, CFNS, CFND",300035,Xq12,Skeletal
382,"Craniometaphyseal dysplasia, 123000 (3)","ANKH, HANK, ANK, CMDJ, CCAL2,
CPPDD",605145,5p15.2-p14.1,Bone
383,"Craniosynostosis, nonspecific (3)","FGFR2, BEK, CFD1, JWS",176943,10q26,Skeletal
383,"Craniosynostosis, type 2, 604757 (3)","MSX2, CRS2, HOX8",123101,5q34-q35,Skeletal
384,"CRASH syndrome, 303350 (3)","L1CAM, CAML1, HSAS1",308840,Xq28,multiple
2385,"Creatine deficiency syndrome, X-linked, 300352 (3)","SLC6A8, CRTR",300036,Xq28,Neurological
385,"Creatine phosphokinase, elevated serum, 123320 (3)","CAV3, LGMD1C",601253,3p25,Metabolic
385,"Creatine phosphokinase, elevated serum, 123320 (3)","CAV3, LGMD1C",601253,3p25,Metabolic
388,"Creutzfeldt-Jakob disease, 123400 (3)","PRNP, PRIP",176640,20pter-p12,Neurological
388,"Creutzfeldt-Jakob disease, variant, resistance to, 123400 (3)",HLA-DQB1,604305,6p21.3,Neurological
389,"Crigler-Najjar syndrome, type I, 218800 (3)","UGT1A1, UGT1, GNT1",191740,2q37,multiple
389,"Crigler-Najjar syndrome, type II, 606785 (3)","UGT1A1, UGT1, GNT1",191740,2q37,multiple
390,"Crohn disease, susceptibility to, 266600 (3)","CARD15, NOD2, IBD1, CD, ACUG,
PSORAS1",605956,16q12,Gastrointestinal
390,"Crohn disease, susceptibility to, 266600 (3)","DLG5, PDLG, KIAA0583",604090,10q23,Gastrointestinal
391,"Crouzon syndrome, 123500 (3)","FGFR2, BEK, CFD1, JWS",176943,10q26,Skeletal
391,Crouzon syndrome with acanthosis nigricans (3),"FGFR3, ACH",134934,4p16.3,Skeletal
392,"Cryptorchidism, bilateral, 219050 (3)","LGR8, GREAT",606655,13q13.1,Renal
392,"Cryptorchidism, idiopathic, 219050 (3)",INSL3,146738,19p13.2,Renal
394,"Currarino syndrome, 176450 (3)","HLXB9, HOXHB9, SCRA1",142994,7q36,Skeletal
395,"Cutis laxa, AD, 123700 (3)",ELN,130160,7q11.2,Connective tissue
395,"Cutis laxa, autosomal dominant, 123700 (3)","FBLN5, ARMD3",604580,14q32.1,Connective tissue
395,"Cutis laxa, autosomal recessive, 219100 (3)","FBLN5, ARMD3",604580,14q32.1,Connective tissue
395,"Cutis laxa, neonatal (3)","ATP7A, MNK, MK, OHS",300011,Xq12-q13,Connective tissue
396,"Cyclic ichthyosis with epidermolytic hyperkeratosis, 607602 (3)",KRT1,139350,12q13,Dermatological
397,"Cylindromatosis, familial, 132700 (3)","CYLD1, CDMT, EAC",605018,16q12-q13,Dermatological
398,"Cystathioninuria, 219500 (3)",CTH,607657,1p31.1,Metabolic
399,"Cystic fibrosis, 219700 (3)","CFTR, ABCC7, CF, MRP7",602421,7q31.2,Respiratory
400,"Cystinosis, atypical nephropathic (3)",CTNS,606272,17p13,Renal
400,"Cystinosis, late-onset juvenile or adolescent nephropathic, 219900 (3)",CTNS,606272,17p13,Renal
400,"Cystinosis, nephropathic, 219800 (3)",CTNS,606272,17p13,Renal
400,"Cystinosis, ocular nonnephropathic, 219750 (3)",CTNS,606272,17p13,Renal
401,"Cystinuria, 220100 (3)","SLC3A1, ATR1, D2H, NBAT",104614,2p16.3,Renal
401,"Cystinuria, type II (3)","SLC7A9, CSNU3",604144,19q13.1,Renal
401,"Cystinuria, type III (3)","SLC7A9, CSNU3",604144,19q13.1,Renal
402,"D-2-hydroxyglutaric aciduria, 600721 (3)",D2HGD,609186,2p25.3,Metabolic
404,"Darier disease, 124200 (3)","ATP2A2, ATP2B, DAR",108740,12q23-q24.1,Dermatological
405,"D-bifunctional protein deficiency, 261515 (3)",HSD17B4,601860,5q2,Metabolic
406,"Deafness, autosomal dominant 10, 601316 (3)","EYA4, DFNA10, CMD1J",603550,6q23,"Ear,Nose,Throat"
406,"Deafness, autosomal dominant 1, 124900 (3)","DIAPH1, DFNA1, LFHL1",602121,5q31,"Ear,Nose,Throat"
406,"Deafness, autosomal dominant 11, neurosensory, 601317 (3)","MYO7A, USH1B, DFNB2, DFNA11",276903,11q13.5,"Ear,Nose,Throat"
406,"Deafness, autosomal dominant 12, 601842 (3)","TECTA, DFNA8, DFNA12, DFNB21",602574,11q22-q24,"Ear,Nose,Throat"
406,"Deafness, autosomal dominant 13, 601868 (3)","COL11A2, STL3, DFNA13",120290,6p21.3,"Ear,Nose,Throat"
406,"Deafness, autosomal dominant 15, 602459 (3)","POU4F3, BRN3C",602460,5q31,"Ear,Nose,Throat"
406,"Deafness, autosomal dominant 17, 603622 (3)","MYH9, MHA, FTNS, DFNA17",160775,22q11.2,"Ear,Nose,Throat"
406,"Deafness, autosomal dominant 20/26, 604717 (3)","ACTG1, DFNA20, DFNA26",102560,17q25.3,"Ear,Nose,Throat"
406,"Deafness, autosomal dominant 22, 606346 (3)","MYO6, DFNA22, DFNB37",600970,6q13,"Ear,Nose,Throat"
406,"Deafness, autosomal dominant 2, 600101 (3)","GJB3, CX31, DFNA2",603324,1p35.1,"Ear,Nose,Throat"
406,"Deafness, autosomal dominant 2, 600101 (3)","KCNQ4, DFNA2",603537,1p34,"Ear,Nose,Throat"
406,"Deafness, autosomal dominant 28, 608641 (3)","TFCP2L3, DFNA28",608576,8q22,"Ear,Nose,Throat"
406,"Deafness, autosomal dominant 3, 601544 (3)","GJB2, CX26, DFNB1, PPK, DFNA3, KID,
HID",121011,13q11-q12,"Ear,Nose,Throat"
406,"Deafness, autosomal dominant 3, 601544 (3)","GJB6, CX30, DFNA3, HED, ED2",604418,13q12,"Ear,Nose,Throat"
406,"Deafness, autosomal dominant 36, 606705 (3)","TMC1, DFNB7, DFNB11, DFNA36",606706,9q13-q21,"Ear,Nose,Throat"
406,"Deafness, autosomal dominant 36, with dentinogenesis, 605594 (3)","DSPP, DPP, DGI1, DFNA39, DTDP2",125485,4q21.3,"Ear,Nose,Throat"
406,"Deafness, autosomal dominant 40 (3)","CRYM, DFNA40",123740,16p13.11-p12.3,"Ear,Nose,Throat"
406,"Deafness, autosomal dominant 4, 600652 (3)","MYH14, KIAA2034, DFNA4",608568,19q13.33,"Ear,Nose,Throat"
406,"Deafness, autosomal dominant 5 (3)",DFNA5,600994,7p15,"Ear,Nose,Throat"
406,"Deafness, autosomal dominant 8, 601543 (3)","TECTA, DFNA8, DFNA12, DFNB21",602574,11q22-q24,"Ear,Nose,Throat"
406,"Deafness, autosomal dominant 9, 601369 (3)","COCH, DFNA9",603196,14q12-q13,"Ear,Nose,Throat"
406,"Deafness, autosomal dominant nonsyndromic sensorineural, 607841 (3)",MYO1A,601478,12q13-q15,"Ear,Nose,Throat"
406,"Deafness, autosomal dominant, with peripheral neuropathy (3)","GJB3, CX31, DFNA2",603324,1p35.1,"Ear,Nose,Throat"
406,"Deafness, autosomal recessive 10, congenital, 605316 (3)","TMPRSS3, ECHOS1, DFNB8, DFNB10",605511,21q22.3,"Ear,Nose,Throat"
406,"Deafness, autosomal recessive 1, 220290 (3)","GJB2, CX26, DFNB1, PPK, DFNA3, KID,
HID",121011,13q11-q12,"Ear,Nose,Throat"
406,"Deafness, autosomal recessive 12, 601386 (3)","CDH23, USH1D",605516,10q21-q22,"Ear,Nose,Throat"
406,"Deafness, autosomal recessive 12, modifier of, 601386 (3)","ATP2B2, PMCA2",108733,3p26-p25,"Ear,Nose,Throat"
406,"Deafness, autosomal recessive 16, 603720 (3)","STRC, DFNB16",606440,15q15,"Ear,Nose,Throat"
406,"Deafness, autosomal recessive 18, 602092 (3)","USH1C, DFNB18",605242,11p15.1,"Ear,Nose,Throat"
406,"Deafness, autosomal recessive 21, 603629 (3)","TECTA, DFNA8, DFNA12, DFNB21",602574,11q22-q24,"Ear,Nose,Throat"
406,"Deafness, autosomal recessive 22, 607039 (3)","OTOA, DFNB22",607038,16p12.2,"Ear,Nose,Throat"
406,"Deafness, autosomal recessive 23, 609533 (3)","PCDH15, DFNB23",605514,10q21-q22,"Ear,Nose,Throat"
406,"Deafness, autosomal recessive 29 (3)","CLDN14, DFNB29",605608,21q22.3,"Ear,Nose,Throat"
406,"Deafness, autosomal recessive 2, neurosensory, 600060 (3)","MYO7A, USH1B, DFNB2, DFNA11",276903,11q13.5,"Ear,Nose,Throat"
406,"Deafness, autosomal recessive 30, 607101 (3)","MYO3A, DFNB30",606808,10p11.1,"Ear,Nose,Throat"
406,"Deafness, autosomal recessive 31, 607084 (3)","WHRN, CIP98, KIAA1526, DFNB31",607928,9q32-q34,"Ear,Nose,Throat"
406,"Deafness, autosomal recessive 3, 600316 (3)","MYO15A, DFNB3",602666,17p11.2,"Ear,Nose,Throat"
406,"Deafness, autosomal recessive 36, 609006 (3)",ESPN,606351,1p36.3-p36.1,"Ear,Nose,Throat"
406,"Deafness, autosomal recessive 37, 607821 (3)","MYO6, DFNA22, DFNB37",600970,6q13,"Ear,Nose,Throat"
406,"Deafness, autosomal recessive (3)","GJB3, CX31, DFNA2",603324,1p35.1,"Ear,Nose,Throat"
406,"Deafness, autosomal recessive 4, 600791 (3)","SLC26A4, PDS, DFNB4",605646,7q31,"Ear,Nose,Throat"
406,"Deafness, autosomal recessive 61 (3)","PRES, DFNB61, SLC26A5",604943,7q22.1,"Ear,Nose,Throat"
406,"Deafness, autosomal recessive 6, 600971 (3)","TMIE, DFNB6",607237,3p21,"Ear,Nose,Throat"
406,"Deafness, autosomal recessive 7, 600974 (3)","TMC1, DFNB7, DFNB11, DFNA36",606706,9q13-q21,"Ear,Nose,Throat"
406,"Deafness, autosomal recessive 8, childhood onset, 601072 (3)","TMPRSS3, ECHOS1, DFNB8, DFNB10",605511,21q22.3,"Ear,Nose,Throat"
406,"Deafness, autosomal recessive 9, 601071 (3)","OTOF, DFNB9, NSRD9",603681,2p23-p22,"Ear,Nose,Throat"
406,"Deafness, congenital heart defects, and posterior embryotoxon (3)","JAG1, AGS, AHD",601920,20p12,"Ear,Nose,Throat"
406,"Deafness, nonsyndromic (3) ()",KIAA1199,608366,15q24,"Ear,Nose,Throat"
406,"Deafness, nonsyndromic neurosensory, digenic (3)","GJB6, CX30, DFNA3, HED, ED2",604418,13q12,"Ear,Nose,Throat"
406,"Deafness, sensorineural, with hypertrophic cardiomyopathy, 606346 (3)","MYO6, DFNA22, DFNB37",600970,6q13,"Ear,Nose,Throat"
406,"Deafness, X-linked 1, progressive (3)","TIMM8A, DFN1, DDP, MTS, DDP1",300356,Xq22,"Ear,Nose,Throat"
406,"Deafness, X-linked 3, conductive, with stapes fixation, 304400 (3)","POU3F4, DFN3",300039,Xq21.1,"Ear,Nose,Throat"
407,Debrisoquine sensitivity (3),"CYP2D@, CYP2D, P450C2D",124030,22q13.1,Metabolic
410,"Dejerine-Sottas disease, 145900 (3)","PMP22, CMT1A, CMT1E, DSS",601097,17p11.2,multiple
410,"Dejerine-Sottas neuropathy, 145900 (3)","EGR2, KROX20",129010,10q21.1-q22.1,multiple
410,"Dejerine-Sottas neuropathy, autosomal recessive, 145900 (3)","PRX, CMT4F",605725,19q13.1-q13.2,multiple
410,"Dejerine-Sottas syndrome, 145900 (3)","MPZ, CMT1B, CMTDI3, CHM, DSS",159440,1q22,multiple
411,"Delayed sleep phase syndrome, susceptibility to (3)","AANAT, SNAT",600950,17q25,Psychiatric
412,"Dementia, familial British, 176500 (3)","ITM2B, BRI, ABRI, FBD",603904,13q14,Neurological
412,"Dementia, familial Danish, 117300 (3)","ITM2B, BRI, ABRI, FBD",603904,13q14,Neurological
412,"Dementia, frontotemporal, 600274 (3)","PSEN1, AD3",104311,14q24.3,Neurological
412,"Dementia, frontotemporal, with parkinsonism, 600274 (3)","MAPT, MTBT1, DDPAC, MSTD",157140,17q21.1,Neurological
412,"Dementia, Lewy body, 127750 (3)","SNCA, NACP, PARK1, PARK4",163890,4q21,Neurological
412,"Dementia, Lewy body, 127750 (3)",SNCB,602569,5q35,Neurological
412,"Dementia, Pick disease-like, 172700 (3)","MAPT, MTBT1, DDPAC, MSTD",157140,17q21.1,Neurological
412,"Dementia, vascular, susceptibility to (3)","TNF, TNFA",191160,6p21.3,Neurological
413,"Dengue fever, protection against (3)","CD209, CDSIGN",604672,19p13.3,Immunological
414,"Dental anomalies, isolated (3)","RUNX2, CBFA1, PEBP2A1, AML3",600211,6p21,Skeletal
415,"Dentatorubro-pallidoluysian atrophy, 125370 (3)",DRPLA,607462,12p13.31,Neurological
416,"Dent disease, 300009 (3)","CLCN5, CLCK2, NPHL2, DENTS",300008,Xp11.22,Renal
417,"Dentin dysplasia, type II, 125420 (3)","DSPP, DPP, DGI1, DFNA39, DTDP2",125485,4q21.3,Bone
418,"Dentinogenesis imperfecta, Shields type II, 125490 (3)","DSPP, DPP, DGI1, DFNA39, DTDP2",125485,4q21.3,Bone
418,"Dentinogenesis imperfecta, Shields type III, 125500 (3)","DSPP, DPP, DGI1, DFNA39, DTDP2",125485,4q21.3,Bone
416,"Dent syndrome, 300009 (3)","OCRL, LOCR, OCRL1, NPHL2",300535,Xq26.1,Renal
420,"Denys-Drash syndrome, 194080 (3)",WT1,607102,11p13,Renal
422,Dermatofibrosarcoma protuberans (3),"PDGFB, SIS",190040,22q12.3-q13.1,Cancer
424,"De Sanctis-Cacchione syndrome, 278800 (3)","ERCC6, CKN2, COFS, CSB",609413,10q11,multiple
425,"Desmoid disease, hereditary, 135290 (3)","APC, GS, FPC",175100,5q21-q22,Cancer
426,"Desmosterolosis, 602398 (3)","DHCR24, KIAA0018",606418,1p33-p31.1,Metabolic
2427,"Diabetes insipidus, nephrogenic, 304800 (3)","AVPR2, DIR, DI1, ADHR",300538,Xq28,Endocrine
2427,"Diabetes insipidus, nephrogenic, autosomal dominant, 125800 (3)",AQP2,107777,12q13,Endocrine
2427,"Diabetes insipidus, nephrogenic, autosomal recessive, 222000 (3)",AQP2,107777,12q13,Endocrine
2427,"Diabetes insipidus, neurohypophyseal, 125700 (3)","AVP, AVRP, VP",192340,20p13,Endocrine
427,"Diabetes mellitus, 125853 (3)","ABCC8, SUR, PHHI, SUR1",600509,11p15.1,Endocrine
427,"Diabetes mellitus, insulin-dependent, 222100 (3)","TCF1, HNF1A, MODY3",142410,12q24.2,Endocrine
427,"Diabetes mellitus, insulin-dependent, 5, 600320 (3)","SUMO4, IDDM5",608829,6q25,Endocrine
427,"Diabetes mellitus, insulin-dependent, susceptibility to, 222100 (3)","PTPN8, PEP, PTPN22, LYP",600716,1p13,Endocrine
427,"Diabetes mellitus, insulin-resistant, with acanthosis nigricans (3)",INSR,147670,19p13.2,Endocrine
427,"Diabetes mellitus, insulin-resistant, with acanthosis nigricans and hypertension, 604367
(3)","PPARG, PPARG1, PPARG2",601487,3p25,Endocrine
427,"Diabetes mellitus, neonatal-onset, 606176 (3)",GCK,138079,7p15-p13,Endocrine
427,"Diabetes mellitus, noninsulin-dependent, 125853 (3)",GCGR,138033,17q25,Endocrine
427,"Diabetes mellitus, noninsulin-dependent, 125853 (3)",GPD2,138430,2q24.1,Endocrine
427,"Diabetes mellitus, noninsulin-dependent, 125853 (3)","HNF4A, TCF14, MODY1",600281,20q12-q13.1,Endocrine
427,"Diabetes mellitus, noninsulin-dependent, 125853 (3)",IRS2,600797,13q34,Endocrine
427,"Diabetes mellitus, noninsulin-dependent, 125853 (3)","MAPK8IP1, IB1",604641,11p12-p11.2,Endocrine
427,"Diabetes mellitus, noninsulin-dependent, 125853 (3)","NEUROD1, NIDDM",601724,2q32,Endocrine
427,"Diabetes mellitus, noninsulin-dependent, 125853 (3)","TCF2, HNF2",189907,17cen-q21.3,Endocrine
427,"Diabetes mellitus, noninsulin-dependent, 2, 125853 (3)","TCF1, HNF1A, MODY3",142410,12q24.2,Endocrine
427,"Diabetes mellitus, noninsulin-dependent (3)",IRS1,147545,2q36,Endocrine
427,"Diabetes mellitus, noninsulin-dependent (3)","SLC2A2, GLUT2",138160,3q26.1-q26.3,Endocrine
427,"Diabetes mellitus, noninsulin-dependent (3)","SLC2A4, GLUT4",138190,17p13,Endocrine
427,"Diabetes mellitus, noninsulin-dependent, 601283 (3)",CAPN10,605286,2q37.3,Endocrine
427,"Diabetes mellitus, non-insulin-dependent, susceptibility to, 125853 (3)","ENPP1, PDNP1, NPPS, M6S1, PCA1",173335,6q22-q23,Endocrine
427,"Diabetes mellitus, noninsulin-dependent, susceptibility to, 125853 (3)","RETN, RSTN, FIZZ3",605565,19p13.2,Endocrine
427,"Diabetes mellitus, permanent neonatal, with cerebellar agenesis, 609069 (3)",PTF1A,607194,10p12.3,Endocrine
427,"Diabetes mellitus, permanent neonatal, with neurologic features, 606176 (3)","KCNJ11, BIR, PHHI",600937,11p15.1,Endocrine
427,"Diabetes mellitus, type II, 125853 (3)",AKT2,164731,19q13.1-q13.2,Endocrine
427,"Diabetes mellitus, type II, susceptibility to, 125853 (3)",IPF1,600733,13q12.1,Endocrine
427,"Diabetes mellitus, type I, susceptibility to, 222100 (3)","FOXP3, IPEX, AIID, XPID, PIDX",300292,Xp11.23-q13.3,Endocrine
427,"Diabetes, permanent neonatal, 606176 (3)","KCNJ11, BIR, PHHI",600937,11p15.1,Endocrine
427,"Diabetic nephropathy, susceptibility to, 603933 (3)","ACE, DCP1, ACE1",106180,17q23,Endocrine
427,"Diabetic retinopathy, NIDDM-related, susceptibility to, 125853 (3)",VEGF,192240,6p12,Endocrine
430,"Diastrophic dysplasia, 222600 (3)","SLC26A2, DTD, DTDST, D5S1708,
EDM4",606718,5q32-q33.1,Skeletal
430,"Diastrophic dysplasia, broad bone-platyspondylic variant (3)","SLC26A2, DTD, DTDST, D5S1708,
EDM4",606718,5q32-q33.1,Skeletal
432,"DiGeorge syndrome, 188400 (3)","TBX1, DGS, CTHM, CAFS, TGA, DORV,
VCFS, DGCR",602054,22q11.2,multiple
433,Dihydropyrimidinuria (3),"DPYS, DHP",222748,8q22,Metabolic
434,"Dilated cardiomyopathy with woolly hair and keratoderma, 605676 (3)","DSP, KPPS2, PPKS2",125647,6p24,multiple
435,"Dimethylglycine dehydrogenase deficiency, 605850 (3)","DMGDH, DMGDHD",605849,5q12.2-q12.3,Metabolic
438,"Disordered steroidogenesis, isolated (3)",POR,124015,7q11.2,Metabolic
439,Dissection of cervical arteries (3),COL1A1,120150,17q21.31-q22,Connective tissue
2440,DNA ligase I deficiency (3),LIG1,126391,19q13.2-q13.3,multiple
440,"DNA topoisomerase I, camptothecin-resistant (3)",TOP1,126420,20q12-q13.1,Metabolic
440,"DNA topoisomerase II, resistance to inhibition of, by amsacrine (3)","TOP2A, TOP2",126430,17q21-q22,Metabolic
441,"Dopamine-beta-hydroxylase activity levels, plasma (3)",DBH,609312,9q34,Metabolic
441,"Dopamine beta-hydroxylase deficiency, 223360 (3)",DBH,609312,9q34,Metabolic
443,"Dosage-sensitive sex reversal, 300018 (3)","DAX1, AHC, AHX, NROB1",300473,Xp21.3-p21.2,Endocrine
444,"Double-outlet right ventricle, 217095 (3)","CFC1, CRYPTIC, HTX2",605194,2q21.1,Cardiovascular
445,"Down syndrome, risk of, 190685 (3)",MTR,156570,1q43,multiple
446,"Doyne honeycomb degeneration of retina, 126600 (3)","EFEMP1, FBNL, DHRD",601548,2p16,Ophthamological
447,"Drug addiction, susceptibility to (3)",FAAH,602935,1p35-p34,Psychiatric
449,"Duane-radial ray syndrome, 607323 (3)","SALL4, HSAL4",607343,20q13.13-q13.2,multiple
450,"Dubin-Johnson syndrome, 237500 (3)","ABCC2, CMOAT",601107,10q24,Metabolic
451,"Duchenne muscular dystrophy, 310200 (3)","DMD, BMD",300377,Xp21.2,Muscular
452,"Dyggve-Melchior-Clausen disease, 223800 (3)","DYM, FLJ90130, DMC, SMC",607461,18q12-q21.1,multiple
453,Dysalbuminemic hyperthyroxinemia (3),ALB,103600,4q11-q13,Hematological
454,"Dysautonomia, familial, 223900 (3)","IKBKAP, IKAP",603722,9q31,Neurological
455,"Dyschromatosis symmetrica hereditaria, 127400 (3)","ADAR, DRADA, DSH, DSRAD",601059,1q21.3,Dermatological
456,"Dyserythropoietic anemia with thrombocytopenia, 300367 (3)","GATA1, GF1, ERYF1, NFE1",305371,Xp11.23,Hematological
457,"Dysfibrinogenemia, alpha type, causing bleeding diathesis (3)",FGA,134820,4q28,Hematological
457,"Dysfibrinogenemia, alpha type, causing recurrent thrombosis (3)",FGA,134820,4q28,Hematological
457,"Dysfibrinogenemia, beta type (3)",FGB,134830,4q28,Hematological
457,"Dysfibrinogenemia, gamma type (3)",FGG,134850,4q28,Hematological
458,"Dyskeratosis congenita-1, 305000 (3)","DKC1, DKC",300126,Xq28,Dermatological
458,"Dyskeratosis congenita, autosomal dominant, 127550 (3)","TERC, TRC3, TR",602322,3q21-q28,Dermatological
459,"Dyslexia, susceptibility to, 1, 127700 (3)","DYX1C1, DYXC1, DYX1",608706,15q21,Psychiatric
459,"Dyslexia, susceptibility to, 2, 600202 (3)","KIAA0319, DYX2, DYLX2, DLX2",609269,6p22.2,Psychiatric
460,Dysprothrombinemia (3),F2,176930,11p11-q12,Hematological
461,"Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3)","HSPG2, PLC, SJS, SJA, SJS1",142461,1p36.1,Neurological
462,"Dystonia-12, 128235 (3)","ATP1A3, DYT12, RDP",182350,19q12-q13.2,Neurological
462,"Dystonia-1, torsion, 128100 (3)","DYT1, TOR1A",605204,9q34,Neurological
462,"Dystonia, DOPA-responsive, 128230 (3)","GCH1, DYT5",600225,14q22.1-q22.2,Neurological
462,"Dystonia, early-onset atypical, with myoclonic features (3)","DYT1, TOR1A",605204,9q34,Neurological
462,"Dystonia, myoclonic, 159900 (3)",DRD2,126450,11q23,Neurological
462,"Dystonia, myoclonic, 159900 (3)","SGCE, DYT11",604149,7q21,Neurological
462,"Dystonia, primary cervical (3)","DRD5, DRD1B, DRD1L2",126453,4p16.1-p15.3,Neurological
463,Dystransthyretinemic hyperthyroxinemia(3),"TTR, PALB",176300,18q11.2-q12.1,Hematological
465,"EBD, Bart type, 132000 (3)",COL7A1,120120,3p21.3,Dermatological
465,"EBD, localisata variant (3)",COL7A1,120120,3p21.3,Dermatological
466,"Ectodermal dysplasia-1, anhidrotic, 305100 (3)","ED1, EDA, HED",300451,Xq12-q13.1,Dermatological
466,"Ectodermal dysplasia 2, hidrotic, 129500 (3)","GJB6, CX30, DFNA3, HED, ED2",604418,13q12,Dermatological
466,"Ectodermal dysplasia, anhidrotic, 224900 (3)",EDARADD,606603,1q42.2-q43,Dermatological
466,"Ectodermal dysplasia, anhidrotic, lymphedema and immunodeficiency, 300301 (3)","IKBKG, NEMO, FIP3, IP2",300248,Xq28,Dermatological
466,"Ectodermal dysplasia, anhidrotic, with T-cell immunodeficiency (3)","NFKBIA, IKBA",164008,14q13,Dermatological
466,"Ectodermal dysplasia, hypohidrotic, autosomal dominant, 129490 (3)","EDAR, DL, ED3, EDA3",604095,2q11-q13,Dermatological
466,"Ectodermal dysplasia, hypohidrotic, autosomal recessive, 224900 (3)","EDAR, DL, ED3, EDA3",604095,2q11-q13,Dermatological
466,"Ectodermal dysplasia, hypohidrotic, with immune deficiency, 300291 (3)","IKBKG, NEMO, FIP3, IP2",300248,Xq28,Dermatological
466,"Ectodermal dysplasia, Margarita Island type, 225060 (3)","HVEC, PVRL1, PVRR1, PRR1",600644,11q23-q24,Dermatological
466,"Ectodermal dysplasia/skin fragility syndrome, 604536 (3)",PKP1,601975,1q32,Dermatological
467,"Ectopia lentis, familial, 129600 (3)","FBN1, MFS1, WMS",134797,15q21.1,Ophthamological
467,"Ectopia pupillae, 129750 (3)","PAX6, AN2, MGDA",607108,11p13,Ophthamological
468,"Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3, 604292 (3)","TP73L, TP63, KET, EEC3, SHFM4, LMS,
RHS",603273,3q27,Skeletal
470,"Ehlers-Danlos due to tenascin X deficiency, 606408 (3)","TNXB, TNX, TNXB1, TNXBS, TNXB2",600985,6p21.3,Connective tissue
470,"Ehlers-Danlos syndrome, hypermobility type, 130020 (3)","TNXB, TNX, TNXB1, TNXBS, TNXB2",600985,6p21.3,Connective tissue
470,"Ehlers-Danlos syndrome, progeroid form, 130070 (3)","B4GALT7, XGALT1, XGPT1",604327,5q35.2-q35.3,Connective tissue
470,"Ehlers-Danlos syndrome, type I, 130000 (3)",COL1A1,120150,17q21.31-q22,Connective tissue
470,"Ehlers-Danlos syndrome, type I, 130000 (3)",COL5A1,120215,9q34.2-q34.3,Connective tissue
470,"Ehlers-Danlos syndrome, type I, 130000 (3)",COL5A2,120190,2q31,Connective tissue
470,"Ehlers-Danlos syndrome, type II, 130010 (3)",COL5A1,120215,9q34.2-q34.3,Connective tissue
470,"Ehlers-Danlos syndrome, type III, 130020 (3)",COL3A1,120180,2q31,Connective tissue
470,"Ehlers-Danlos syndrome, type IV, 130050 (3)",COL3A1,120180,2q31,Connective tissue
470,"Ehlers-Danlos syndrome, type VI, 225400 (3)","PLOD, PLOD1",153454,1p36.3-p36.2,Connective tissue
470,"Ehlers-Danlos syndrome, type VII, 130060 (3)",COL1A1,120150,17q21.31-q22,Connective tissue
470,"Ehlers-Danlos syndrome, type VIIA2, 130060 (3)",COL1A2,120160,7q22.1,Connective tissue
470,"Ehlers-Danlos syndrome, type VIIC, 225410 (3)","ADAMTS2, NPI",604539,5q23,Connective tissue
471,Elite sprint athletic performance (3),ACTN3,102574,11q13-q14,Muscular
472,Elliptocytosis-1 (3),"EPB41, EL1",130500,1p36.2-p34,Hematological
472,Elliptocytosis-2 (3),SPTA1,182860,1q21,Hematological
472,Elliptocytosis-3 (3),SPTB,182870,14q22-q23.2,Hematological
472,"Elliptocytosis, Malaysian-Melanesian type (3)","SLC4A1, AE1, EPB3",109270,17q21-q22,Hematological
473,"Ellis-van Creveld syndrome, 225500 (3)",EVC,604831,4p16,Skeletal
473,"Ellis-van Creveld syndrome, 225500 (3)","LBN, EVC2",607261,4p16,Skeletal
474,"Emery-Dreifuss muscular dystrophy, 310300 (3)","EMD, EDMD, STA",300384,Xq28,Muscular
474,"Emery-Dreifuss muscular dystrophy, AD, 181350 (3)","LMNA, LMN1, EMD2, FPLD, CMD1A,
HGPS, LGMD1B",150330,1q21.2,Muscular
474,"Emery-Dreifuss muscular dystrophy, AR, 604929 (3)","LMNA, LMN1, EMD2, FPLD, CMD1A,
HGPS, LGMD1B",150330,1q21.2,Muscular
475,Emphysema (3),"PI, AAT",107400,14q32.1,Respiratory
475,Emphysema-cirrhosis (3),"PI, AAT",107400,14q32.1,Respiratory
476,"Encephalopathy, familial, with neuroserpin inclusion bodies, 604218 (3)","SERPINI1, PI12",602445,3q26,Neurological
476,"Encephalopathy, progressive mitochondrial, with proximal renal tubulopathy due to
cytochrome c oxidase deficiency (3)",COX10,602125,17p12-p11.2,Neurological
477,"Enchondromatosis, Ollier type, 166000 (3)","PTHR1, PTHR",168468,3p22-p21.1,Cancer
479,Endometrial carcinoma (3),"CDH1, UVO",192090,16q22.1,Cancer
479,Endometrial carcinoma (3),MSH3,600887,5q11-q12,Cancer
479,Endometrial carcinoma (3),"MSH6, GTBP, HNPCC5",600678,2p16,Cancer
479,Endometrial carcinoma (3),"PTEN, MMAC1",601728,10q23.31,Cancer
481,Endotoxin hyporesponsiveness (3),TLR4,603030,9q32-q33,Immunological
482,"Endplate acetylcholinesterase deficiency, 603034 (3)","COLQ, EAD",603033,3p25,Neurological
483,"Enhanced S-cone syndrome, 268100 (3)","NR2E3, PNR, ESCS",604485,15q23,Ophthamological
484,"Enlarged vestibular aqueduct, 603545 (3)","SLC26A4, PDS, DFNB4",605646,7q31,"Ear,Nose,Throat"
485,Enolase-beta deficiency (3),ENO3,131370,17pter-p12,Metabolic
487,"Enterokinase deficiency, 226200 (3)","PRSS7, ENTK",606635,21q21,Gastrointestinal
491,"Eosinophil peroxidase deficiency, 261500 (3)",EPX,131399,17q23.1,Hematological
492,"Epidermodysplasia verruciformis, 226400 (3)","EVER1, EV1",605828,17q25,Dermatological
492,"Epidermodysplasia verruciformis, 226400 (3)","EVER2, EV2",605829,17q25,Dermatological
493,"Epidermolysis bullosa dystrophica, AD, 131750 (3)",COL7A1,120120,3p21.3,Dermatological
493,"Epidermolysis bullosa dystrophica, AR, 226600 (3)",COL7A1,120120,3p21.3,Dermatological
493,"Epidermolysis bullosa, generalized atrophic benign, 226650 (3)","COL17A1, BPAG2",113811,10q24.3,Dermatological
493,"Epidermolysis bullosa, generalized atrophic benign, 226650 (3)",ITGB4,147557,17q11-qter,Dermatological
493,"Epidermolysis bullosa, generalized atrophic benign, 226650 (3)","LAMA3, LOCS",600805,18q11.2,Dermatological
493,"Epidermolysis bullosa, generalized atrophic benign, 226650 (3)",LAMB3,150310,1q32,Dermatological
493,"Epidermolysis bullosa, generalized atrophic benign, 226650 (3)","LAMC2, LAMNB2, LAMB2T",150292,1q25-q31,Dermatological
493,"Epidermolysis bullosa, Herlitz junctional type, 226700 (3)",LAMB3,150310,1q32,Dermatological
493,"Epidermolysis bullosa, Herlitz junctional type, 226700 (3)","LAMC2, LAMNB2, LAMB2T",150292,1q25-q31,Dermatological
493,"Epidermolysis bullosa, junctional, Herlitz type, 226700 (3)","LAMA3, LOCS",600805,18q11.2,Dermatological
493,"Epidermolysis bullosa, junctional, with pyloric atresia, 226730 (3)",ITGB4,147557,17q11-qter,Dermatological
493,"Epidermolysis bullosa, junctional, with pyloric stenosis, 226730 (3)",ITGA6,147556,Chr.2,Dermatological
493,"Epidermolysis bullosa, lethal acantholytic, 609638 (3)","DSP, KPPS2, PPKS2",125647,6p24,Dermatological
493,"Epidermolysis bullosa of hands and feet, 131800 (3)",ITGB4,147557,17q11-qter,Dermatological
493,"Epidermolysis bullosa, pretibial, 131850 (3)",COL7A1,120120,3p21.3,Dermatological
493,"Epidermolysis bullosa pruriginosa, 604129 (3)",COL7A1,120120,3p21.3,Dermatological
493,"Epidermolysis bullosa simplex, Koebner, Dowling-Meara, and Weber-Cockayne types,
131900, 131760, 131800 (3)",KRT14,148066,17q12-q21,Dermatological
493,"Epidermolysis bullosa simplex, Koebner, Dowling-Meara, and Weber-Cockayne types,
131900, 131760, 131800 (3)",KRT5,148040,12q13,Dermatological
493,"Epidermolysis bullosa simplex, Ogna type, 131950 (3)","PLEC1, PLTN, EBS1",601282,8q24,Dermatological
493,"Epidermolysis bullosa simplex, recessive, 601001 (3)",KRT14,148066,17q12-q21,Dermatological
493,"Epidermolysis bullosa simplex with mottled pigmentation, 131960 (3)",KRT5,148040,12q13,Dermatological
494,"Epidermolytic hyperkeratosis, 113800 (3)",KRT10,148080,17q21-q22,Dermatological
494,"Epidermolytic hyperkeratosis, 113800 (3)",KRT1,139350,12q13,Dermatological
494,"Epidermolytic palmoplantar keratoderma, 144200 (3)","KRT9, EPPK",607606,17q12-q21,Dermatological
495,"Epilepsy, benign, neonatal, type 1, 121200 (3)","KCNQ2, EBN1",602235,20q13.3,Neurological
495,"Epilepsy, benign neonatal, type 2, 121201 (3)","KCNQ3, EBN2, BFNC2",602232,8q24,Neurological
495,"Epilepsy, childhood absence, 607681 (3)","GABRG2, GEFSP3, CAE2, ECA2",137164,5q31.1-q33.1,Neurological
495,"Epilepsy, childhood absence, 607682 (3)","CLCN2, EGMA, ECA3, EGI3",600570,3q26-qter,Neurological
495,"Epilepsy, childhood absence, evolving to juvenile myoclonic epilepsy (3)","JRK, JH8",603210,8q24,Neurological
495,"Epilepsy, generalized idiopathic, 600669 (3)","CACNB4, EJM",601949,2q22-q23,Neurological
495,"Epilepsy, generalized, with febrile seizures plus, 604233 (3)","GABRG2, GEFSP3, CAE2, ECA2",137164,5q31.1-q33.1,Neurological
495,"Epilepsy, generalized, with febrile seizures plus, type 2, 604233 (3)","SCN1A, GEFSP2, SMEI",182389,2q24,Neurological
495,"Epilepsy, idopathic generalized, susceptibility to, 600669 (3)",ME2,154270,18q21,Neurological
495,"Epilepsy, juvenile absence, 607631 (3)","CLCN2, EGMA, ECA3, EGI3",600570,3q26-qter,Neurological
495,"Epilepsy, juvenile myoclonic, 606904 (3)","CACNB4, EJM",601949,2q22-q23,Neurological
495,"Epilepsy, juvenile myoclonic, 606904 (3)","CLCN2, EGMA, ECA3, EGI3",600570,3q26-qter,Neurological
495,"Epilepsy, juvenile myoclonic, 606904 (3)","GABRA1, EJM",137160,5q34-q35,Neurological
495,"Epilepsy, myoclonic, Lafora type, 254780 (3)","EPM2A, MELF, EPM2",607566,6q24,Neurological
495,"Epilepsy, myoclonic, Lafora type, 254780 (3)","NHLRC1, EPM2A, EPM2B",608072,6p22.3,Neurological
495,"Epilepsy, neonatal myoclonic, with suppression-burst pattern, 609304 (3)","SLC25A22, GC1",609302,11p15.5,Neurological
495,"Epilepsy, nocturnal frontal lobe, 1, 600513 (3)","CHRNA4, ENFL1",118504,20q13.2-q13.3,Neurological
495,"Epilepsy, nocturnal frontal lobe, 3, 605375 (3)","CHRNB2, EFNL3",118507,1q21,Neurological
495,"Epilepsy, partial, with auditory features, 600512 (3)","LGI1, EPT, ETL1",604619,10q24,Neurological
495,"Epilepsy, progressive myoclonic 1, 254800 (3)","CSTB, STFB, EPM1",601145,21q22.3,Neurological
495,"Epilepsy, progressive myoclonic 2B, 254780 (3)","NHLRC1, EPM2A, EPM2B",608072,6p22.3,Neurological
495,"Epilepsy, severe myoclonic, of infancy, 607208 (3)","SCN1A, GEFSP2, SMEI",182389,2q24,Neurological
495,"Epilepsy with grand mal seizures on awakening, 607628 (3)","CLCN2, EGMA, ECA3, EGI3",600570,3q26-qter,Neurological
495,"Epilepsy, X-linked, with variable learning disabilities and behavior disorders, 300491 (3)",SYN1,313440,Xp11.4-p11.2,Neurological
496,"Epiphyseal dysplasia, multiple 1, 132400 (3)","COMP, EDM1, MED, PSACH",600310,19p13.1,Bone
496,"Epiphyseal dysplasia, multiple, 226900 (3)","SLC26A2, DTD, DTDST, D5S1708,
EDM4",606718,5q32-q33.1,Bone
496,"Epiphyseal dysplasia, multiple, 3, 600969 (3)","COL9A3, EDM3, IDD",120270,20q13.3,Bone
496,"Epiphyseal dysplasia, multiple, 5, 607078 (3)","MATN3, EDM5, HOA",602109,2p24-p23,Bone
496,"Epiphyseal dysplasia, multiple, COL9A1-related (3)","COL9A1, MED",120210,6q13,Bone
496,"Epiphyseal dysplasia, multiple, type 2, 600204 (3)","COL9A2, EDM2",120260,1p33-p32.2,Bone
496,"Epiphyseal dysplasia, multiple, with myopathy (3)","COL9A3, EDM3, IDD",120270,20q13.3,Bone
497,"Episodic ataxia/myokymia syndrome, 160120 (3)","KCNA1, AEMK, EA1",176260,12p13,Neurological
497,"Episodic ataxia, type 2, 108500 (3)","CACNA1A, CACNL1A4, SCA6",601011,19p13,Neurological
498,"Epithelial ovarian cancer, somatic, 604370 (3)",OPCML,600632,11q25,Cancer
500,"Epstein syndrome, 153650 (3)","MYH9, MHA, FTNS, DFNA17",160775,22q11.2,Hematological
502,"Erythermalgia, primary, 133020 (3)","SCN9A, NENA, PN1",603415,2q24,Neurological
504,"Erythremias, alpha- (3)",HBA1,141800,16pter-p13.3,Hematological
504,"Erythremias, beta- (3)",HBB,141900,11p15.5,Hematological
505,Erythrocytosis (3),HBA2,141850,16pter-p13.3,Hematological
505,"Erythrocytosis, familial, 133100 (3)",EPOR,133171,19p13.3-p13.2,Hematological
507,"Erythrokeratoderma, progressive symmetric, 602036 (3)",LOR,152445,1q21,Dermatological
507,"Erythrokeratodermia variabilis, 133200 (3)","GJB3, CX31, DFNA2",603324,1p35.1,Dermatological
507,"Erythrokeratodermia variabilis with erythema gyratum repens, 133200 (3)","GJB4, CX30.3",605425,1p35.1,Dermatological
508,"Esophageal cancer, 133239 (3)","TGFBR2, HNPCC6",190182,3p22,Cancer
508,"Esophageal carcinoma, somatic, 133239 (3)",RNF6,604242,13q12.11,Cancer
508,"Esophageal squamous cell carcinoma, 133239 (3)","LZTS1, F37, FEZ1",606551,8p22,Cancer
508,"Esophageal squamous cell carcinoma, 133239 (3)","WWOX, FOR",605131,16q23.3-q24.1,Cancer
509,Estrogen resistance (3),"ESR1, ESR",133430,6q25.1,Endocrine
510,"Ethylmalonic encephalopathy, 602473 (3)","ETHE1, HSCO, D83198",608451,19q13.32,Metabolic
511,Ewing sarcoma (3),"EWSR1, EWS",133450,22q12,Cancer
512,Exertional myoglobinuria due to deficiency of LDH-A (3),"LDHA, LDH1",150000,11p15.4,Metabolic
514,"Exostoses, multiple, type 1, 133700 (3)",EXT1,608177,8q24.11-q24.13,Bone
514,"Exostoses, multiple, type 2, 133701 (3)",EXT2,608210,11p12-p11,Bone
515,"Exudative vitreoretinopathy, 133780 (3)","FZD4, EVR1",604579,11q14-q21,Ophthamological
515,"Exudative vitreoretinopathy, dominant, 133780 (3)","LRP5, BMND1, LRP7, LR3, OPPG,
VBCH2",603506,11q13.4,Ophthamological
515,"Exudative vitreoretinopathy, recessive, 601813 (3)","LRP5, BMND1, LRP7, LR3, OPPG,
VBCH2",603506,11q13.4,Ophthamological
515,"Exudative vitreoretinopathy, X-linked, 305390 (3)","NDP, ND",310600,Xp11.4,Ophthamological
516,"Eye anomalies, multiplex (3)","PAX6, AN2, MGDA",607108,11p13,Ophthamological
517,"Ezetimibe, nonresponse to (3)",NPC1L1,608010,7p13,Unclassified
518,Fabry disease (3),GLA,301500,Xq22,Metabolic
519,Facioscapulohumeral muscular dystrophy-1A (3),"FSHMD1A, FSHD1A",158900,4q35,Muscular
520,Factor H and factor H-like 1 (3),"HF1, CFH, HUS",134370,1q32,Hematological
520,"Factor V and factor VIII, combined deficiency of, 227300 (3)",MCFD2,607788,2p21-p16.3,Hematological
520,Factor VII deficiency (3),F7,227500,13q34,Hematological
520,Factor X deficiency (3),F10,227600,13q34,Hematological
520,"Factor XI deficiency, autosomal dominant (3)",F11,264900,4q35,Hematological
520,"Factor XI deficiency, autosomal recessive (3)",F11,264900,4q35,Hematological
520,Factor XII deficiency (3),"F12, HAF",234000,5q33-qter,Hematological
520,Factor XIIIA deficiency (3),"F13A1, F13A",134570,6p25-p24,Hematological
520,Factor XIIIB deficiency (3),F13B,134580,1q31-q32.1,Hematological
522,"Familial Mediterranean fever, 249100 (3)","MEFV, MEF, FMF",608107,16p13,Immunological
523,"Fanconi anemia, complementation group A, 227650 (3)","FANCA, FACA, FA1, FA, FAA",607139,16q24.3,multiple
523,"Fanconi anemia, complementation group B, 300514 (3)","FAAP95, FAAP90, FLJ34064, FANCB",300515,Xp22.31,multiple
523,"Fanconi anemia, complementation group C (3)","FANCC, FACC",227645,9q22.3,multiple
523,"Fanconi anemia, complementation group D1, 605724 (3)","BRCA2, FANCD1",600185,13q12.3,multiple
523,"Fanconi anemia, complementation group D2 (3)","FANCD2, FANCD, FACD, FAD",227646,3p25.3,multiple
523,"Fanconi anemia, complementation group E (3)","FANCE, FACE",600901,6p22-p21,multiple
523,"Fanconi anemia, complementation group F (3)",FANCF,603467,11p15,multiple
523,"Fanconi anemia, complementation group G (3)","XRCC9, FANCG",602956,9p13,multiple
523,"Fanconi anemia, complementation group J, 609054 (3)","BRIP1, BACH1, FANCJ",605882,17q22,multiple
523,"Fanconi anemia, complementation group L (3)","PHF9, FANCL",608111,2p16.1,multiple
523,"Fanconi anemia, complementation group M (3)","FANCM, KIAA1596",609644,14q21.3,multiple
524,"Fanconi-Bickel syndrome, 227810 (3)","SLC2A2, GLUT2",138160,3q26.1-q26.3,Metabolic
526,Farber lipogranulomatosis (3),"ASAH, AC",228000,8p22-p21.3,Metabolic
527,"Fatty liver, acute, of pregnancy (3)","HADHA, MTPA",600890,2p23,Metabolic
528,Favism (3),"G6PD, G6PD1",305900,Xq28,Metabolic
530,"Fechtner syndrome, 153640 (3)","MYH9, MHA, FTNS, DFNA17",160775,22q11.2,multiple
531,"Feingold syndrome, 164280 (3)","MYCN, NMYC, ODED, MODED",164840,2p24.1,multiple
532,"Fertile eunuch syndrome, 228300 (3)","GNRHR, LHRHR",138850,4q21.2,Endocrine
535,"Fibrocalculous pancreatic diabetes, susceptibility to (3)","SPINK1, PSTI, PCTT, TATI",167790,5q32,Gastrointestinal
537,"Fibromatosis, gingival, 135300 (3)","SOS1, GINGF, GF1, HGF",182530,2p22-p21,Connective tissue
537,"Fibromatosis, juvenile hyaline, 228600 (3)","ANTXR2, CMG2, JHF, ISH",608041,4q21,Connective tissue
538,"Fibrosis of extraocular muscles, congenital, 1, 135700 (3)","KIF21A, KIAA1708, FEOM1, CFEOM1",608283,12q12,Ophthamological
538,"Fibrosis of extraocular muscles, congenital, 2, 602078 (3)","PHOX2A, ARIX, CFEOM2",602753,11q13.3-q13.4,Ophthamological
539,"Fibular hypoplasia and complex brachydactyly, 228900 (3)","GDF5, CDMP1",601146,20q11.2,Skeletal
540,"Fish-eye disease, 136120 (3)",LCAT,606967,16q22.1,Metabolic
541,"Fish-odor syndrome, 602079 (3)",FMO3,136132,1q23-q25,Metabolic
542,Fitzgerald factor deficiency (3),KNG,228960,3q27,Hematological
544,"Fluorouracil toxicity, sensitivity to (3)","DPYD, DPD",274270,1p22,Metabolic
545,"Focal cortical dysplasia, Taylor balloon cell type, 607341 (3)","TSC1, LAM",605284,9q34,Developmental
546,"Follicle-stimulating hormone deficiency, isolated, 229070 (3)",FSHB,136530,11p13,Endocrine
547,Forebrain defects (3),TDGF1,187395,3p23-p21,Neurological
548,"Foveal hypoplasia, isolated, 136520 (3)","PAX6, AN2, MGDA",607108,11p13,Ophthamological
549,"Foveomacular dystrophy, adult-onset, with choroidal neovascularization, 608161 (3)","RDS, RP7, PRPH2, PRPH, AVMD,
AOFMD",179605,6p21.1-cen,Ophthamological
550,Fragile X syndrome (3),"FMR1, FRAXA",309550,Xq27.3,Neurological
551,"Fraser syndrome, 219000 (3)",FRAS1,607830,4q21,multiple
551,"Fraser syndrome, 219000 (3)",FREM2,608945,13q13.3,multiple
552,"Frasier syndrome, 136680 (3)",WT1,607102,11p13,multiple
553,"Friedreich ataxia, 229300 (3)","FRDA, FARR",606829,9q13,Neurological
553,"Friedreich ataxia with retained reflexes, 229300 (3)","FRDA, FARR",606829,9q13,Neurological
554,"Frontometaphyseal dysplasia, 304120 (3)","FLNA, FLN1, ABPX, NHBP, OPD1,
OPD2, FMD, MNS",300017,Xq28,Skeletal
555,Fructose-bisphosphatase deficiency (3),FBP1,229700,9q22.2-q22.3,Metabolic
556,Fructose intolerance (3),ALDOB,229600,9q22.3,Metabolic
557,Fructosuria (3),KHK,229800,2p23.3-p23.2,Metabolic
558,"Fuchs endothelial corneal dystrophy, 136800 (3)","COL8A2, FECD, PPCD2",120252,1p34.3-p32.3,Ophthamological
559,Fucosidosis (3),FUCA1,230000,1p34,Metabolic
560,Fucosyltransferase-6 deficiency (3),FUT6,136836,19p13.3,Metabolic
561,"Fumarase deficiency, 606812 (3)",FH,136850,1q42.1,Metabolic
562,"Fundus albipunctatus, 136880 (3)",RDH5,601617,12q13-q14,Ophthamological
562,"Fundus albipunctatus, 136880 (3)",RLBP1,180090,15q26,Ophthamological
562,"Fundus flavimaculatus, 248200 (3)","ABCA4, ABCR, STGD1, FFM, RP19",601691,1p21-p13,Ophthamological
563,G6PD deficiency (3),"G6PD, G6PD1",305900,Xq28,Metabolic
564,GABA-transaminase deficiency (3),"ABAT, GABAT",137150,16p13.3,Metabolic
565,"Galactokinase deficiency with cataracts, 230200 (3)",GALK1,604313,17q24,Metabolic
566,"Galactose epimerase deficiency, 230350 (3)",GALE,606953,1p36-p35,Metabolic
567,"Galactosemia, 230400 (3)",GALT,606999,9p13,Metabolic
568,Galactosialidosis (3),"PPGB, GSL, NGBE, GLB2, CTSA",256540,20q13.1,Metabolic
570,GAMT deficiency (3),GAMT,601240,19p13.3,Metabolic
571,Gardner syndrome (3),"APC, GS, FPC",175100,5q21-q22,Cancer
572,"Gastric cancer, 137215 (3)","APC, GS, FPC",175100,5q21-q22,Cancer
572,"Gastric cancer, 137215 (3)","IRF1, MAR",147575,5q31.1,Cancer
572,"Gastric cancer, familial diffuse, 137215 (3)","CDH1, UVO",192090,16q22.1,Cancer
572,"Gastric cancer risk after H. pylori infection, 137215 (3)",IL1B,147720,2q14,Cancer
572,"Gastric cancer risk after H. pylori infection, 137215 (3)",IL1RN,147679,2q14.2,Cancer
572,"Gastric cancer, somatic, 137215 (3)","CASP10, MCH4, ALPS2",601762,2q33-q34,Cancer
572,"Gastric cancer, somatic, 137215 (3)","ERBB2, NGL, NEU, HER2",164870,17q21.1,Cancer
572,"Gastric cancer, somatic, 137215 (3)","FGFR2, BEK, CFD1, JWS",176943,10q26,Cancer
572,"Gastric cancer, somatic, 137215 (3)","KLF6, COPEB, BCD1, ZF9",602053,10p15,Cancer
572,"Gastric cancer, somatic, 137215 (3)",MUTYH,604933,1p34.3-p32.1,Cancer
574,"Gastrointestinal stromal tumor, somatic, 606764 (3)","KIT, PBT",164920,4q12,Cancer
574,"Gastrointestinal stromal tumor, somatic, 606764 (3)",PDGFRA,173490,4q12,Cancer
575,"Gaucher disease, 230800 (3)",GBA,606463,1q21,Metabolic
575,"Gaucher disease, variant form (3)","PSAP, SAP1",176801,10q22.1,Metabolic
575,"Gaucher disease with cardiovascular calcification, 231005 (3)",GBA,606463,1q21,Metabolic
576,"Gaze palsy, horizontal, with progressive scoliosis, 607313 (3)","ROBO3, RBIG1, RIG1, HGPPS",608630,11q23-q25,Neurological
578,"Generalized epilepsy and paroxysmal dyskinesia, 609446 (3)","KCNMA1, SLO",600150,10q22.3,Neurological
578,"Generalized epilepsy with febrile seizures plus, 604233 (3)","SCN1B, GEFSP1",600235,19q13.1,Neurological
580,Germ cell tumor (3),BCL10,603517,1p22,Cancer
580,"Germ cell tumors, 273300 (3)","KIT, PBT",164920,4q12,Cancer
581,"Gerstmann-Straussler disease, 137440 (3)","PRNP, PRIP",176640,20pter-p12,Neurological
582,"Giant axonal neuropathy-1, 256850 (3)","GAN, GAN1",605379,16q24.1,Neurological
583,Giant-cell fibroblastoma (3),"PDGFB, SIS",190040,22q12.3-q13.1,Cancer
2584,"Giant cell hepatitis, neonatal, 231100 (3)",CYP7B1,603711,8q21.3,Gastrointestinal
584,"Giant platelet disorder, isolated (3)",GP1BB,138720,22q11.2,Hematological
586,"Gilbert syndrome, 143500 (3)","UGT1A1, UGT1, GNT1",191740,2q37,Metabolic
587,"Gitelman syndrome, 263800 (3)","SLC12A3, NCCT, TSC",600968,16q13,Renal
588,"Glanzmann thrombasthenia, type A, 273800 (3)","ITGA2B, GP2B, CD41B",607759,17q21.32,Hematological
588,"Glanzmann thrombasthenia, type B (3)","ITGB3, GP3A",173470,17q21.32,Hematological
589,"Glaucoma 1A, primary open angle, juvenile-onset, 137750 (3)","MYOC, TIGR, GLC1A, JOAG, GPOA",601652,1q24.3-q25.2,Ophthamological
589,"Glaucoma 1A, primary open angle, recessive (3)","MYOC, TIGR, GLC1A, JOAG, GPOA",601652,1q24.3-q25.2,Ophthamological
589,"Glaucoma 1E, primary open angle, adult-onset, 137760 (3)","OPTN, GLC1E, FIP2, HYPL, NRP",602432,10p15-p14,Ophthamological
589,"Glaucoma 3A, primary congenital, 231300 (3)","CYP1B1, GLC3A",601771,2p22-p21,Ophthamological
589,"Glaucoma, early-onset, digenic (3)","CYP1B1, GLC3A",601771,2p22-p21,Ophthamological
589,"Glaucoma, early-onset, digenic (3)","MYOC, TIGR, GLC1A, JOAG, GPOA",601652,1q24.3-q25.2,Ophthamological
589,"Glaucoma, normal tension, susceptibility to, 606657 (3)","OPA1, NTG, NPG",605290,3q28-q29,Ophthamological
589,"Glaucoma, normal tension, susceptibility to, 606657 (3)","OPTN, GLC1E, FIP2, HYPL, NRP",602432,10p15-p14,Ophthamological
589,"Glaucoma, primary open angle, adult-onset, 137760 (3)","CYP1B1, GLC3A",601771,2p22-p21,Ophthamological
589,"Glaucoma, primary open angle, juvenile-onset, 137750 (3)","CYP1B1, GLC3A",601771,2p22-p21,Ophthamological
590,"Glioblastoma, early-onset, 137800 (3)","MSH2, COCA1, FCC1, HNPCC1",609309,2p22-p21,Cancer
590,"Glioblastoma multiforme, somatic, 137800 (3)",DMBT1,601969,10q25.3-q26.1,Cancer
590,"Glioblastoma, somatic, 137800 (3)","ERBB2, NGL, NEU, HER2",164870,17q21.1,Cancer
590,"Glioblastoma, somatic, 137800 (3)","LGI1, EPT, ETL1",604619,10q24,Cancer
590,"Glioblastoma, susceptibility to, 137800 (3)","PPARG, PPARG1, PPARG2",601487,3p25,Cancer
594,"Glomerulocystic kidney disease, hypoplastic, 137920 (3)","TCF2, HNF2",189907,17cen-q21.3,Renal
596,"Glomerulosclerosis, focal segmental, 1, 603278 (3)","ACTN4, FSGS1, FSGS",604638,19q13,Renal
596,"Glomerulosclerosis, focal segmental, 2, 603965 (3)","TRPC6, TRP6, FSGS2",603652,11q21-q22,Renal
596,"Glomerulosclerosis, focal segmental, 3, 607832 (3)","CD2AP, CMS",604241,Chr.6,Renal
597,"Glomuvenous malformations, 138000 (3)","GLML, GVM, VMGLOM",601749,1p22-p21,Cardiovascular
598,"Glucocorticoid deficiency 2, 607398 (3)","MRAP, FALP, C21orf61",609196,21q22.1,Endocrine
598,"Glucocorticoid deficiency, due to ACTH unresponsiveness, 202200 (3)",MC2R,607397,18p11.2,Endocrine
599,"Glucose/galactose malabsorption, 606824 (3)","SLC5A1, SGLT1",182380,22q13.1,Metabolic
600,"Glucose transport defect, blood-brain barrier, 606777 (3)","SLC2A1, GLUT1",138140,1p35-p31.3,Metabolic
601,"Glucosidase I deficiency, 606056 (3)",GCS1,601336,2p13-p12,Metabolic
602,"Glutamate formiminotransferase deficiency, 229100 (3)",FTCD,606806,21q22.3,Metabolic
603,"Glutaricaciduria, type I, 231670 (3)",GCDH,608801,19p13.2,Metabolic
603,"Glutaricaciduria, type IIA, 231680 (3)","ETFA, GA2, MADD",608053,15q23-q25,Metabolic
603,"Glutaricaciduria, type IIB, 231680 (3)","ETFB, MADD",130410,19q13.3,Metabolic
603,"Glutaricaciduria, type IIC, 231680 (3)","ETFDH, MADD",231675,4q32-qter,Metabolic
604,"Glutathione synthetase deficiency, 266130 (3)","GSS, GSHS",601002,20q11.2,Metabolic
607,"Glycerol kinase deficiency, 307030 (3)",GK,300474,Xp21.3-p21.2,Metabolic
608,"Glycine encephalopathy, 605899 (3)","AMT, NKH, GCE",238310,3p21.2-p21.1,Metabolic
608,"Glycine encephalopathy, 605899 (3)","GCSH, NKH",238330,16q24,Metabolic
608,"Glycine encephalopathy, 605899 (3)","GLDC, HYGN1, GCSP, GCE, NKH",238300,9p22,Metabolic
608,"Glycine N-methyltransferase deficiency, 606664 (3)",GNMT,606628,6p12,Metabolic
609,"Glycogenosis, hepatic, autosomal (3)",PHKG2,172471,16p12.1-p11.2,Metabolic
609,"Glycogenosis, X-linked hepatic, type I (3)","PHKA2, PHK",306000,Xp22.2-p22.1,Metabolic
609,"Glycogenosis, X-linked hepatic, type II (3)","PHKA2, PHK",306000,Xp22.2-p22.1,Metabolic
610,Glycogen storage disease I (3),"G6PC, G6PT",232200,17q21,Metabolic
610,"Glycogen storage disease Ib, 232220 (3)",G6PT1,602671,11q23,Metabolic
610,"Glycogen storage disease Ic, 232240 (3)",G6PT1,602671,11q23,Metabolic
610,"Glycogen storage disease II, 232300 (3)",GAA,606800,17q25.2-q25.3,Metabolic
610,"Glycogen storage disease IIb, 300257 (3)","LAMP2, LAMPB",309060,Xq24,Metabolic
610,Glycogen storage disease IIIa (3),"AGL, GDE",232400,1p21,Metabolic
610,Glycogen storage disease IIIb (3),"AGL, GDE",232400,1p21,Metabolic
610,"Glycogen storage disease IV, 232500 (3)",GBE1,607839,3p12,Metabolic
610,"Glycogen storage disease, type 0, 240600 (3)",GYS2,138571,12p12.2,Metabolic
610,Glycogen storage disease VI (3),PYGL,232700,14q21-q22,Metabolic
610,Glycogen storage disease VII (3),PFKM,232800,12q13.3,Metabolic
614,GM1-gangliosidosis (3),GLB1,230500,3p21.33,Metabolic
614,"GM2-gangliosidosis, AB variant (3)",GM2A,272750,5q31.3-q33.1,Metabolic
614,"GM2-gangliosidosis, several forms, 272800 (3)","HEXA, TSD",606869,15q23-q24,Metabolic
615,"Gnthodiaphyseal dysplasia, 166260 (3)","TMEM16E, GDD1",608662,11p14.3,Bone
617,"Goiter, congenital (3)","TPO, TPX",606765,2p25,Endocrine
617,"Goiter, nonendemic, simple (3)","TG, AITD3",188450,8q24.2-q24.3,Endocrine
618,"Goldberg-Shprintzen megacolon syndrome, 609460 (3)",KIAA1279,609367,10q22.1,multiple
619,"Gonadal dysgenesis, 46XY, partial, with minifascicular neuropathy, 607080 (3)",DHH,605423,12q13.1,Endocrine
619,"Gonadal dysgenesis, XY type (3)","SRY, TDF",480000,Yp11.3,Endocrine
622,"GRACILE syndrome, 603358 (3)","BCS1L, FLNMS, GRACILE",603647,2q33,Metabolic
623,"Graft-versus-host disease, protection against (3)","IL10, CSIF",124092,1q31-q32,Immunological
624,"Graves disease, susceptibility to, 275000 (3)",CTLA4,123890,2q33,Endocrine
624,"Graves disease, susceptibility to, 3, 275000 (3)","GC, DBP",139200,4q12,Endocrine
625,"Greenberg dysplasia, 215140 (3)","LBR, PHA",600024,1q42.1,Skeletal
626,"Greig cephalopolysyndactyly syndrome, 175700 (3)","GLI3, PAPA, PAPB, ACLS",165240,7p13,Skeletal
627,"Griscelli syndrome, type 1, 214450 (3)","MYO5A, MYH12, GS1",160777,15q21,Dermatological
627,"Griscelli syndrome, type 2, 607624 (3)","RAB27A, RAM, GS2",603868,15q21,Dermatological
627,"Griscelli syndrome, type 3, 609227 (3)",MLPH,606526,2q37,Dermatological
628,Growth hormone deficient dwarfism (3),GHRHR,139191,7p15-p14,Endocrine
628,"Growth hormone insensitivity with immunodeficiency, 245590 (3)",STAT5B,604260,17q11.2,Endocrine
2628,"Growth retardation with deafness and mental retardation due to IGF1 deficiency,
608747 (3)",IGF1,147440,12q22-q24.1,Developmental
630,"Guttmacher syndrome, 176305 (3)","HOXA13, HOX1J",142959,7p15-p14.2,multiple
632,"Gyrate atrophy of choroid and retina with ornithinemia, B6 responsive or unresponsive
(3)",OAT,258870,10q26,Metabolic
633,"Hailey-Hailey disease, 169600 (3)","ATP2C1, BCPM, HHD",604384,3q21-q24,Dermatological
634,"Haim-Munk syndrome, 245010 (3)","CTSC, CPPI, PALS, PLS, HMS",602365,11q14.1-q14.3,multiple
638,"Hand-foot-uterus syndrome, 140000 (3)","HOXA13, HOX1J",142959,7p15-p14.2,multiple
639,Harderoporphyrinuria (3),CPO,121300,3q12,Metabolic
640,"HARP syndrome, 607236 (3)","PANK2, NBIA1, PKAN, HARP",606157,20p13-p12.3,Metabolic
641,"Hartnup disorder, 234500 (3)","SLC6A19, HND",608893,5p15,Metabolic
643,"Hay-Wells syndrome, 106260 (3)","TP73L, TP63, KET, EEC3, SHFM4, LMS,
RHS",603273,3q27,multiple
644,"HDL deficiency, familial, 604091 (3)","ABCA1, ABC1, HDLDT1, TGD",600046,9q22-q31,Metabolic
644,"HDL response to hormone replacement, augmented (3)","ESR1, ESR",133430,6q25.1,Metabolic
646,"Hearing loss, low-frequency sensorineural, 600965 (3)","WFS1, WFRS, WFS, DFNA6",606201,4p16.1,"Ear,Nose,Throat"
647,"Heart block, nonprogressive, 113900 (3)","SCN5A, LQT3, IVF, HB1, SSS1",600163,3p21,Cardiovascular
647,"Heart block, progressive, type I, 113900 (3)","SCN5A, LQT3, IVF, HB1, SSS1",600163,3p21,Cardiovascular
648,Heinz body anemia (3),HBA2,141850,16pter-p13.3,Hematological
648,"Heinz body anemias, alpha- (3)",HBA1,141800,16pter-p13.3,Hematological
648,"Heinz body anemias, beta- (3)",HBB,141900,11p15.5,Hematological
649,"HELLP syndrome, maternal, of pregnancy (3)","HADHA, MTPA",600890,2p23,Metabolic
650,"Hemangioblastoma, cerebellar, somatic (3)",VHL,608537,3p26-p25,Cancer
651,"Hemangioma, capillary infantile, somatic, 602089 (3)","FLT4, VEGFR3, PCL",136352,5q35.3,Cancer
651,"Hemangioma, capillary infantile, somatic, 602089 (3)",KDR,191306,4q12,Cancer
652,"Hematopoiesis, cyclic, 162800 (3)",ELA2,130130,19p13.3,Hematological
653,"Hematuria, familial benign (3)",COL4A4,120131,2q36-q37,Renal
654,Heme oxygenase-1 deficiency (3),HMOX1,141250,22q12,Metabolic
656,"Hemiplegic migraine, familial, 141500 (3)","CACNA1A, CACNL1A4, SCA6",601011,19p13,Neurological
657,Hemochromatosis (3),"HFE, HLA-H, HFE1",235200,6p21.3,Metabolic
657,"Hemochromatosis, juvenile, 602390 (3)","HAMP, LEAP1, HEPC, HFE2",606464,19q13,Metabolic
657,"Hemochromatosis, juvenile, digenic, 602390 (3)","HAMP, LEAP1, HEPC, HFE2",606464,19q13,Metabolic
657,"Hemochromatosis, type 2A, 602390 (3)","HJV, HFE2A",608374,1q21,Metabolic
657,"Hemochromatosis, type 3, 604250 (3)","TFR2, HFE3",604720,7q22,Metabolic
657,"Hemochromatosis, type 4, 606069 (3)","SLC40A1, SLC11A3, FPN1, IREG1,
HFE4",604653,2q32,Metabolic
659,Hemoglobin H disease (3),HBA2,141850,16pter-p13.3,Hematological
660,Hemolytic anemia due to adenylate kinase deficiency (3),AK1,103000,9q34.1,Hematological
660,Hemolytic anemia due to band 3 defect defect (3),"SLC4A1, AE1, EPB3",109270,17q21-q22,Hematological
660,Hemolytic anemia due to bisphosphoglycerate mutase deficiency (3),BPGM,222800,7q31-q34,Hematological
660,Hemolytic anemia due to G6PD deficiency (3),"G6PD, G6PD1",305900,Xq28,Hematological
660,"Hemolytic anemia due to gamma-glutamylcysteine synthetase deficiency, 230450 (3)","GCLC, GLCLC",606857,6p12,Hematological
660,Hemolytic anemia due to glucosephosphate isomerase deficiency (3),GPI,172400,19q13.1,Hematological
660,"Hemolytic anemia due to glutathione synthetase deficiency, 231900 (3)","GSS, GSHS",601002,20q11.2,Hematological
660,Hemolytic anemia due to hexokinase deficiency (3),HK1,142600,10q22,Hematological
660,Hemolytic anemia due to PGK deficiency (3),"PGK1, PGKA",311800,Xq13,Hematological
660,Hemolytic anemia due to triosephosphate isomerase deficiency (3),TPI1,190450,12p13,Hematological
661,"Hemolytic-uremic syndrome, 235400 (3)","HF1, CFH, HUS",134370,1q32,Hematological
662,"Hemophagocytic lymphohistiocytosis, familial, 2, 603553 (3)","PRF1, HPLH2",170280,10q22,Hematological
662,"Hemophagocytic lymphohistiocytosis, familial, 3, 608898 (3)","UNC13D, MUNC13-4, HPLH3, HLH3,
FHL3",608897,17q25.1,Hematological
663,Hemophilia A (3),"F8, F8C, HEMA",306700,Xq28,Hematological
663,Hemophilia B (3),"F9, HEMB",306900,Xq27.1-q27.2,Hematological
664,Hemorrhagic diathesis due to \`antithrombin\' Pittsburgh (3),"PI, AAT",107400,14q32.1,Hematological
664,Hemorrhagic diathesis due to factor V deficiency (3),F5,227400,1q23,Hematological
665,"Hemosiderosis, systemic, due to aceruloplasminemia, 604290 (3)",CP,117700,3q23-q24,Hematological
668,"Hepatic adenoma, 142330 (3)","TCF1, HNF1A, MODY3",142410,12q24.2,Cancer
666,"Hepatic failure, early onset, and neurologic disorder (3)","SCOD1, SCO1",603644,17p13-p12,Gastrointestinal
4666,Hepatic lipase deficiency (3),LIPC,151670,15q21-q23,Metabolic
668,Hepatoblastoma (3),CTNNB1,116806,3p22-p21.3,Cancer
668,"Hepatocellular cancer, 114550 (3)","PDGFRL, PDGRL, PRLTS",604584,8p22-p21.3,Cancer
668,"Hepatocellular carcinoma, 114550 (3)","AXIN1, AXIN",603816,16p13.3,Cancer
668,"Hepatocellular carcinoma, 114550 (3)",CTNNB1,116806,3p22-p21.3,Cancer
668,"Hepatocellular carcinoma, 114550 (3)","TP53, P53, LFS1",191170,17p13.1,Cancer
668,Hepatocellular carcinoma (3),"IGF2R, MPRI",147280,6q26,Cancer
668,"Hepatocellular carcinoma, childhood type, 114550 (3)",MET,164860,7q31,Cancer
668,"Hepatocellular carcinoma, somatic, 114550 (3)","CASP8, MCH5",601763,2q33-q34,Cancer
669,"Hereditary hemorrhagic telangiectasia-1, 187300 (3)","ENG, END, HHT1, ORW",131195,9q34.1,Cardiovascular
669,"Hereditary hemorrhagic telangiectasia-2, 600376 (3)","ACVRL1, ACVRLK1, ALK1, HHT2",601284,12q11-q14,Cardiovascular
2669,Hereditary persistence of alpha-fetoprotein (3),"AFP, HPAFP",104150,4q11-q13,Hematological
670,"Hermansky-Pudlak syndrome, 203300 (3)",HPS1,604982,10q23.1,multiple
670,"Hermansky-Pudlak syndrome, 203300 (3)",HPS3,606118,3q24,multiple
670,"Hermansky-Pudlak syndrome, 203300 (3)",HPS4,606682,22q11.2-q12.2,multiple
670,"Hermansky-pudlak syndrome, 203300 (3)","HPS5, RU2, KIAA1017",607521,11p15-p13,multiple
670,"Hermansky-Pudlak syndrome, 203300 (3)","HPS6, RU",607522,10q24.32,multiple
670,"Hermansky-Pudlak syndrome, 608233 (3)","AP3B1, ADTB3A, HPS2",603401,5q14.1,multiple
670,"Hermansky-Pudlak syndrome 7, 203300 (3)","DTNBP1, HPS7",607145,6p22.3,multiple
675,"Heterotaxy, visceral, 605376 (3)","CFC1, CRYPTIC, HTX2",605194,2q21.1,multiple
675,"Heterotaxy, X-linked visceral, 306955 (3)","ZIC3, HTX1, HTX",300265,Xq26.2,multiple
676,"Heterotopia, periventricular, 300049 (3)","FLNA, FLN1, ABPX, NHBP, OPD1,
OPD2, FMD, MNS",300017,Xq28,Neurological
676,"Heterotopia, periventricular, ED variant, 300537 (3)","FLNA, FLN1, ABPX, NHBP, OPD1,
OPD2, FMD, MNS",300017,Xq28,Neurological
676,"Heterotopia, periventricular nodular, with frontometaphyseal dysplasia, 300049 (3)","FLNA, FLN1, ABPX, NHBP, OPD1,
OPD2, FMD, MNS",300017,Xq28,Neurological
677,"Hex A pseudodeficiency, 272800 (3)","HEXA, TSD",606869,15q23-q24,Metabolic
679,High-molecular-weight kininogen deficiency (3),KNG,228960,3q27,Hematological
681,"Hirschsprung disease, 142623 (3)",EDN3,131242,20q13.2-q13.3,Gastrointestinal
681,"Hirschsprung disease, 142623 (3)",GDNF,600837,5p13.1-p12,Gastrointestinal
681,"Hirschsprung disease, 142623 (3)","NRTN, NTN",602018,19p13.3,Gastrointestinal
681,"Hirschsprung disease, 142623 (3)","RET, MEN2A",164761,10q11.2,Gastrointestinal
681,"Hirschsprung disease-2, 600155 (3)","EDNRB, HSCR2, ABCDS",131244,13q22,Gastrointestinal
681,"Hirschsprung disease, cardiac defects, and autonomic dysfunction (3)",ECE1,600423,1p36.1,Gastrointestinal
681,"Hirschsprung disease, short-segment, 142623 (3)","PMX2B, NBPHOX, PHOX2B",603851,4p12,Gastrointestinal
682,"Histidinemia, 235800 (3)","HAL, HSTD",609457,12q22-q23,Metabolic
683,Histiocytoma (3),"TP53, P53, LFS1",191170,17p13.1,Cancer
684,"HIV-1 disease, delayed progression of (3)","CCL5, SCYA5, D17S136E, TCP228",187011,17q11.2-q12,Immunological
684,"HIV-1 disease, rapid progression of (3)","CCL5, SCYA5, D17S136E, TCP228",187011,17q11.2-q12,Immunological
684,"HIV-1, susceptibility to (3)","IL10, CSIF",124092,1q31-q32,Immunological
684,"HIV infection, susceptibility/resistance to (3)","CMKBR2, CCR2",601267,3p21,Immunological
684,"HIV infection, susceptibility/resistance to (3)","CMKBR5, CCCKR5",601373,3p21,Immunological
686,HMG-CoA lyase deficiency (3),HMGCL,246450,1pter-p33,Metabolic
686,"HMG-CoA synthase-2 deficiency, 605911 (3)",HMGCS2,600234,1p13-p12,Metabolic
688,"Holocarboxylase synthetase deficiency, 253270 (3)","HLCS, HCS",609018,21q22.1,Metabolic
689,"Holoprosencephaly-2, 157170 (3)","SIX3, HPE2",603714,2p21,Developmental
689,"Holoprosencephaly-3, 142945 (3)","SHH, HPE3, HLP3, SMMCI",600725,7q36,Developmental
689,"Holoprosencephaly-4, 142946 (3)","TGIF, HPE4",602630,18p11.3,Developmental
689,"Holoprosencephaly-5, 609637 (3)","ZIC2, HPE5",603073,13q32,Developmental
689,Holoprosencephaly-7 (3),"PTCH, NBCCS, BCNS, HPE7",601309,9q22.3,Developmental
696,"Holt-Oram syndrome, 142900 (3)",TBX5,601620,12q24.1,Developmental
697,"Homocysteine, total plasma, elevated (3)",CTH,607657,1p31.1,Metabolic
698,"Homocystinuria, B6-responsive and nonresponsive types (3)",CBS,236200,21q22.3,Metabolic
698,"Homocystinuria due to MTHFR deficiency, 236250 (3)",MTHFR,607093,1p36.3,Metabolic
699,"Homocystinuria-megaloblastic anemia, cbl E type, 236270 (3)",MTRR,602568,5p15.3-p15.2,Metabolic
701,"Homozygous 2p16 deletion syndrome, 606407 (3)","SLC3A1, ATR1, D2H, NBAT",104614,2p16.3,multiple
702,"Hoyeraal-Hreidarsson syndrome, 300240 (3)","DKC1, DKC",300126,Xq28,multiple
703,"HPFH, deletion type (3)",HBB,141900,11p15.5,Hematological
703,"HPFH, nondeletion type A (3)",HBG1,142200,11p15.5,Hematological
703,"HPFH, nondeletion type G (3)",HBG2,142250,11p15.5,Hematological
704,"HPRT-related gout, 300323 (3)","HPRT1, HPRT",308000,Xq26-q27.2,Metabolic
705,"H. pylori infection, susceptibility to, 600263 (3)",IFNGR1,107470,6q23-q24,Immunological
708,Huntington disease (3),"HD, IT15",143100,4p16.3,Neurological
708,"Huntington disease-like 1, 603218 (3)","PRNP, PRIP",176640,20pter-p12,Neurological
708,"Huntington disease-like 2, 606438 (3)","JPH3, JP3, HDL2",605268,16q24.3,Neurological
708,"Huntington disease-like-4, 607136 (3)","TBP, SCA17",600075,6q27,Neurological
710,"Hyalinosis, infantile systemic, 236490 (3)","ANTXR2, CMG2, JHF, ISH",608041,4q21,multiple
712,"Hydrocephalus due to aqueductal stenosis, 307000 (3)","L1CAM, CAML1, HSAS1",308840,Xq28,Neurological
712,"Hydrocephalus with congenital idiopathic intestinal pseudoobstruction, 307000 (3)","L1CAM, CAML1, HSAS1",308840,Xq28,Neurological
712,"Hydrocephalus with Hirschsprung disease and cleft palate, 142623 (3)","L1CAM, CAML1, HSAS1",308840,Xq28,Neurological
716,"Hyperalphalipoproteinemia, 143470 (3)",CETP,118470,16q21,Metabolic
717,"Hyperammonemia with hypoornithinemia, hypocitrullinemia, hypoargininemia, and
hypoprolinemia (3)","PYCS, GSAS",138250,10q24.3,Metabolic
718,"Hyperandrogenism, nonclassic type, due to 21-hydroxylase deficiency (3)","CYP21A2, CYP21, CA21H",201910,6p21.3,Endocrine
719,"Hyperapobetalipoproteinemia, susceptibility to (3)","PPARA, PPAR",170998,22q12-q13.1,Metabolic
720,"Hyperbilirubinemia, familial transcient neonatal, 237900 (3)","UGT1A1, UGT1, GNT1",191740,2q37,Gastrointestinal
721,"Hypercalciuria, absorptive, susceptibility to, 143870 (3)","SAC, HCA2",605205,1q24,Renal
723,"Hypercholanemia, familial, 607748 (3)",BAAT,602938,9q22.3,Gastrointestinal
723,"Hypercholanemia, familial, 607748 (3)",EPHX1,132810,1q42.1,Gastrointestinal
723,"Hypercholanemia, familial, 607748 (3)","TJP2, ZO2",607709,9q12-q13,Gastrointestinal
724,"Hypercholesterolemia, due to ligand-defective apo B, 144010 (3)","APOB, FLDB",107730,2p24,Metabolic
724,"Hypercholesterolemia, familial, 143890 (3)","LDLR, FHC, FH",606945,19p13.2,Metabolic
724,"Hypercholesterolemia, familial, 3, 603776 (3)","PCSK9, NARC1, HCHOLA3, FH3",607786,1p34.1-p32,Metabolic
724,"Hypercholesterolemia, familial, autosomal recessive, 603813 (3)","ARH, FHCB2, FHCB1",605747,1p36-p35,Metabolic
724,"Hypercholesterolemia, familial, due to LDLR defect, modifier of, 143890 (3)",EPHX2,132811,8p21-p12,Metabolic
724,"Hypercholesterolemia, familial, modification of, 143890 (3)",APOA2,107670,1q21-q23,Metabolic
724,"Hypercholesterolemia, susceptibility to, 143890 (3)",GSBS,604088,7p15,Metabolic
724,"Hypercholesterolemia, susceptibility to, 143890 (3)","ITIH4, PK120, ITIHL1",600564,3p21.2-p14.1,Metabolic
725,Hyperekplexia and spastic paraparesis (3),"GLRA1, STHE",138491,5q32,Neurological
725,"Hyperekplexia, autosomal recessive, 149400 (3)",GLRB,138492,4q31.3,Neurological
726,"Hypereosinophilic syndrome, idiopathic, resistant to imatinib, 607685 (3)",PDGFRA,173490,4q12,Hematological
727,"Hyperferritinemia-cataract syndrome, 600886 (3)",FTL,134790,19q13.3-q13.4,Ophthamological
728,"Hyper-IgD syndrome, 260920 (3)","MVK, MVLK",251170,12q24,Immunological
731,"Hyperinsulinism, familial, 602485 (3)",GCK,138079,7p15-p13,Metabolic
732,"Hyperinsulinism-hyperammonemia syndrome, 606762 (3)",GLUD1,138130,10q23.3,Metabolic
733,"Hyperkalemic periodic paralysis, 170500 (3)","SCN4A, HYPP, NAC1A",603967,17q23.1-q25.3,Neurological
734,"Hyperkeratotic cutaneous capillary-venous malformations associated with cerebral
capillary malformations, 116860 (3)","CCM1, CAM, KRIT1",604214,7q11.2-q21,Neurological
736,"Hyperlipidemia, familial combined, susceptibility to, 602491 (3)","USF1, HYPLIP1",191523,1q22-q23,Metabolic
737,"Hyperlipoproteinemia, type Ib, 207750 (3)",APOC2,608083,19q13.2,Metabolic
737,"Hyperlipoproteinemia, type III (3)","APOE, AD2",107741,19q13.2,Metabolic
738,"Hyperlysinemia, 238700 (3)",AASS,605113,7q31.3,Metabolic
739,"Hypermethioninemia, persistent, autosomal dominant, due to methionine
adenosyltransferase I/III deficiency (3)","MAT1A, MATA1, SAMS1",250850,10q22,Metabolic
739,Hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase (3),"AHCY, SAHH",180960,20cen-q13.1,Metabolic
740,"Hyperornithinemia-hyperammonemia-homocitrullinemia syndrome, 238970 (3)","SLC25A15, ORNT1, HHH",603861,13q14,Metabolic
741,"Hyperostosis, endosteal, 144750 (3)","LRP5, BMND1, LRP7, LR3, OPPG,
VBCH2",603506,11q13.4,Bone
742,"Hyperoxaluria, primary, type 1, 259900 (3)","AGXT, SPAT",604285,2q36-q37,Metabolic
742,"Hyperoxaluria, primary, type II, 260000 (3)","GRHPR, GLXR",604296,9cen,Metabolic
743,"Hyperparathyroidism, AD, 145000 (3)",MEN1,131100,11q13,Endocrine
743,"Hyperparathyroidism, familial primary, 145000 (3)","HRPT2, C1orf28",607393,1q25-q31,Endocrine
743,"Hyperparathyroidism-jaw tumor syndrome, 145001 (3)","HRPT2, C1orf28",607393,1q25-q31,Endocrine
743,"Hyperparathyroidism, neonatal, 239200 (3)","CASR, HHC1, PCAR1, FIH",601199,3q13.3-q21,Endocrine
746,"Hyperphenylalaninemia due to pterin-4a-carbinolamine dehydratase deficiency, 264070
(3)","PCBD, DCOH",126090,10q22,Metabolic
746,"Hyperphenylalaninemia, mild (3)","PAH, PKU1",261600,12q24.1,Metabolic
748,"Hyperproinsulinemia, familial (3)",INS,176730,11p15.5,Endocrine
749,"Hyperprolinemia, type I, 239500 (3)","PRODH, PRODH2, SCZD4",606810,22q11.2,Metabolic
749,"Hyperprolinemia, type II, 239510 (3)","ALDH4A1, ALDH4, P5CDH",606811,1p36,Metabolic
750,Hyperproreninemia (3),REN,179820,1q32,Cardiovascular
751,Hyperprothrombinemia (3),F2,176930,11p11-q12,Hematological
752,"Hypertension, diastolic, resistance to, 608622 (3)",KCNMB1,603951,5q34,Cardiovascular
752,"Hypertension, early-onset, autosomal dominant, with exacerbation in pregnancy,
605115 (3)","NR3C2, MLR, MCR",600983,4q31.1,Cardiovascular
752,"Hypertension, essential, 145500 (3)","AGTR1, AGTR1A, AT2R1",106165,3q21-q25,Cardiovascular
752,"Hypertension, essential, 145500 (3)","PTGIS, CYP8A1, PGIS, CYP8",601699,20q13.11-q13.13,Cardiovascular
752,"Hypertension, essential, salt-sensitive, 145500 (3)",ADD1,102680,4p16.3,Cardiovascular
752,"Hypertension, essential, susceptibility to, 145500 (3)","AGT, SERPINA8",106150,1q42-q43,Cardiovascular
752,"Hypertension, essential, susceptibility to, 145500 (3)",ECE1,600423,1p36.1,Cardiovascular
752,"Hypertension, essential, susceptibility to, 145500 (3)",GNB3,139130,12p13,Cardiovascular
752,"Hypertension, insulin resistance-related, susceptibility to, 125853 (3)","RETN, RSTN, FIZZ3",605565,19p13.2,Cardiovascular
752,"Hypertension, mild low-renin (3)","HSD11B2, HSD11K",218030,16q22,Cardiovascular
752,"Hypertension, pregnancy-induced, 189800 (3)",NOS3,163729,7q36,Cardiovascular
752,"Hypertension, salt-sensitive essential, susceptibility to, 145500 (3)","CYP3A5, P450PCN3",605325,7q22.1,Cardiovascular
752,"Hypertension, susceptibility to, 145500 (3)",NOS3,163729,7q36,Cardiovascular
754,"Hyperthroidism, congenital (3)",TSHR,603372,14q31,Endocrine
755,"Hyperthyroidism, congenital (3)","TPO, TPX",606765,2p25,Endocrine
757,"Hypertriglyceridemia, one form (3)",APOA1,107680,11q23,Metabolic
757,"Hypertriglyceridemia, susceptibility to, 145750 (3)",APOA5,606368,11q23,Metabolic
757,"Hypertriglyceridemia, susceptibility to, 145750 (3)","LIPI, LPDL, PRED5",609252,21q11.2,Metabolic
757,"Hypertriglyceridemia, susceptibility to, 145750 (3)","RP1, ORP1",603937,8q11-q13,Metabolic
758,"Hypertrypsinemia, neonatal (3)","CFTR, ABCC7, CF, MRP7",602421,7q31.2,Gastrointestinal
759,"Hyperuricemic nephropathy, familial juvenile, 162000 (3)","UMOD, HNFJ, FJHN, MCKD2,
ADMCKD2",191845,16p12.3,Renal
761,"Hypoaldosteronism, congenital, due to CMO I deficiency, 203400 (3)",CYP11B2,124080,8q21,Metabolic
761,"Hypoaldosteronism, congenital, due to CMO II deficiency (3)",CYP11B2,124080,8q21,Metabolic
762,Hypoalphalipoproteinemia (3),APOA1,107680,11q23,Metabolic
763,Hypobetalipoproteinemia (3),"APOB, FLDB",107730,2p24,Metabolic
764,"Hypocalcemia, autosomal dominant, 146200 (3)","CASR, HHC1, PCAR1, FIH",601199,3q13.3-q21,Endocrine
764,"Hypocalcemia, autosomal dominant, with Bartter syndrome (3)","CASR, HHC1, PCAR1, FIH",601199,3q13.3-q21,Endocrine
765,"Hypocalciuric hypercalcemia, type I, 145980 (3)","CASR, HHC1, PCAR1, FIH",601199,3q13.3-q21,Endocrine
766,"Hypoceruloplasminemia, hereditary, 604290 (3)",CP,117700,3q23-q24,Metabolic
767,"Hypochondroplasia, 146000 (3)","FGFR3, ACH",134934,4p16.3,Skeletal
768,Hypochromic microcytic anemia (3),HBA2,141850,16pter-p13.3,Hematological
769,"Hypodontia, 106600 (3)",PAX9,167416,14q12-q13,Skeletal
769,"Hypodontia, autosomal dominant, 106600 (3)","MSX1, HOX7, HYD1, OFC5",142983,4p16.1,Skeletal
769,"Hypodontia with orofacial cleft, 106600 (3)","MSX1, HOX7, HYD1, OFC5",142983,4p16.1,Skeletal
770,"Hypofibrinogenemia, gamma type (3)",FGG,134850,4q28,Hematological
771,Hypoglobulinemia and absent B cells (3),"BLNK, SLP65",604515,10q23.2,Immunological
772,"Hypoglycemia of infancy, leucine-sensitive, 240800 (3)","ABCC8, SUR, PHHI, SUR1",600509,11p15.1,Metabolic
772,"Hypoglycemia of infancy, persistent hyperinsulinemic, 256450 (3)","ABCC8, SUR, PHHI, SUR1",600509,11p15.1,Metabolic
773,"Hypogonadism, hypergonadotropic (3)",LHB,152780,19q13.32,Endocrine
774,"Hypogonadotropic hypogonadism, 146110 (3)",GPR54,604161,19p13.3,Endocrine
774,"Hypogonadotropic hypogonadism, 146110 (3)",NELF,608137,9q34.3,Endocrine
774,Hypogonadotropic hypogonadism (3),"GNRHR, LHRHR",138850,4q21.2,Endocrine
774,Hypogonadotropic hypogonadism (3),LHCGR,152790,2p21,Endocrine
775,Hypohaptoglobinemia (3),HP,140100,16q22.1,Hematological
776,"Hypokalemic periodic paralysis, 170400 (3)","CACNA1S, CACNL1A3, CCHL1A3",114208,1q32,Renal
776,"Hypokalemic periodic paralysis, 170400 (3)","KCNE3, HOKPP",604433,11q13-q14,Renal
776,"Hypokalemic periodic paralysis, 170400 (3)","SCN4A, HYPP, NAC1A",603967,17q23.1-q25.3,Renal
777,"Hypolactasia, adult type, 223100 (3)","LCT, LAC, LPH",603202,2q21,Metabolic
777,"Hypolactasia, adult type, 223100 (3)",MCM6,601806,2q21,Metabolic
778,"Hypomagnesemia-2, renal, 154020 (3)","FXYD2, ATP1G1, HOMG2",601814,11q23,Renal
778,"Hypomagnesemia, primary, 248250 (3)","CLDN16, PCLN1",603959,3q27,Renal
778,"Hypomagnesemia with secondary hypocalcemia, 602014 (3)","TRPM6, CHAK2",607009,9q22,Renal
779,"Hypoparathyroidism, autosomal dominant(3)",PTH,168450,11p15.3-p15.1,Endocrine
779,"Hypoparathyroidism, autosomal recessive (3)",PTH,168450,11p15.3-p15.1,Endocrine
779,"Hypoparathyroidism, familial isolated, 146200 (3)",GCMB,603716,6p24.2,Endocrine
780,"Hypoparathyroidism-retardation-dysmorphism syndrome, 241410 (3)","TBCE, KCS, KCS1, HRD",604934,1q42-q43,Endocrine
781,"Hypoparathyroidism, sensorineural deafness, and renal dysplasia, 146255 (3)","GATA3, HDR",131320,10p15,Endocrine
782,"Hypophosphatasia, childhood, 241510 (3)","ALPL, HOPS, TNSALP",171760,1p36.1-p34,Metabolic
782,"Hypophosphatasia, infantile, 241500 (3)","ALPL, HOPS, TNSALP",171760,1p36.1-p34,Metabolic
783,"Hypophosphatemia, type III (3)","CLCN5, CLCK2, NPHL2, DENTS",300008,Xp11.22,Metabolic
783,"Hypophosphatemia, X-linked, 307800 (3)","PHEX, HYP, HPDR1",300550,Xp22.2-p22.1,Metabolic
784,"Hypophosphatemic rickets, autosomal dominant, 193100 (3)","FGF23, ADHR, HPDR2, PHPTC",605380,12p13.3,Bone
785,"Hypoplastic enamel pitting, localized, 608563 (3)",ENAM,606585,4q21,Connective tissue
2785,"Hypoplastic left heart syndrome, 241550 (3)","GJA1, CX43, ODDD, SDTY3, ODOD",121014,6q21-q23.2,Cardiovascular
786,Hypoprothrombinemia (3),F2,176930,11p11-q12,Hematological
787,"Hypothyroidism, autoimmune, 140300 (3)",CTLA4,123890,2q33,Endocrine
787,"Hypothyroidism, congenital, 274400 (3)","SLC5A5, NIS",601843,19p13.2-p12,Endocrine
787,"Hypothyroidism, congenital, due to DUOX2 deficiency, 607200 (3)","DUOX2, THOX2",606759,15q15.3,Endocrine
787,"Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia, 218700 (3)",PAX8,167415,2q12-q14,Endocrine
787,"Hypothyroidism, congenital, due to TSH resistance, 275200 (3)",TSHR,603372,14q31,Endocrine
787,"Hypothyroidism, hereditary congenital (3)","TG, AITD3",188450,8q24.2-q24.3,Endocrine
787,"Hypothyroidism, nongoitrous (3)",TSHB,188540,1p13,Endocrine
787,"Hypothyroidism, subclinical (3)",TSHR,603372,14q31,Endocrine
788,"Hypotrichosis, congential, with juvenile macular dystrophy, 601553 (3)","CDH3, CDHP, PCAD, HJMD",114021,16q22.1,Dermatological
788,"Hypotrichosis, localized, autosomal recessive, 607903 (3)","DSG4, LAH",607892,18q12,Dermatological
788,"Hypotrichosis-lymphedema-telangiectasia syndrome, 607823 (3)","SOX18, HLTS",601618,20q13.33,Dermatological
788,"Hypotrichosis simplex of scalp, 146520 (3)","CDSN, HTSS",602593,6p21.3,Dermatological
791,"Hypouricemia, renal, 220150 (3)","SLC22A12, OAT4L, URAT1",607096,11q13,Renal
792,"Hystrix-like ichthyosis with deafness, 602540 (3)","GJB2, CX26, DFNB1, PPK, DFNA3, KID,
HID",121011,13q11-q12,multiple
793,"Ichthyosiform erythroderma, congenital, 242100 (3)","TGM1, ICR2, LI1",190195,14q11.2,Dermatological
793,"Ichthyosiform erythroderma, congenital, nonbullous, 1, 242100 (3)",ALOX12B,603741,17pter-p13.1,Dermatological
793,"Ichthyosiform erythroderma, congenital, nonbullous, 1, 242100 (3)",ALOXE3,607206,17p13.1,Dermatological
794,"Ichthyosis bullosa of Siemens, 146800 (3)","KRT2A, KRT2E",600194,12q11-q13,Dermatological
794,"Ichthyosis, congenital, autosomal recessive (3)",ICHYN,609383,5q33,Dermatological
794,"Ichthyosis, cyclic, with epidermolytic hyperkeratosis, 607602 (3)",KRT10,148080,17q21-q22,Dermatological
794,"Ichthyosis, harlequin, 242500 (3)","ABCA12, ICR2B, LI2",607800,2q34,Dermatological
794,"Ichthyosis histrix, Curth-Macklin type, 146590 (3)",KRT1,139350,12q13,Dermatological
794,"Ichthyosis, lamellar 2, 601277 (3)","ABCA12, ICR2B, LI2",607800,2q34,Dermatological
794,"Ichthyosis, lamellar, autosomal recessive, 242300 (3)","TGM1, ICR2, LI1",190195,14q11.2,Dermatological
794,"Ichthyosis, X-linked (3)","STS, ARSC1, ARSC, SSDD",308100,Xp22.32,Dermatological
795,"ICOS deficiency, 607594 (3)","ICOS, AILIM",604558,2q33,Immunological
797,"IgE levels QTL, 147050 (3)","PHF11, NYREN34",607796,13q14.1,Immunological
798,"IgG2 deficiency, selective (3)",IGHG2,147110,14q32.33,Immunological
799,"IgG receptor I, phagocytic, familial deficiency of (3)","FCGR1A, IGFR1, CD64",146760,1q21.2-q21.3,Immunological
801,"Immunodeficiency-centromeric instability-facial anomalies syndrome, 242860 (3)","DNMT3B, ICF",602900,20q11.2,multiple
802,Immunodeficiency due to defect in CD3-epsilon (3),CD3E,186830,11q23,Immunological
802,Immunodeficiency due to defect in CD3-gamma (3),CD3G,186740,11q23,Immunological
802,"Immunodeficiency with hyper-IgM, type 2, 605258 (3)","AICDA, AID, HIGM2",605257,12p13,Immunological
802,"Immunodeficiency with hyper-IgM, type 3, 606843 (3)","TNFRSF5, CD40",109535,20q12-q13.2,Immunological
802,"Immunodeficiency with hyper IgM, type 4, 608106 (3)","UNG, DGU, HIGM4",191525,12q23-q24.1,Immunological
802,"Immunodeficiency, X-linked, with hyper-IgM, 308230 (3)","TNFSF5, CD40LG, HIGM1, IGM",300386,Xq26,Immunological
803,"Immunodysregulation, polyendocrinopathy, and enteropathy, X-linked, 304790 (3)","FOXP3, IPEX, AIID, XPID, PIDX",300292,Xp11.23-q13.3,multiple
804,"Immunoglobulin A deficiency, 609529 (3)","TNFRSF14B, TACI",604907,17p11.2,Immunological
805,"Inclusion body myopathy-3, 605637 (3)",MYH2,160740,17p13.1,Muscular
805,"Inclusion body myopathy, autosomal recessive, 600737 (3)","GNE, GLCNE, IBM2, DMRV, NM",603824,9p12-p11,Muscular
805,"Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia,
167320 (3)","VCP, IBMPFD",601023,9p13-p12,Muscular
806,"Incontinentia pigmenti, type II, 308300 (3)","IKBKG, NEMO, FIP3, IP2",300248,Xq28,Dermatological
807,"Infantile spasm syndrome, 308350 (3)","ARX, ISSX, PRTS, MRXS1, MRX36,
MRX54",300382,Xp22.13,Neurological
809,Infundibular hypoplasia and hypopituitarism (3),"SOX3, MRGH",313430,Xq26.3,Endocrine
810,Inosine triphosphatase deficiency (3),ITPA,147520,20p,Metabolic
811,"Insensitivity to pain, congenital, with anhidrosis, 256800 (3)","NTRK1, TRKA, MTC",191315,1q21-q22,Neurological
812,Insomnia (3) (),GABRB3,137192,15q11.2-q12,Psychiatric
812,"Insomnia, fatal familial, 600072 (3)","PRNP, PRIP",176640,20pter-p12,Psychiatric
814,"Insulin resistance, severe, digenic, 604367 (3)","PPARG, PPARG1, PPARG2",601487,3p25,Metabolic
814,"Insulin resistance, severe, digenic, 604367 (3)","PPP1R3A, PPP1R3",600917,7q11.23-q21.11,Metabolic
814,"Insulin resistance, susceptibility to (3)","PTPN1, PTP1B",176885,20q13.1-q13.2,Metabolic
816,"Interleukin-2 receptor, alpha chain, deficiency of (3)","IL2RA, IL2R",147730,10p15-p14,Immunological
817,"Intervertebral disc disease, susceptibility to, 603932 (3)","COL9A2, EDM2",120260,1p33-p32.2,Neurological
817,"Intervertebral disc disease, susceptibility to, 603932 (3)","COL9A3, EDM3, IDD",120270,20q13.3,Neurological
819,Intrauterine and postnatal growth retardation (3),IGF1R,147370,15q25-q26,Developmental
819,Intrauterine and postnatal growth retardation (3),IGF2,147470,11p15.5,Developmental
820,"Intrinsic factor deficiency, 261000 (3)","GIF, IF",609342,11q13,Hematological
821,"IRAK4 deficiency, 607676 (3)","IRAK4, REN64",606883,12q12,Immunological
822,"Iridogoniodysgenesis, 601631 (3)","FOXC1, FKHL7, FREAC3",601090,6p25,Ophthamological
822,"Iridogoniodysgenesis syndrome-2, 137600 (3)","PITX2, IDG2, RIEG1, RGS, IGDS2",601542,4q25-q26,Ophthamological
823,Iris hypoplasia and glaucoma (3),"FOXC1, FKHL7, FREAC3",601090,6p25,Ophthamological
824,"Iron deficiency anemia, susceptibility to (3)",TF,190000,3q21,Hematological
824,"Iron overload, autosomal dominant (3)","FTH1, FTHL6",134770,11q12-q13,Hematological
825,"Isolated growth hormone deficiency, Illig type with absent GH and Kowarski type with
bioinactive GH (3)","GH1, GHN",139250,17q22-q24,Endocrine
826,"Isovaleric acidemia, 243500 (3)",IVD,607036,15q14-q15,Metabolic
827,"Jackson-Weiss syndrome, 123150 (3)","FGFR1, FLT2, KAL2",136350,8p11.2-p11.1,Skeletal
827,"Jackson-Weiss syndrome, 123150 (3)","FGFR2, BEK, CFD1, JWS",176943,10q26,Skeletal
829,"Jensen syndrome, 311150 (3)","TIMM8A, DFN1, DDP, MTS, DDP1",300356,Xq22,Neurological
830,"Jervell and Lange-Nielsen syndrome, 220400 (3)","KCNE1, JLNS, LQT5",176261,21q22.1-q22.2,multiple
830,"Jervell and Lange-Nielsen syndrome, 220400 (3)","KCNQ1, KCNA9, LQT1, KVLQT1,
ATFB1",607542,11p15.5,multiple
831,"Joubert syndrome, 213300 (3)","NPHP1, NPH1, SLSN1",607100,2q13,multiple
831,"Joubert syndrome-3, 608629 (3)",AHI1,608894,6q23.3,multiple
832,"Juberg-Marsidi syndrome, 309590 (3)","ATRX, XH2, XNP, MRXS3, SHS",300032,Xq13,multiple
833,"Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome, 175050 (3)","MADH4, DPC4, SMAD4, JIP",600993,18q21.1,Cancer
835,"Kallikrein, decreased urinary activity of (3)","KLK1, KLKR",147910,19q13.2-q13.4,Renal
836,"Kallmann syndrome 2, 147950 (3)","FGFR1, FLT2, KAL2",136350,8p11.2-p11.1,multiple
836,Kallmann syndrome (3),"KAL1, KMS, ADMLX",308700,Xp22.3,multiple
837,"Kanzaki disease, 609242 (3)",NAGA,104170,22q11,Metabolic
838,"Kaposi sarcoma, susceptibility to, 148000 (3)","IL6, IFNB2, BSF2",147620,7p21,Immunological
839,Kappa light chain deficiency (3),IGKC,147200,2p12,Immunological
840,"Kartagener syndrome, 244400 (3)","DNAH11, DNAHC11",603339,Chr.7,multiple
840,"Kartagener syndrome, 244400 (3)","DNAH5, HL1, PCD, CILD3",603335,5p15-p14,multiple
840,"Kartagener syndrome, 244400 (3)","DNAI1, CILD1, ICS, PCD",604366,9p21-p13,multiple
841,"Kenny-Caffey syndrome-1, 244460 (3)","TBCE, KCS, KCS1, HRD",604934,1q42-q43,multiple
842,"Keratitis, 148190 (3)","PAX6, AN2, MGDA",607108,11p13,Ophthamological
843,"Keratitis-ichthyosis-deafness syndrome, 148210 (3)","GJB2, CX26, DFNB1, PPK, DFNA3, KID,
HID",121011,13q11-q12,multiple
844,"Keratoconus, 148300 (3)","VSX1, RINX, PPCD, PPD, KTCN",605020,20p11.2,Ophthamological
845,"Keratoderma, palmoplantar, with deafness, 148350 (3)","GJB2, CX26, DFNB1, PPK, DFNA3, KID,
HID",121011,13q11-q12,Dermatological
847,"Keratosis follicularis spinulosa decalvans, 308800 (3)","SAT, SSAT, KFSD",313020,Xp22.1,Dermatological
847,"Keratosis palmoplantaria striata, 148700 (3)",KRT1,139350,12q13,Dermatological
847,"Keratosis palmoplantaris striata I, 148700 (3)",DSG1,125670,18q12.1-q12.2,Dermatological
847,Keratosis palmoplantaris striata II (3),"DSP, KPPS2, PPKS2",125647,6p24,Dermatological
847,"Keratosis palmoplantaris striata III, 607654 (3)",KRT1,139350,12q13,Dermatological
848,Ketoacidosis due to SCOT deficiency (3),"SCOT, OXCT",245050,5p13,Metabolic
849,"Keutel syndrome, 245150 (3)","MGP, NTI",154870,12p13.1-p12.3,multiple
850,"Kindler syndrome, 173650 (3)","KIND1, URP1, C20orf42",607900,20p13,Dermatological
851,Kininogen deficiency (3),KNG,228960,3q27,Hematological
853,"Klippel-Trenaunay syndrome, 149000 (3)","VG5Q, HUS84971, FLJ10283",608464,5q13.3,multiple
854,"Kniest dysplasia, 156550 (3)",COL2A1,120140,12q13.11-q13.2,Skeletal
855,"Knobloch syndrome, 267750 (3)","COL18A1, KNO",120328,21q22.3,multiple
856,"Krabbe disease, 245200 (3)",GALC,606890,14q31,Neurological
857,"L-2-hydroxyglutaric aciduria, 236792 (3)","L2HGDH, C14orf160",609584,14q22.1,Metabolic
858,Lactate dehydrogenase-B deficiency (3),LDHB,150100,12p12.2-p12.1,Metabolic
859,"Lacticacidemia due to PDX1 deficiency, 245349 (3)",PDX1,608769,11p13,Metabolic
862,"Langer mesomelic dysplasia, 249700 (3)","SHOX, GCFX, SS, PHOG",312865,Xpter-p22.32,Skeletal
862,"Langer mesomelic dysplasia, 249700 (3)",SHOXY,400020,Ypter-p11.2,Skeletal
863,"Laron dwarfism, 262500 (3)",GHR,600946,5p13-p12,Skeletal
865,"Larson syndrome, 150250 (3)","FLNB, SCT, AOI",603381,3p14.3,Skeletal
868,"Laryngoonychocutaneous syndrome, 245660 (3)","LAMA3, LOCS",600805,18q11.2,multiple
869,"Lathosterolosis, 607330 (3)","SC5DL, ERG3",602286,11q23.3,Metabolic
870,LCHAD deficiency (3),"HADHA, MTPA",600890,2p23,Metabolic
871,"Lead poisoning, susceptibility to (3)",ALAD,125270,9q34,Metabolic
872,"Leanness, inherited (3)","AGRP, ART, AGRT",602311,16q22,Nutritional
873,"Leber congenital amaurosis, 204000 (3)","CRB1, RP12",604210,1q31-q32.1,Ophthamological
873,"Leber congenital amaurosis, 204000 (3)","CRX, CORD2, CRD",602225,19q13.3,Ophthamological
873,"Leber congenital amaurosis, 204000 (3)","RPGRIP1, LCA6, CORD9",605446,14q11,Ophthamological
873,"Leber congenital amaurosis-2, 204100 (3)","RPE65, RP20",180069,1p31,Ophthamological
873,"Leber congenital amaurosis, 604393 (3)","AIPL1, LCA4",604392,17p13.1,Ophthamological
873,"Leber congenital amaurosis, type I, 204000 (3)","GUCY2D, GUC2D, LCA1, CORD6",600179,17p13.1,Ophthamological
873,"Leber congenital amaurosis, type III, 604232 (3)","RDH12, LCA3",608830,14q23.3,Ophthamological
874,Left-right axis malformations (3),ACVR2B,602730,3p22-p21.3,Developmental
874,Left-right axis malformations (3),"EBAF, TGFB4, LEFTY2, LEFTA,
LEFTYA",601877,1q42.1,Developmental
875,"Left ventricular noncompaction, familial isolated, 1, 604169 (3)","DTNA, D18S892E, DRP3, LVNC1",601239,18q12.1-q12.2,Cardiovascular
875,"Left ventricular noncompaction with congenital heart defects, 606617 (3)","DTNA, D18S892E, DRP3, LVNC1",601239,18q12.1-q12.2,Cardiovascular
876,"Legionaire disease, susceptibility to, 608556 (3)","TLR5, TIL3",603031,1q41-q42,Immunological
877,"Leigh syndrome, 256000 (3)","BCS1L, FLNMS, GRACILE",603647,2q33,Neurological
877,"Leigh syndrome, 256000 (3)","DLD, LAD, PHE3",238331,7q31-q32,Neurological
877,"Leigh syndrome, 256000 (3)",NDUFS3,603846,11p11.11,Neurological
877,"Leigh syndrome, 256000 (3)","NDUFS4, AQDQ",602694,5q11.1,Neurological
877,"Leigh syndrome, 256000 (3)","NDUFS7, PSST",601825,19p13,Neurological
877,"Leigh syndrome, 256000 (3)",NDUFS8,602141,11q13,Neurological
877,"Leigh syndrome, 256000 (3)","NDUFV1, UQOR1",161015,11q13,Neurological
877,"Leigh syndrome, 256000 (3)","SDHA, SDH2, SDHF",600857,5p15,Neurological
877,"Leigh syndrome, due to COX deficiency, 256000 (3)",SURF1,185620,9q34,Neurological
877,"Leigh syndrome due to cytochrome c oxidase deficiency, 256000 (3)",COX15,603646,10q24,Neurological
877,"Leigh syndrome, French-Canadian type, 220111 (3)","LRPPRC, LRP130, LSFC",607544,2p21-p16,Neurological
877,"Leigh syndrome, X-linked, 308930 (3)","PDHA1, PHE1A",312170,Xp22.2-p22.1,Neurological
878,"Leiomyomatosis and renal cell cancer, 605839 (3)",FH,136850,1q42.1,Cancer
878,"Leiomyomatosis, diffuse, with Alport syndrome, 308940 (3)",COL4A6,303631,Xq22.3,Cancer
880,"Leopard syndrome, 151100 (3)","PTPN11, PTP2C, SHP2, NS1",176876,12q24.1,multiple
881,"Leprechaunism, 246200 (3)",INSR,147670,19p13.2,Developmental
882,"Leprosy, susceptibility to, 607572 (3)","PRKN, PARK2, PDJ",602544,6q25.2-q27,Immunological
883,"Leri-Weill dyschondrosteosis, 127300 (3)","SHOX, GCFX, SS, PHOG",312865,Xpter-p22.32,Skeletal
883,"Leri-Weill dyschondrosteosis, 127300 (3)",SHOXY,400020,Ypter-p11.2,Skeletal
884,"Lesch-Nyhan syndrome, 300322, (3)","HPRT1, HPRT",308000,Xq26-q27.2,Metabolic
886,"Leukemia-1, T-cell acute lymphocytic (3)","TAL1, TCL5, SCL",187040,1p32,Cancer
886,"Leukemia-2, T-cell acute lymphoblastic (3)",TAL2,186855,9q31,Cancer
886,"Leukemia, acute lymphoblastic (3)",FLT3,136351,13q12,Cancer
886,"Leukemia, acute lymphoblastic (3)","NBS1, NBS",602667,8q21,Cancer
886,"Leukemia, acute lymphoblastic (3)","ZNFN1A1, IK1, LYF1",603023,7p12,Cancer
886,"Leukemia, acute lymphoblastic, susceptibility to (3)","HOXD4, HOX4B",142981,2q31-q32,Cancer
886,"Leukemia, acute lymphocytic (3)","BCR, CML, PHL, ALL",151410,22q11.21,Cancer
886,"Leukemia, acute myeloblastic (3)",ARNT,126110,1q21,Cancer
886,"Leukemia, acute myelogenous (3)","KRAS2, RASK2",190070,12p12.1,Cancer
886,"Leukemia, acute myelogenous, 601626 (3)",GMPS,600358,3q24,Cancer
886,"Leukemia, acute myeloid, 601626 (3)",AF10,602409,10p12,Cancer
886,"Leukemia, acute myeloid, 601626 (3)","ARHGEF12, LARG, KIAA0382",604763,11q23.3,Cancer
886,"Leukemia, acute myeloid, 601626 (3)","CALM, CLTH",603025,11q14,Cancer
886,"Leukemia, acute myeloid, 601626 (3)","CEBPA, CEBP",116897,19q13.1,Cancer
886,"Leukemia, acute myeloid, 601626 (3)","CHIC2, BTL",604332,4q11-q12,Cancer
886,"Leukemia, acute myeloid, 601626 (3)",FLT3,136351,13q12,Cancer
886,"Leukemia, acute myeloid, 601626 (3)","KIT, PBT",164920,4q12,Cancer
886,"Leukemia, acute myeloid, 601626 (3)",LPP,600700,3q28,Cancer
886,"Leukemia, acute myeloid, 601626 (3)",NPM1,164040,5q35,Cancer
886,"Leukemia, acute myeloid, 601626 (3)","NUP214, D9S46E, CAN, CAIN",114350,9q34.1,Cancer
886,"Leukemia, acute myeloid, 601626 (3)","RUNX1, CBFA2, AML1",151385,21q22.3,Cancer
886,"Leukemia, acute myeloid, 601626 (3)","WHSC1L1, NSD3",607083,8p12,Cancer
886,"Leukemia, acute myeloid, reduced survival in (3)",FLT3,136351,13q12,Cancer
886,"Leukemia, acute myelomonocytic (3)",AF1Q,604684,1q21,Cancer
886,"Leukemia, acute promyelocytic, NPM/RARA type (3)",NPM1,164040,5q35,Cancer
886,"Leukemia, acute promyelocytic, NUMA/RARA type (3)",NUMA1,164009,11q13,Cancer
886,"Leukemia, acute promyelocytic, PL2F/RARA type (3)","ZNF145, PLZF",176797,11q23.1,Cancer
886,"Leukemia, acute promyelocytic, PML/RARA type (3)","PML, MYL",102578,15q22,Cancer
886,"Leukemia, acute promyeloyctic, STAT5B/RARA type (3)",STAT5B,604260,17q11.2,Cancer
886,"Leukemia, acute T-cell lymphoblastic (3)",AF10,602409,10p12,Cancer
886,"Leukemia, acute T-cell lymphoblastic (3)","CALM, CLTH",603025,11q14,Cancer
886,"Leukemia, chronic lymphatic, susceptibility to, 151400 (3)","ARL11, ARLTS1",609351,13q14.3,Cancer
886,"Leukemia, chronic lymphatic, susceptibility to, 151400 (3)","P2RX7, P2X7",602566,12q24,Cancer
886,"Leukemia, chronic myeloid, 608232 (3)","BCR, CML, PHL, ALL",151410,22q11.21,Cancer
886,"Leukemia, juvenile myelomonocytic, 607785 (3)",GRAF,605370,5q31,Cancer
886,"Leukemia, juvenile myelomonocytic, 607785 (3)","NF1, VRNF, WSS, NFNS",162200,17q11.2,Cancer
886,"Leukemia, juvenile myelomonocytic, 607785 (3)","PTPN11, PTP2C, SHP2, NS1",176876,12q24.1,Cancer
886,"Leukemia/lymphoma, B-cell, 2 (3)",BCL2,151430,18q21.3,Cancer
886,"Leukemia/lymphoma, chronic B-cell, 151400 (3)","CCND1, PRAD1, BCL1",168461,11q13,Cancer
886,"Leukemia/lymphoma, T-cell (3)",TCRA,186880,14q11.2,Cancer
886,"Leukemia, megakaryoblastic, of Down syndrome, 190685 (3)","GATA1, GF1, ERYF1, NFE1",305371,Xp11.23,Cancer
886,"Leukemia, megakaryoblastic, with or without Down syndrome, 190685 (3)","GATA1, GF1, ERYF1, NFE1",305371,Xp11.23,Cancer
886,"Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)",ABL1,189980,9q34.1,Cancer
886,"Leukemia, post-chemotherapy, susceptibility to (3)","NQO1, DIA4, NMOR1",125860,16q22.1,Cancer
886,"Leukemia, T-cell acute lymphoblastic (3)","NUP214, D9S46E, CAN, CAIN",114350,9q34.1,Cancer
889,"Leukocyte adhesion deficiency, 116920 (3)","ITGB2, CD18, LCAMB, LAD",600065,21q22.3,Immunological
891,"Leukoencephalopathy with vanishing white matter, 603896 (3)","EIF2B1, EIF2BA",606686,Chr.12,Neurological
891,"Leukoencephalopathy with vanishing white matter, 603896 (3)",EIF2B2,606454,14q24,Neurological
891,"Leukoencephalopathy with vanishing white matter, 603896 (3)",EIF2B3,606273,1p34.1,Neurological
891,"Leukoencephalopathy with vanishing white matter, 603896 (3)","EIF2B5, LVWM, CACH, CLE",603945,3q27,Neurological
891,"Leukoencephaly with vanishing white matter, 603896 (3)",EIF2B4,606687,2p23.3,Neurological
894,"Leydig cell adenoma, with precocious puberty (3)",LHCGR,152790,2p21,Cancer
895,Lhermitte-Duclos syndrome (3),"PTEN, MMAC1",601728,10q23.31,Cancer
896,"Liddle syndrome, 177200 (3)",SCNN1B,600760,16p13-p12,Renal
896,"Liddle syndrome, 177200 (3)","SCNN1G, PHA1",600761,16p13-p12,Renal
897,"Li Fraumeni syndrome, 151623 (3)","CDKN2A, MTS1, P16, MLM, CMM2",600160,9p21,Cancer
898,"Li-Fraumeni syndrome, 151623 (3)","TP53, P53, LFS1",191170,17p13.1,Cancer
898,"Li-Fraumeni syndrome, 609265 (3)","CHEK2, RAD53, CHK2, CDS1, LFS2",604373,22q12.1,Cancer
899,"LIG4 syndrome, 606593 (3)",LIG4,601837,13q22-q34,multiple
901,"Limb-mammary syndrome, 603543 (3)","TP73L, TP63, KET, EEC3, SHFM4, LMS,
RHS",603273,3q27,multiple
902,"Lipodystrophy, congenital generalized, type 1, 608594 (3)","AGPAT2, LPAAB, BSCL, BSCL1",603100,9q34.3,Metabolic
902,"Lipodystrophy, congenital generalized, type 2, 269700 (3)","BSCL2, SPG17",606158,11q13,Metabolic
902,"Lipodystrophy, familial partial, 151660 (3)","LMNA, LMN1, EMD2, FPLD, CMD1A,
HGPS, LGMD1B",150330,1q21.2,Metabolic
902,"Lipodystrophy, familial partial, 151660 (3)","PPARG, PPARG1, PPARG2",601487,3p25,Metabolic
902,"Lipodystrophy, familial partial, with decreased subcutaneous fat of face and neck (3)","PPARGC1A, PPARGC1",604517,4p15.1,Metabolic
903,"Lipoid adrenal hyperplasia, 201710 (3)",STAR,600617,8p11.2,Endocrine
903,"Lipoid congenital adrenal hyperplasia, 201710 (3)","CYP11A, P450SCC",118485,15q23-q24,Endocrine
2903,"Lipoid proteinosis, 247100 (3)",ECM1,602201,1q21,Metabolic
904,Lipoma (3),"HMGA2, HMGIC, BABL, LIPO",600698,12q14.3,Cancer
904,Lipoma (3),LPP,600700,3q28,Cancer
904,"Lipoma, sporadic (3)",MEN1,131100,11q13,Cancer
904,"Lipomatosis, mutiple, 151900 (3)","HMGA2, HMGIC, BABL, LIPO",600698,12q14.3,Cancer
906,Lipoprotein lipase deficiency (3),"LPL, LIPD",238600,8p22,Metabolic
908,"Lissencephaly-1, 607432 (3)","PAFAH1B1, LIS1",601545,17p13.3,Neurological
908,"Lissencephaly syndrome, Norman-Roberts type, 257320 (3)","RELN, RL",600514,7q22,Neurological
908,"Lissencephaly, X-linked, 300067 (3)","DCX, DBCN, LISX",300121,Xq22.3-q23,Neurological
908,"Lissencephaly, X-linked with ambiguous genitalia, 300215 (3)","ARX, ISSX, PRTS, MRXS1, MRX36,
MRX54",300382,Xp22.13,Neurological
909,"Listeria monocytogenes, susceptibility to (3)","CDH1, UVO",192090,16q22.1,Immunological
910,"Loeys-Dietz syndrome, 609192 (3)",TGFBR1,190181,9q33-q34,Connective tissue
910,"Loeys-Dietz syndrome, 609192 (3)","TGFBR2, HNPCC6",190182,3p22,Connective tissue
911,"Longevity, exceptional, 152430 (3)",CETP,118470,16q21,Developmental
911,"Longevity, reduced, 152430 (3)",AKAP10,604694,17p11.1,Developmental
912,"Long QT syndrome-1, 192500 (3)","KCNQ1, KCNA9, LQT1, KVLQT1,
ATFB1",607542,11p15.5,Cardiovascular
912,Long QT syndrome-2 (3),"KCNH2, LQT2, HERG",152427,7q35-q36,Cardiovascular
912,"Long QT syndrome-3, 603830 (3)","SCN5A, LQT3, IVF, HB1, SSS1",600163,3p21,Cardiovascular
912,"Long QT syndrome 4, 600919 (3)","ANK2, LQT4",106410,4q25-q27,Cardiovascular
912,Long QT syndrome-5 (3),"KCNE1, JLNS, LQT5",176261,21q22.1-q22.2,Cardiovascular
912,Long QT syndrome-6 (3),"KCNE2, MIRP1, LQT6",603796,21q22.1,Cardiovascular
912,"Long QT syndrome-7, 170390 (3)","KCNJ2, HHIRK1, KIR2.1, IRK1, LQT7",600681,17q23.1-q24.2,Cardiovascular
913,"Lower motor neuron disease, progressive, without sensory symptoms, 607641 (3)",DCTN1,601143,2p13,Neurological
914,"Lowe syndrome, 309000 (3)","OCRL, LOCR, OCRL1, NPHL2",300535,Xq26.1,Metabolic
915,"Low renin hypertension, susceptibility to (3)",CYP11B2,124080,8q21,Cardiovascular
916,"LPA deficiency, congenital (3)",LPA,152200,6q27,Metabolic
917,"Lumbar disc disease, susceptibility to, 603932 (3)",CILP,603489,15q22,Skeletal
918,"Lung cancer, 211980 (3)","KRAS2, RASK2",190070,12p12.1,Cancer
918,"Lung cancer, 211980 (3)",PPP2R1B,603113,11q22-q24,Cancer
918,"Lung cancer, 211980 (3)","SLC22A1L, BWSCR1A, IMPT1",602631,11p15.5,Cancer
918,"Lung cancer, somatic, 211980 (3)","MAP3K8, COT, EST, TPL2",191195,10p11.2,Cancer
919,"Lupus nephritis, susceptibility to (3)","FCGR2A, IGFR2, CD32",146790,1q21-q23,Connective tissue
920,"Lymphangioleiomyomatosis, 606690 (3)","TSC1, LAM",605284,9q34,Respiratory
920,"Lymphangioleiomyomatosis, somatic, 606690 (3)","TSC2, LAM",191092,16p13.3,Respiratory
921,"Lymphedema and ptosis, 153000 (3)","FOXC2, FKHL14, MFH1",602402,16q24.3,Hematological
921,"Lymphedema-distichiasis syndrome, 153400 (3)","FOXC2, FKHL14, MFH1",602402,16q24.3,Hematological
921,Lymphedema-distichiasis syndrome with renal disease and diabetes mellitus (3),"FOXC2, FKHL14, MFH1",602402,16q24.3,Hematological
921,"Lymphedema, hereditary I, 153100 (3)","FLT4, VEGFR3, PCL",136352,5q35.3,Hematological
921,"Lymphedema, hereditary II, 153200 (3)","FOXC2, FKHL14, MFH1",602402,16q24.3,Hematological
925,"Lymphocytic leukemia, acute T-cell (3)",RAP1GDS1,179502,4q21-q25,Cancer
925,"Lymphoma, B-cell non-Hodgkin, somatic (3)","ATM, ATA, AT1",607585,11q22.3,Cancer
925,"Lymphoma, diffuse large cell (3)",BCL8,601889,15q11-q13,Cancer
925,"Lymphoma, follicular (3)",BCL10,603517,1p22,Cancer
925,"Lymphoma, MALT (3)",BCL10,603517,1p22,Cancer
925,"Lymphoma, mantle cell (3)","ATM, ATA, AT1",607585,11q22.3,Cancer
925,"Lymphoma, non-Hodgkin (3)",RAD54B,604289,8q21.3-q22,Cancer
925,"Lymphoma, non-Hodgkin (3)","RAD54L, HR54, HRAD54",603615,1p32,Cancer
925,"Lymphoma, progression of (3)","FCGR2B, CD32",604590,1q22,Cancer
925,"Lymphoma, somatic (3)","MAD1L1, TXBP181",602686,7p22,Cancer
925,"Lymphoma, T-cell (3)","MSH2, COCA1, FCC1, HNPCC1",609309,2p22-p21,Cancer
925,"Lymphoproliferative syndrome, X-linked, 308240 (3)","SH2D1A, LYP, IMD5, XLP, XLPD",300490,Xq25,Cancer
930,"Lynch cancer family syndrome II, 114400 (3)","MSH2, COCA1, FCC1, HNPCC1",609309,2p22-p21,Cancer
931,"Lysinuric protein intolerance, 222700 (3)","SLC7A7, LPI",603593,14q11.2,Metabolic
933,"Machado-Joseph disease, 109150 (3)","ATXN3, MJD, SCA3",607047,14q24.3-q31,Neurological
935,"Macrocytic anemia, refractory, of 5q- syndrome, 153550 (3)","IRF1, MAR",147575,5q31.1,Hematological
936,"Macrothrombocytopenia, 300367 (3)","GATA1, GF1, ERYF1, NFE1",305371,Xp11.23,Hematological
2937,"Macular corneal dystrophy, 217800 (3)","CHST6, MCDC1",605294,16q22,Ophthamological
937,"Macular degeneration, age-related, 1, 603075 (3)","HF1, CFH, HUS",134370,1q32,Ophthamological
937,"Macular degeneration, age-related, 1, 603075 (3)","HMCN1, FBLN6, FIBL6",608548,1q24-q25,Ophthamological
937,"Macular degeneration, age-related, 3, 608895 (3)","FBLN5, ARMD3",604580,14q32.1,Ophthamological
937,"Macular degeneration, juvenile, 248200 (3)","CNGB3, ACHM3",605080,8q21-q22,Ophthamological
937,"Macular degeneration, X-linked atrophic (3)","RPGR, RP3, CRD, RP15, COD1",312610,Xp21.1,Ophthamological
2937,Macular dystrophy (3),"RDS, RP7, PRPH2, PRPH, AVMD,
AOFMD",179605,6p21.1-cen,Ophthamological
2937,"Macular dystrophy, age-related, 2, 153800 (3)","ABCA4, ABCR, STGD1, FFM, RP19",601691,1p21-p13,Ophthamological
2937,"Macular dystrophy, autosomal dominant, chromosome 6-linked, 600110 (3)","ELOVL4, ADMD, STGD2, STGD3",605512,6q14,Ophthamological
2937,"Macular dystrophy, vitelliform, 608161 (3)","RDS, RP7, PRPH2, PRPH, AVMD,
AOFMD",179605,6p21.1-cen,Ophthamological
2937,"Macular dystrophy, vitelliform type, 153700 (3)",VMD2,607854,11q13,Ophthamological
938,"Maculopathy, bull's-eye, 153870 (3)",VMD2,607854,11q13,Ophthamological
939,"Major depressive disorder and accelerated response to antidepressant drug treatment,
608616 (3)","FKBP5, FKBP51",602623,6p21.3-p21.2,Psychiatric
940,"Malaria, cerebral, reduced risk of, 248310 (3)",CD36,173510,7q11.2,Immunological
940,"Malaria, cerebral, susceptibility to, 248310 (3)",CD36,173510,7q11.2,Immunological
940,"Malaria, cerebral, susceptibility to (3)",ICAM1,147840,19p13.3-p13.2,Immunological
940,"Malaria, cerebral, susceptibility to (3)","TNF, TNFA",191160,6p21.3,Immunological
940,"Malaria, resistance to, 248310 (3)","GYPC, GE, GPC",110750,2q14-q21,Immunological
940,"Malaria, resistance to, 248310 (3)","NOS2A, NOS2",163730,17cen-q11.2,Immunological
942,"Malignant hyperthermia susceptibility 1, 145600 (3)","RYR1, MHS, CCO",180901,19q13.1,Neurological
942,"Malignant hyperthermia susceptibility 5, 601887 (3)","CACNA1S, CACNL1A3, CCHL1A3",114208,1q32,Neurological
943,"Malonyl-CoA decarboxylase deficiency, 248360 (3)","MLYCD, MCD",606761,16q24,Metabolic
944,MALT lymphoma (3),"MALT1, MLT",604860,18q21,Cancer
945,"Mandibuloacral dysplasia with type B lipodystrophy, 608612 (3)","ZMPSTE24, FACE1, STE24, MADB",606480,1p34,multiple
947,"Mannosidosis, alpha-, types I and II, 248500 (3)","MAN2B1, MANB",609458,19cen-q12,Metabolic
947,"Mannosidosis, beta, 248510 (3)","MANBA, MANB1",609489,4q22-q25,Metabolic
948,"Maple syrup urine disease, type Ia, 248600 (3)","BCKDHA, MSUD1",608348,19q13.1-q13.2,Metabolic
948,"Maple syrup urine disease, type Ib (3)","BCKDHB, E1B",248611,6p22-p21,Metabolic
948,"Maple syrup urine disease, type II (3)","DBT, BCATE2",248610,1p31,Metabolic
948,"Maple syrup urine disease, type III, 248600 (3)","DLD, LAD, PHE3",238331,7q31-q32,Metabolic
950,"Marfan syndrome, 154700 (3)","FBN1, MFS1, WMS",134797,15q21.1,Connective tissue
950,"Marfan syndrome, atypical (3)",COL1A2,120160,7q22.1,Connective tissue
952,"Maroteaux-Lamy syndrome, several forms (3)","ARSB, MPS6",253200,5q11-q13,Metabolic
953,"Marshall syndrome, 154780 (3)","COL11A1, STL2",120280,1p21,multiple
955,"MASA syndrome, 303350 (3)","L1CAM, CAML1, HSAS1",308840,Xq28,multiple
956,MASP2 deficiency (3),MASP2,605102,1p36.3-p36.2,Immunological
957,"MASS syndrome, 604308 (3)","FBN1, MFS1, WMS",134797,15q21.1,Connective tissue
958,Mast cell leukemia (3),"KIT, PBT",164920,4q12,Cancer
959,Mastocytosis with associated hematologic disorder (3),"KIT, PBT",164920,4q12,Immunological
960,"Mast syndrome, 248900 (3)","ACP33, MAST, SPG21",608181,15q21-q22,Neurological
961,"May-Hegglin anomaly, 155100 (3)","MYH9, MHA, FTNS, DFNA17",160775,22q11.2,Hematological
962,"McArdle disease, 232600 (3)",PYGM,608455,11q13,Metabolic
963,"McCune-Albright syndrome, 174800 (3)","GNAS, GNAS1, GPSA, POH, PHP1B,
PHP1A, AHO",139320,20q13.2,multiple
964,"McKusick-Kaufman syndrome, 236700 (3)","MKKS, HMCS, KMS, MKS, BBS6",604896,20p12,Developmental
965,McLeod syndrome (3),XK,314850,Xp21.2-p21.1,Hematological
965,McLeod syndrome with neuroacanthosis (3),XK,314850,Xp21.2-p21.1,Hematological
969,"Medullary cystic kidney disease 2, 603860 (3)","UMOD, HNFJ, FJHN, MCKD2,
ADMCKD2",191845,16p12.3,Renal
2969,"Medullary thyroid carcinoma, 155240 (3)","RET, MEN2A",164761,10q11.2,Cancer
2969,"Medullary thyroid carcinoma, familial, 155240 (3)","NTRK1, TRKA, MTC",191315,1q21-q22,Cancer
970,"Medulloblastoma, 155255 (3)",PTCH2,603673,1p32,Cancer
970,"Medulloblastoma, desmoplastic, 155255 (3)","SUFU, SUFUXL, SUFUH",607035,10q24-q25,Cancer
971,"Meesmann corneal dystrophy, 122100 (3)",KRT12,601687,17q12,Ophthamological
971,"Meesmann corneal dystrophy, 122100 (3)",KRT3,148043,12q13,Ophthamological
973,"Megakaryoblastic leukemia, acute (3)","MKL1, AMKL, MAL",606078,22q13,Cancer
974,"Megalencephalic leukoencephalopathy with subcortical cysts, 604004 (3)","MLC1, LVM, VL",605908,22qter,Neurological
975,"Megaloblastic anemia-1, Finnish type, 261100 (3)","CUBN, IFCR, MGA1",602997,10p12.1,Hematological
975,"Megaloblastic anemia-1, Norwegian type, 261100 (3)",AMN,605799,14q32,Hematological
978,Melanoma (3),"CDK4, CMM3",123829,12q14,Cancer
978,"Melanoma and neural system tumor syndrome, 155755 (3)","CDKN2A, MTS1, P16, MLM, CMM2",600160,9p21,Cancer
978,"Melanoma, cutaneous malignant, 2, 155601 (3)","CDKN2A, MTS1, P16, MLM, CMM2",600160,9p21,Cancer
978,"Melanoma, cutaneous malignant, susceptibility to (3)",XRCC3,600675,14q32.3,Cancer
978,"Melanoma, malignant sporadic (3)","STK11, PJS, LKB1",602216,19p13.3,Cancer
978,"Melanoma, melignant, somatic (3)",BRAF,164757,7q34,Cancer
979,"Meleda disease, 248300 (3)","SLURP1, MDM",606119,8qter,Dermatological
981,"Melnick-Needles syndrome, 309350 (3)","FLNA, FLN1, ABPX, NHBP, OPD1,
OPD2, FMD, MNS",300017,Xq28,Skeletal
982,"Melorheostosis with osteopoikilosis, 155950 (3)","LEMD3, MAN1",607844,12q14,Developmental
984,"Memory impairment, susceptibility to (3)",BDNF,113505,11p13,Neurological
985,Meniere disease 156000 (3) (),"COCH, DFNA9",603196,14q12-q13,Neurological
986,"Meningioma, 607174 (3)","MN1, MGCR",156100,22q12.3-qter,Cancer
986,"Meningioma, 607174 (3)","PTEN, MMAC1",601728,10q23.31,Cancer
986,"Meningioma, NF2-related, somatic, 607174 (3)",NF2,607379,22q12.2,Cancer
986,"Meningioma, SIS-related (3)","PDGFB, SIS",190040,22q12.3-q13.1,Cancer
987,"Meningococcal disease, susceptibility to (3)","MBL2, MBL, MBP1",154545,10q11.2-q21,Immunological
988,"Menkes disease, 309400 (3)","ATP7A, MNK, MK, OHS",300011,Xq12-q13,Neurological
990,"Mental retardation, nonsyndromic, autosomal recessive, 249500 (3)","PRSS12, BSSP3",606709,4q25-q26,Neurological
990,"Mental retardation, nonsyndromic, autosomal recessive, 2A, 607417 (3)","CRBN, MRT2A",609262,3p26.2,Neurological
990,"Mental retardation, X-linked, 300425 (3)","NLGN4, KIAA1260, AUTSX2",300427,Xp22.33,Neurological
990,"Mental retardation, X-linked, 300458 (3)","MECP2, RTT, PPMX, MRX16, MRX79",300005,Xq28,Neurological
990,"Mental retardation, X-linked 30, 300558 (3)","PAK3, MRX30, MRX47",300142,Xq21.3-q24,Neurological
990,"Mental retardation, X-linked, 34, 300426 (3)","IL1RAPL, MRX34",300206,Xp22.1-p21.3,Neurological
990,"Mental retardation, X-linked 36, 300430 (3)","ARX, ISSX, PRTS, MRXS1, MRX36,
MRX54",300382,Xp22.13,Neurological
990,"Mental retardation, X-linked (3)","SLC6A8, CRTR",300036,Xq28,Neurological
990,"Mental retardation, X-linked-44, 300501 (3)","FTSJ1, JM23, SPB1, MRX44, MRX9",300499,Xp11.23,Neurological
990,"Mental retardation, X-linked 45, 300498 (3)","ZNF81, MRX45",314998,Xp22.1-p11,Neurological
990,"Mental retardation, X-linked 54, 300419 (3)","ARX, ISSX, PRTS, MRXS1, MRX36,
MRX54",300382,Xp22.13,Neurological
990,"Mental retardation, X-linked 58, 300218 (3)","TM4SF2, MXS1, A15",300096,Xq11,Neurological
990,"Mental retardation, X-linked, 60, 300486 (3)",OPHN1,300127,Xq12,Neurological
990,"Mental retardation, X-linked-9, 309549 (3)","FTSJ1, JM23, SPB1, MRX44, MRX9",300499,Xp11.23,Neurological
990,"Mental retardation, X-linked, FRAXE type (3)","FMR2, FRAXE, MRX2",309548,Xq28,Neurological
990,"Mental retardation, X-linked, JARID1C-related, 300534 (3)","SMCX, MRXJ, DXS1272E, XE169,
JARID1C",314690,Xp11.22-p11.21,Neurological
990,"Mental retardation, X-linked nonspecific, 309541 (3)","GDI1, RABGD1A, MRX41, MRX48",300104,Xq28,Neurological
990,"Mental retardation, X-linked nonspecific, 63, 300387 (3)","FACL4, ACS4, MRX63",300157,Xq22.3,Neurological
990,"Mental retardation, X-linked nonspecific, type 19 (3)","RPS6KA3, RSK2, MRX19",300075,Xp22.2-p22.1,Neurological
990,"Mental retardation, X-linked nonspecific, type 46, 300436 (3)","ARHGEF6, MRX46, COOL2",300267,Xq26,Neurological
990,"Mental retardation, X-linked nonsyndromic (3)",AGTR2,300034,Xq22-q23,Neurological
990,"Mental retardation, X-linked nonsyndromic (3)","FGD1, FGDY, AAS",305400,Xp11.21,Neurological
990,"Mental retardation, X-linked nonsyndromic (3)",ZNF41,314995,Xp22.1-cen,Neurological
990,"Mental retardation, X-linked nonsyndromic, DLG3-related (3)","DLG3, NEDLG, SAP102, MRX",300189,Xq13.1,Neurological
990,"Mental retardation, X-linked, Snyder-Robinson type, 309583 (3)","SMS, SRS, MRSR",300105,Xp22.1,Neurological
990,"Mental retardation, X-linked, with isolated growth hormone deficiency, 300123 (3)","SOX3, MRGH",313430,Xq26.3,Neurological
990,"Mental retardation, X-linked, with progressive spasticity, 300279 (3)","MECP2, RTT, PPMX, MRX16, MRX79",300005,Xq28,Neurological
990,"Mental retardation, X-linked, with seizures and carrier manifestations, 300397 (3)","SLC6A8, CRTR",300036,Xq28,Neurological
991,Mephenytoin poor metabolizer (3),"CYP2C, CYP2C19",124020,10q24.1-q24.3,Metabolic
992,"Merkel cell carcinoma, somatic (3)","SDHD, PGL1",602690,11q23,Cancer
993,"Mesangial sclerosis, isolated diffuse, 256370 (3)",WT1,607102,11p13,Renal
995,Mesothelioma (3),BCL10,603517,1p22,Cancer
996,"Metachromatic leukodystrophy, 250100 (3)",ARSA,607574,22q13.31-qter,Neurological
996,Metachromatic leukodystrophy due to deficiency of SAP-1 (3),"PSAP, SAP1",176801,10q22.1,Neurological
997,"Metaphyseal chondrodysplasia, Murk Jansen type, 156400 (3)","PTHR1, PTHR",168468,3p22-p21.1,Connective tissue
997,"Metaphyseal chondrodysplasia, Schmid type (3)",COL10A1,120110,6q21-q22.3,Connective tissue
997,"Metaphyseal dysplasia without hypotrichosis, 250460 (3)","RMRP, RMRPR, CHH",157660,9p21-p12,Connective tissue
999,Methemoglobinemia due to cytochrome b5 deficiency (3),CYB5,250790,18q23,Hematological
999,"Methemoglobinemias, alpha- (3)",HBA1,141800,16pter-p13.3,Hematological
999,"Methemoglobinemias, beta- (3)",HBB,141900,11p15.5,Hematological
999,"Methemoglobinemia, type I (3)",DIA1,250800,22q13.31-qter,Hematological
999,"Methemoglobinemia, type II (3)",DIA1,250800,22q13.31-qter,Hematological
1001,"Methionine adenosyltransferase deficiency, autosomal recessive (3)","MAT1A, MATA1, SAMS1",250850,10q22,Metabolic
1002,"Methylcobalamin deficiency, cblG type, 250940 (3)",MTR,156570,1q43,Metabolic
1003,Methylmalonate semialdehyde dehydrogenase deficiency (3),"ALDH6A1, MMSDH",603178,14q24.3,Metabolic
1004,"Methylmalonic aciduria, mut(0) type, 251000 (3)","MUT, MCM",609058,6p21,Metabolic
1004,"Methylmalonic aciduria, vitamin B12-responsive, 251100 (3)",MMAA,607481,4q31.1-q31.2,Metabolic
1004,"Methylmalonic aciduria, vitamin B12-responsive, due to defect in synthesis of
adenosylcobalamin, cblB complementation type, 251110 (3)",MMAB,607568,12q24,Metabolic
1005,Mevalonicaciduria (3),"MVK, MVLK",251170,12q24,Metabolic
1006,"MHC class II deficiency, complementation group B, 209920 (3)",RFXANK,603200,19p12,Immunological
1007,"Microcephaly, Amish type, 607196 (3)","SLC25A19, DNC, MUP1, MCPHA",606521,17q25.3,Neurological
1007,"Microcephaly, autosomal recessive 1, 251200 (3)",MCPH1,607117,8p23,Neurological
1007,"Microcephaly, primary autosomal recessive, 3, 604804 (3)","CDK5RAP2, KIAA1633, MCPH3",608201,9q33.3,Neurological
1007,"Microcephaly, primary autosomal recessive, 5, 608716 (3)","ASPM, MCPH5",605481,1q31,Neurological
1007,"Microcephaly, primary autosomal recessive, 6, 608393 (3)","CEMPJ, CPAP, MCPH6",609279,13q12.2,Neurological
1009,"Microcoria-congenital nephrosis syndrome, 609049 (3)","LAMB2, LAMS",150325,3p21,Ophthamological
1011,Micropenis (3),LHCGR,152790,2p21,Renal
1012,"Microphthalmia, cataracts, and iris abnormalities (3)","CHX10, HOX10",142993,14q24.3,Ophthamological
1012,"Microphthalmia, SIX6-related (3)",SIX6,606326,14q23,Ophthamological
1012,"Microphthalmia with associated anomalies 2, 300412 (3)","BCOR, KIAA1575, MAA2, ANOP2",300485,Xp11.4,Ophthamological
1013,"Migraine, familial hemiplegic, 2, 602481 (3)","ATP1A2, FHM2, MHP2",182340,1q21-q23,Neurological
1013,"Migraine, resistance to, 157300 (3)",EDNRA,131243,4q31.2,Neurological
1013,"Migraine, susceptibility to, 157300 (3)","ESR1, ESR",133430,6q25.1,Neurological
1013,"Migraine without aura, susceptibility to, 157300 (3)","TNF, TNFA",191160,6p21.3,Neurological
1014,"Miller-Dieker lissencephaly, 247200 (3)","YWHAE, MDCR, MDS",605066,17p13.3,multiple
1016,"Mitochondrial complex I deficiency, 252010 (3)",NDUFS1,157655,2q33-q34,multiple
1016,"Mitochondrial complex I deficiency, 252010 (3)",NDUFS2,602985,1q23,multiple
1016,"Mitochondrial complex I deficiency, 252010 (3)","NDUFS4, AQDQ",602694,5q11.1,multiple
1016,"Mitochondrial complex I deficiency, 252010 (3)","NDUFV1, UQOR1",161015,11q13,multiple
1016,"Mitochondrial complex III deficiency, 124000 (3)","BCS1L, FLNMS, GRACILE",603647,2q33,multiple
1016,"Mitochondrial complex III deficiency, 124000 (3)","UQCRB, UQBP, QPC",191330,8q22,multiple
3016,"Mitochondrial DNA depletion myopathy, 251880 (3)",TK2,188250,16q22,Muscular
5016,"Mitochondrial DNA depletion syndrome, 251880 (3)",SUCLA2,603921,13q12.2-q13,multiple
5016,"Mitochondrial DNA-depletion syndrome, hepatocerebral form, 251880 (3)","DGUOK, DGK",601465,2p13,multiple
7016,"Mitochondrial myopathy and sideroblastic anemia, 600462 (3)","PUS1, MLASA",608109,12q24.33,multiple
1016,"Mitochondrial respiratory chain complex II deficiency, 252011 (3)","SDHA, SDH2, SDHF",600857,5p15,multiple
1018,"Miyoshi myopathy, 254130 (3)","DYSF, LGMD2B",603009,2p13.3-p13.1,Muscular
1020,MODY5 with nephron agenesis (3),"TCF2, HNF2",189907,17cen-q21.3,Endocrine
1020,MODY5 with non-diabetic renal disease and Mullerian aplasia (3),"TCF2, HNF2",189907,17cen-q21.3,Endocrine
1020,"MODY, one form, 125850 (3)",INS,176730,11p15.5,Endocrine
1020,"MODY, type I, 125850 (3)","HNF4A, TCF14, MODY1",600281,20q12-q13.1,Endocrine
1020,"MODY, type II, 125851 (3)",GCK,138079,7p15-p13,Endocrine
1020,"MODY, type III, 600496 (3)","TCF1, HNF1A, MODY3",142410,12q24.2,Endocrine
1020,"MODY, type IV (3)",IPF1,600733,13q12.1,Endocrine
1020,"MODY, type V, 604284 (3)","TCF2, HNF2",189907,17cen-q21.3,Endocrine
1022,"Mohr-Tranebjaerg syndrome, 304700 (3)","TIMM8A, DFN1, DDP, MTS, DDP1",300356,Xq22,Neurological
1023,"Molybdenum cofactor deficiency, type A, 252150 (3)","MOCS1, MOCOD",603707,6p21.3,Metabolic
1023,"Molybdenum cofactor deficiency, type B, 252150 (3)","MOCS2, MPTS",603708,5q11,Metabolic
1023,"Molybdenum cofactor deficiency, type C, 252150 (3)","GPH, KIAA1385, GEPH",603930,14q24,Metabolic
1024,"Monilethrix, 158000 (3)","KRTHB1, HB1",602153,12q13,Dermatological
1024,"Monilethrix, 158000 (3)","KRTHB6, HB6",601928,12q13,Dermatological
1026,Morning glory disc anomaly (3),"PAX6, AN2, MGDA",607108,11p13,Skeletal
1028,"Mowat-Wilson syndrome, 235730 (3)","ZFHX1B, SMADIP1, SIP1",605802,2q22,Developmental
1029,Moyamoya disease 3 (3),MYMY3,608796,8q24,Neurological
1030,"Muckle-Wells syndrome, 191900 (3)","CIAS1, C1orf7, FCU, FCAS",606416,1q44,multiple
1031,Mucoepidermoid salivary gland carcinoma (3),"MAML2, MAM3",607537,11q21,Cancer
1031,Mucoepidermoid salivary gland carcinoma (3),"MECT1, KIAA0616",607536,19p13,Cancer
1032,"Mucolipidosis IIIA, 252600 (3)","GNPTAB, GNPTA",607840,4q21-q23,Metabolic
1032,"Mucolipidosis IIIC, 252605 (3)",GNPTAG,607838,16p,Metabolic
1032,"Mucolipidosis IV, 252650 (3)","MCOLN1, ML4",605248,19p13.3-p13.2,Metabolic
1033,"Mucopolysaccharidosis Ih, 607014 (3)","IDUA, IDA",252800,4p16.3,Metabolic
1033,"Mucopolysaccharidosis Ih/s, 607015 (3)","IDUA, IDA",252800,4p16.3,Metabolic
1033,Mucopolysaccharidosis II (3),"IDS, MPS2, SIDS",309900,Xq28,Metabolic
1033,"Mucopolysaccharidosis Is, 607016 (3)","IDUA, IDA",252800,4p16.3,Metabolic
1033,Mucopolysaccharidosis IVA (3),"GALNS, MPS4A",253000,16q24.3,Metabolic
1033,Mucopolysaccharidosis IVB (3),GLB1,230500,3p21.33,Metabolic
1033,"Mucopolysaccharidosis type IIID, 252940 (3)","GNS, G6S",607664,12q14,Metabolic
1033,"Mucopolysaccharidosis type IX, 601492 (3)",HYAL1,607071,3p21.3-p21.2,Metabolic
1033,Mucopolysaccharidosis VII (3),"GUSB, MPS7",253220,7q21.11,Metabolic
1034,"Muenke syndrome, 602849 (3)","FGFR3, ACH",134934,4p16.3,Skeletal
1035,"Muir-Torre syndrome, 158320 (3)","MLH1, COCA2, HNPCC2",120436,3p21.3,Cancer
1035,"Muir-Torre syndrome, 158320 (3)","MSH2, COCA1, FCC1, HNPCC1",609309,2p22-p21,Cancer
1036,"Mulibrey nanism, 253250 (3)","TRIM37, MUL, KIAA0898",605073,17q22-q23,multiple
3037,"Multiple cutaneous and uterine leiomyomata, 150800 (3)",FH,136850,1q42.1,Cancer
1037,Multiple endocrine neoplasia I (3),MEN1,131100,11q13,Cancer
1037,"Multiple endocrine neoplasia IIA, 171400 (3)","RET, MEN2A",164761,10q11.2,Cancer
1037,"Multiple endocrine neoplasia IIB, 162300 (3)","RET, MEN2A",164761,10q11.2,Cancer
5037,Multiple malignancy syndrome (3),"TP53, P53, LFS1",191170,17p13.1,Cancer
9037,Multiple myeloma (3),"IRF4, LSIRF",601900,6p25-p23,Cancer
9037,"Multiple myeloma, resistance to, 254500 (3)",LIG4,601837,13q22-q34,Cancer
9038,"Multiple sclerosis, susceptibility to, 126200 (3)","MHC2TA, C2TA",600005,16p13,Neurological
9038,"Multiple sclerosis, susceptibility to, 126200 (3)","PTPRC, CD45, LCA",151460,1q31-q32,Neurological
9039,"Multiple sulfatase deficiency, 272200 (3)","SUMF1, FGE",607939,3p26,Metabolic
1038,"Muscle-eye-brain disease, 253280 (3)","POMGNT1, MEB",606822,1p34-p33,multiple
1039,Muscle glycogenosis (3),PHKA1,311870,Xq13,Muscular
1039,Muscle hypertrophy (3),"GDF8, MSTN",601788,2q32.2,Muscular
1040,"Muscular dystrophy, congenital, 1C (3)","FKRP, MDC1C, LGMD2I",606596,19q13.3,Muscular
1040,"Muscular dystrophy, congenital, due to partial LAMA2 deficiency, 607855 (3)","LAMA2, LAMM",156225,6q22-q23,Muscular
1040,"Muscular dystrophy, congenital merosin-deficient, 607855 (3)","LAMA2, LAMM",156225,6q22-q23,Muscular
1040,"Muscular dystrophy, congenital, type 1D, 608840 (3)","LARGE, KIAA0609, MDC1D",603590,22q12.3-q13.1,Muscular
1040,"Muscular dystrophy, Fukuyama congenital, 253800 (3)",FCMD,607440,9q31,Muscular
1040,"Muscular dystrophy, limb-girdle, type 1A, 159000 (3)","TTID, MYOT",604103,5q31,Muscular
1040,"Muscular dystrophy, limb-girdle, type 2A, 253600 (3)","CAPN3, CANP3",114240,15q15.1-q21.1,Muscular
1040,"Muscular dystrophy, limb-girdle, type 2B, 253601 (3)","DYSF, LGMD2B",603009,2p13.3-p13.1,Muscular
1040,"Muscular dystrophy, limb-girdle, type 2C, 253700 (3)","SGCG, LGMD2C, DMDA1, SCG3",608896,13q12,Muscular
1040,"Muscular dystrophy, limb-girdle, type 2D, 608099 (3)","SGCA, ADL, DAG2, LGMD2D, DMDA2",600119,17q12-q21.33,Muscular
1040,"Muscular dystrophy, limb-girdle, type 2E, 604286 (3)","SGCB, LGMD2E",600900,4q12,Muscular
1040,"Muscular dystrophy, limb-girdle, type 2F, 601287 (3)","SGCD, SGD, LGMD2F, CMD1L",601411,5q33,Muscular
1040,"Muscular dystrophy, limb-girdle, type 2G, 601954 (3)","TCAP, LGMD2G, CMD1N",604488,17q12,Muscular
1040,"Muscular dystrophy, limb-girdle, type 2H, 254110 (3)","TRIM32, HT2A, LGMD2H",602290,9q31-q34.1,Muscular
1040,"Muscular dystrophy, limb-girdle, type 2I, 607155 (3)","FKRP, MDC1C, LGMD2I",606596,19q13.3,Muscular
1040,"Muscular dystrophy, limb-girdle, type 2J, 608807 (3)","TTN, CMD1G, TMD, LGMD2J",188840,2q24.3,Muscular
1040,"Muscular dystrophy, limb-girdle, type 2K, 609308 (3)",POMT1,607423,9q34.1,Muscular
1040,"Muscular dystrophy, limb-girdle, type IC, 607801 (3)","CAV3, LGMD1C",601253,3p25,Muscular
1040,"Muscular dystrophy, rigid spine, 1, 602771 (3)","SEPN1, SELN, RSMD1",606210,1p36-p35,Muscular
1040,"Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3)","PLEC1, PLTN, EBS1",601282,8q24,Muscular
1041,"Myasthenia, familial infantile, 1, 605809 (3)","CMS1A1, FIM1",605809,17p13,Muscular
1042,Myasthenic syndrome (3),"SCN4A, HYPP, NAC1A",603967,17q23.1-q25.3,Muscular
1042,"Myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency,
608931 (3)","CHRNB1, ACHRB, SCCMS, CMS2A,
CMS1D",100710,17p12-p11,Muscular
1042,"Myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency,
608931 (3)","CHRNE, SCCMS, CMS2A, FCCMS,
CMS1E, CMS1D",100725,17p13-p12,Muscular
1042,"Myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency,
608931 (3)","RAPSN, CMS1D, CMS1E",601592,11p11.2-p11.1,Muscular
1042,"Myasthenic syndrome, congenital, associated with episodic apnea, 254210 (3)","CHAT, CMS1A2",118490,10q11.2,Muscular
1042,"Myasthenic syndrome, congenital, associated with facial dysmorphism and
acetylcholine receptor deficiency, 608931 (3)","RAPSN, CMS1D, CMS1E",601592,11p11.2-p11.1,Muscular
1042,"Myasthenic syndrome, fast-channel congenital, 608930 (3)","CHRNA1, ACHRD, CMS2A, SCCMS,
FCCMS",100690,2q24-q32,Muscular
1042,"Myasthenic syndrome, fast-channel congenital, 608930 (3)","CHRND, ACHRD, SCCMS, CMS2A,
FCCMS",100720,2q33-q34,Muscular
1042,"Myasthenic syndrome, fast-channel congenital, 608930 (3)","CHRNE, SCCMS, CMS2A, FCCMS,
CMS1E, CMS1D",100725,17p13-p12,Muscular
1042,"Myasthenic syndrome, slow-channel congenital, 601462 (3)","CHRNA1, ACHRD, CMS2A, SCCMS,
FCCMS",100690,2q24-q32,Muscular
1042,"Myasthenic syndrome, slow-channel congenital, 601462 (3)","CHRNB1, ACHRB, SCCMS, CMS2A,
CMS1D",100710,17p12-p11,Muscular
1042,"Myasthenic syndrome, slow-channel congenital, 601462 (3)","CHRND, ACHRD, SCCMS, CMS2A,
FCCMS",100720,2q33-q34,Muscular
1042,"Myasthenic syndrome, slow-channel congenital, 601462 (3)","CHRNE, SCCMS, CMS2A, FCCMS,
CMS1E, CMS1D",100725,17p13-p12,Muscular
1043,"Mycobacterial and salmonella infections, susceptibility to, 209950 (3)",IL12RB1,601604,19p13.1,Immunological
1043,"Mycobacterial infection, atypical, familial disseminated, 209950 (3)",IFNGR1,107470,6q23-q24,Immunological
1043,"Mycobacterial infection, atypical, familial disseminated, 209950 (3)","IFNGR2, IFNGT1, IFGR2",147569,21q22.1-q22.2,Immunological
1043,"Mycobacterial infection, atypical, familial disseminated, 209950 (3)",STAT1,600555,2q32.2-q32.3,Immunological
1043,"Mycobacterium tuberculosis, suceptibility to infection by, 607948 (3)","NRAMP1, NRAMP",600266,2q35,Immunological
1045,Myelodysplasia syndrome-1 (3),MDS1,600049,3q26,Muscular
1045,Myelodysplastic syndrome (3),"FACL6, ACS2",604443,5q31,Muscular
1045,"Myelodysplastic syndrome, preleukemic (3)","IRF1, MAR",147575,5q31.1,Muscular
1046,"Myelofibrosis, idiopathic, 254450 (3)",JAK2,147796,9p24,Hematological
1047,"Myelogenous leukemia, acute (3)","FACL6, ACS2",604443,5q31,Cancer
1047,"Myelogenous leukemia, acute (3)","IRF1, MAR",147575,5q31.1,Cancer
1047,"Myeloid leukemia, acute, M4Eo subtype (3)",CBFB,121360,16q22,Cancer
1047,"Myeloid malignancy, predisposition to (3)","CSF1R, FMS",164770,5q33.2-q33.3,Cancer
1049,"Myelokathexis, isolated (3)","CXCR4, D2S201E, NPY3R, WHIM",162643,2q21,Immunological
1050,"Myelomonocytic leukemia, chronic (3)","PDGFRB, PDGFR",173410,5q31-q32,Cancer
1051,"Myeloperoxidase deficiency, 254600 (3)",MPO,606989,17q23.1,Immunological
1052,"Myeloproliferative disorder with eosinophilia, 131440 (3)","PDGFRB, PDGFR",173410,5q31-q32,Cancer
1053,Myoadenylate deaminase deficiency (3),AMPD1,102770,1p21-p13,Muscular
1054,"Myocardial infarction, decreased susceptibility to (3)",F7,227500,13q34,Cardiovascular
1054,Myocardial infarction susceptibility (3),"APOE, AD2",107741,19q13.2,Cardiovascular
1054,"Myocardial infarction, susceptibility to (3)","ACE, DCP1, ACE1",106180,17q23,Cardiovascular
1054,"Myocardial infarction, susceptibility to (3)","ALOX5AP, FLAP",603700,13q12,Cardiovascular
1054,"Myocardial infarction, susceptibility to (3)",LGALS2,150571,22q13.1,Cardiovascular
1054,"Myocardial infarction, susceptibility to (3)","LTA, TNFB",153440,6p21.3,Cardiovascular
1054,"Myocardial infarction, susceptibility to (3)","OLR1, LOX1",602601,12p13-p12,Cardiovascular
1054,"Myocardial infarction, susceptibility to (3)","THBD, THRM",188040,20p11.2,Cardiovascular
1054,"Myocardial infarction, susceptibility to, 608446 (3)","GCLM, GLCLR",601176,1p22.1,Cardiovascular
1054,"Myocardial infarction, susceptibility to, 608446 (3)","TNFSF4, GP34, OX4OL",603594,1q25,Cardiovascular
1055,"Myoclonic epilepsy, juvenile, 1, 254770 (3)","EFHC1, FLJ10466, EJM1",608815,6p12-p11,Neurological
1055,"Myoclonic epilepsy, severe, of infancy, 607208 (3)","GABRG2, GEFSP3, CAE2, ECA2",137164,5q31.1-q33.1,Neurological
1055,"Myoclonic epilepsy with mental retardation and spasticity, 300432 (3)","ARX, ISSX, PRTS, MRXS1, MRX36,
MRX54",300382,Xp22.13,Neurological
1056,Myoglobinuria/hemolysis due to PGK deficiency (3),"PGK1, PGKA",311800,Xq13,Metabolic
1057,"Myokymia with neonatal epilepsy, 606437 (3)","KCNQ2, EBN1",602235,20q13.3,Neurological
1058,"Myoneurogastrointestinal encephalomyopathy syndrome, 603041 (3)",ECGF1,131222,22q13.32-qter,multiple
1059,"Myopathy, actin, congenital, with cores (3)","ACTA1, ASMA, NEM3, NEM1",102610,1q42.1,Muscular
1059,"Myopathy, actin, congenital, with excess of thin myofilaments, 161800 (3)","ACTA1, ASMA, NEM3, NEM1",102610,1q42.1,Muscular
1059,"Myopathy, cardioskeletal, desmin-related, with cataract, 608810 (3)","CRYAB, CRYA2, CTPP2",123590,11q22.3-q23.1,Muscular
1059,"Myopathy, centronuclear, 160150 (3)",MYF6,159991,12q21,Muscular
1059,"Myopathy, congenital (3)",ITGA7,600536,12q13,Muscular
1059,"Myopathy, desmin-related, cardioskeletal, 601419 (3)","DES, CMD1I",125660,2q35,Muscular
1059,"Myopathy, distal, with anterior tibial onset, 606768 (3)","DYSF, LGMD2B",603009,2p13.3-p13.1,Muscular
1059,"Myopathy, distal, with decreased caveolin 3 (3)","CAV3, LGMD1C",601253,3p25,Muscular
1059,"Myopathy due to CPT II deficiency, 255110 (3)",CPT2,600650,1p32,Muscular
1059,Myopathy due to phosphoglycerate mutase deficiency (3),"PGAM2, PGAMM",261670,7p13-p12.3,Muscular
1059,"Myopathy, Laing distal, 160500 (3)","MYH7, CMH1, MPD1",160760,14q12,Muscular
1059,"Myopathy, myosin storage, 608358 (3)","MYH7, CMH1, MPD1",160760,14q12,Muscular
1059,"Myopathy, nemaline, 3, 161800 (3)","ACTA1, ASMA, NEM3, NEM1",102610,1q42.1,Muscular
1061,"Myotilinopathy, 609200 (3)","TTID, MYOT",604103,5q31,Muscular
1062,"Myotonia congenita, atypical, acetazolamide-responsive, 608390 (3)","SCN4A, HYPP, NAC1A",603967,17q23.1-q25.3,Muscular
1062,"Myotonia congenita, dominant, 160800 (3)",CLCN1,118425,7q35,Muscular
1062,"Myotonia congenita, recessive, 255700 (3)",CLCN1,118425,7q35,Muscular
1062,"Myotonia levior, recessive (3)",CLCN1,118425,7q35,Muscular
1063,"Myotonic dystrophy, 160900 (3)","DMPK, DM, DMK",605377,19q13.2-q13.3,Muscular
1063,"Myotonic dystrophy, type 2, 602668 (3)","ZNF9, CNBP1, DM2, PROMM",116955,3q13.3-q24,Muscular
1064,"Myotubular myopathy, X-linked, 310400 (3)","MTM1, MTMX",300415,Xq28,Muscular
1065,Myxoid liposarcoma (3),"DDIT3, GADD153, CHOP10",126337,12q13.1-q13.2,Cancer
1066,"Myxoma, intracardiac, 255960 (3)","PRKAR1A, TSE1, CNC1, CAR",188830,17q23-q24,Cardiovascular
1067,"N-acetylglutamate synthase deficiency, 237310 (3)",NAGS,608300,17q21.31,Metabolic
1070,"Nail-patella syndrome, 161200 (3)","LMX1B, NPS1",602575,9q34.1,multiple
1070,"Nail-patella syndrome with open-angle glaucoma, 137750 (3)","LMX1B, NPS1",602575,9q34.1,multiple
1071,"Nance-Horan syndrome, 302350 (3)",NHS,300457,Xp22.13,Ophthamological
1073,"Narcolepsy, 161400 (3)","HCRT, OX",602358,17q21,Psychiatric
1074,"Nasopharyngeal carcinoma, 161550 (3)","TP53, P53, LFS1",191170,17p13.1,Cancer
1075,"Nasu-Hakola disease, 221770 (3)",TREM2,605086,6p21.2,Bone
1075,"Nasu-Hakola disease, 221770 (3)","TYROBP, PLOSL, DAP12",604142,19q13.1,Bone
1077,"Naxos disease, 601214 (3)","JUP, DP3, PDGB",173325,17q21,multiple
1078,"Nemaline myopathy, 161800 (3)","TPM2, TMSB, AMCD1, DA1",190990,9p13.2-p13.1,Muscular
1078,"Nemaline myopathy 1, autosomal dominant, 161800 (3)","TPM3, NEM1",191030,1q22-q23,Muscular
1078,"Nemaline myopathy 2, autosomal recessive, 256030 (3)","NEB, NEM2",161650,2q22,Muscular
1078,"Nemaline myopathy, Amish type, 605355 (3)","TNNT1, ANM",191041,19q13.4,Muscular
3079,"Neonatal ichthyosis-sclerosing cholangitis syndrome, 607626 (3)","CLDN1, SEMP1",603718,3q28-q29,multiple
1080,"Nephrogenic syndrome of inappropriate antidiuresis, 300539 (3)","AVPR2, DIR, DI1, ADHR",300538,Xq28,Renal
1081,"Nephrolithiasis, type I, 310468 (3)","CLCN5, CLCK2, NPHL2, DENTS",300008,Xp11.22,Renal
1081,"Nephrolithiasis, uric acid, susceptibility to, 605990 (3)","ZNF365, UAN",607818,10q21.2,Renal
1082,"Nephronophthisis 2, infantile, 602088 (3)","INVS, INV, NPHP2, NPH2",243305,9q31,Renal
1082,"Nephronophthisis 4, 606966 (3)","NPHP4, SLSN4",607215,1p36,Renal
1082,"Nephronophthisis, adolescent, 604387 (3)","NPHP3, NPH3",608002,3q22,Renal
1082,"Nephronophthisis, juvenile, 256100 (3)","NPHP1, NPH1, SLSN1",607100,2q13,Renal
1084,"Nephropathy, chronic hypocomplementemic (3)","HF1, CFH, HUS",134370,1q32,Renal
1085,"Nephropathy with pretibial epidermolysis bullosa and deafness, 609057 (3)","CD151, PETA3, SFA1",602243,11p15.5,Renal
1087,"Nephrosis-1, congenital, Finnish type, 256300 (3)","NPHS1, NPHN",602716,19q13.1,Renal
1087,"Nephrotic syndrome, steroid-resistant, 600995 (3)","PDCN, NPHS2, SRN1",604766,1q25-q31,Renal
1088,"Netherton syndrome, 256500 (3)","SPINK5, LEKTI",605010,5q32,Dermatological
1090,"Neural tube defects, maternal risk of, 601634 (3)","MTHFD, MTHFC",172460,14q24,Developmental
1091,"Neuroblastoma, 256700 (3)","NME1, NM23",156490,17q21.3,Cancer
1091,"Neuroblastoma, 256700 (3)","PMX2B, NBPHOX, PHOX2B",603851,4p12,Cancer
1092,"Neurodegeneration, pantothenate kinase-associated, 234200 (3)","PANK2, NBIA1, PKAN, HARP",606157,20p13-p12.3,Neurological
1093,"Neuroectodermal tumors, supratentorial primitive, with cafe-au-lait spots, 608623 (3)","PMS2, PMSL2, HNPCC4",600259,7p22,multiple
1095,"Neurofibromatosis, familial spinal, 162210 (3)","NF1, VRNF, WSS, NFNS",162200,17q11.2,Cancer
1096,"Neurofibromatosis-Noonan syndrome, 601321 (3)","NF1, VRNF, WSS, NFNS",162200,17q11.2,Cancer
1097,"Neurofibromatosis, type 1 (3)","NF1, VRNF, WSS, NFNS",162200,17q11.2,Cancer
1097,"Neurofibromatosis, type 2, 101000 (3)",NF2,607379,22q12.2,Cancer
1097,"Neurofibromatosis, type I, with leukemia, 162200 (3)","MSH2, COCA1, FCC1, HNPCC1",609309,2p22-p21,Cancer
1098,Neurofibrosarcoma (3),MXI1,600020,10q25,Cancer
1099,"Neuropathy, congenital hypomyelinating, 1, 605253 (3)","EGR2, KROX20",129010,10q21.1-q22.1,Neurological
1099,"Neuropathy, congenital hypomyelinating, 605253 (3)","MPZ, CMT1B, CMTDI3, CHM, DSS",159440,1q22,Neurological
1099,"Neuropathy, distal hereditary motor, 608634 (3)","HSPB1, HSP27, CMT2F",602195,7q11.23,Neurological
1099,"Neuropathy, distal hereditary motor, type II, 158590 (3)","HSPB8, H11, E2IG1, DHMN2",608014,12q24-qter,Neurological
1099,"Neuropathy, hereditary sensory and autonomic, type 1, 162400 (3)","SPTLC1, LBC1, SPT1, HSN1, HSAN",605712,9q22.1-q22.3,Neurological
1099,"Neuropathy, hereditary sensory and autonomic, type V, 608654 (3)","NGFB, HSAN5",162030,1p13.1,Neurological
1099,"Neuropathy, hereditary sensory, type II, 201300 (3)",HSN2,608620,12p13.33,Neurological
1099,"Neuropathy, recurrent, with pressure palsies, 162500 (3)","PMP22, CMT1A, CMT1E, DSS",601097,17p11.2,Neurological
1101,"Neutropenia, alloimmune neonatal (3)","FCGR3A, CD16, IGFR3",146740,1q23,Hematological
1101,"Neutropenia, congenital, 202700 (3)",ELA2,130130,19p13.3,Hematological
1101,"Neutropenia, severe congenital, 202700 (3)","GFI1, ZNF163",600871,1p22,Hematological
1101,"Neutropenia, severe congenital, X-linked, 300299 (3)","WAS, IMD2, THC",300392,Xp11.23-p11.22,Hematological
1102,"Neutrophil immunodeficiency syndrome, 608203 (3)",RAC2,602049,22q12.3-q13.2,Immunological
1103,"Nevo syndrome, 601451 (3)","PLOD, PLOD1",153454,1p36.3-p36.2,Connective tissue
1104,"Nevus, epidermal, epidermolytic hyperkeratotic type, 600648 (3)",KRT10,148080,17q21-q22,Dermatological
1105,"Newfoundland rod-cone dystrophy, 607476 (3)",RLBP1,180090,15q26,Ophthamological
1106,"Nicotine addiction, protection from (3)","CYP2A6, CYP2A3, CYP2A, P450C2A",122720,19q13.2,Psychiatric
1106,"Nicotine addiction, susceptibility to, 188890 (3)","CHRNA4, ENFL1",118504,20q13.2-q13.3,Psychiatric
1106,"Nicotine dependence, susceptibility to, 188890 (3)","GPR51, GABBR2",607340,9q22.1,Psychiatric
1107,"Niemann-Pick disease, type A, 257200 (3)","SMPD1, NPD",607608,11p15.4-p15.1,Metabolic
1107,"Niemann-Pick disease, type B, 607616 (3)","SMPD1, NPD",607608,11p15.4-p15.1,Metabolic
1107,"Niemann-Pick disease, type C1, 257220 (3)","NPC1, NPC",607623,18q11-q12,Metabolic
1107,"Niemann-pick disease, type C2, 607625 (3)","NPC2, HE1",601015,14q24.3,Metabolic
1107,"Niemann-Pick disease, type D, 257220 (3)","NPC1, NPC",607623,18q11-q12,Metabolic
1110,"Night blindness, congenital stationary (3)",GNAT1,139330,3p21,Ophthamological
1110,"Night blindness, congenital stationary, type 1, 310500 (3)","CSNB1, NYX",300278,Xp11.4,Ophthamological
1110,"Night blindness, congenital stationary, type 3, 163500 (3)","PDE6B, PDEB, CSNB3",180072,4p16.3,Ophthamological
1110,"Night blindness, congenital stationary, X-linked, type 2, 300071 (3)","CACNA1F, CSNB2",300110,Xp11.23,Ophthamological
1110,"Night blindness, congenital stationery, rhodopsin-related (3)","RHO, RP4, OPN2",180380,3q21-q24,Ophthamological
1111,"Nijmegen breakage syndrome, 251260 (3)","NBS1, NBS",602667,8q21,multiple
1112,"Nonaka myopathy, 605820 (3)","GNE, GLCNE, IBM2, DMRV, NM",603824,9p12-p11,Muscular
1113,"Noncompaction of left ventricular myocardium, isolated, 300183 (3)","TAZ, EFE2, BTHS, CMD3A, LVNCX",300394,Xq28,Cardiovascular
1114,"Non-Hodgkin lymphoma, somatic, 605027 (3)","CASP10, MCH4, ALPS2",601762,2q33-q34,Cancer
1115,Nonsmall cell lung cancer (3),"IRF1, MAR",147575,5q31.1,Cancer
1115,"Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, 211980 (3)",EGFR,131550,7p12.3-p12.1,Cancer
1115,"Nonsmall cell lung cancer, somatic (3)",BRAF,164757,7q34,Cancer
1116,"Noonan syndrome 1, 163950 (3)","PTPN11, PTP2C, SHP2, NS1",176876,12q24.1,Developmental
1117,Norrie disease (3),"NDP, ND",310600,Xp11.4,Neurological
1118,"Norum disease, 245900 (3)",LCAT,606967,16q22.1,Metabolic
1119,"Norwalk virus infection, resistance to (3)","FUT2, SE",182100,19q13.3,Immunological
1122,"Nucleoside phosphorylase deficiency, immunodeficiency due to (3)",NP,164050,14q13.1,Immunological
1126,"Obesity, adrenal insufficiency, and red hair (3)",POMC,176830,2p23.3,Nutritional
1126,"Obesity, autosomal dominant, 601665 (3)",MC4R,155541,18q22,Nutritional
1126,"Obesity, hyperphagia, and developmental delay (3)","AKR1C2, DDH2, DD2, HAKRD",600450,10p15-p14,Nutritional
1126,"Obesity, hyperphagia, and developmental delay (3)","NTRK2, TRKB",600456,9q22.1,Nutritional
1126,"Obesity, late-onset, 601665 (3)","AGRP, ART, AGRT",602311,16q22,Nutritional
1126,"Obesity, mild, early-onset, 601665 (3)","NR0B2, SHP",604630,1p36.1,Nutritional
1126,"Obesity, morbid, with hypogonadism (3)","LEP, OB",164160,7q31.3,Nutritional
1126,"Obesity, morbid, with hypogonadism (3)","LEPR, OBR",601007,1p31,Nutritional
1126,"Obesity, resistance to (3)","PPARG, PPARG1, PPARG2",601487,3p25,Nutritional
1126,"Obesity, severe, 601665 (3)","PPARG, PPARG1, PPARG2",601487,3p25,Nutritional
1126,"Obesity, severe, 601665 (3)",SIM1,603128,6q16.3-q21,Nutritional
1126,"Obesity, severe, and type II diabetes, 601665 (3)",UCP3,602044,11q13,Nutritional
1126,"Obesity, severe, due to leptin deficiency (3)","LEP, OB",164160,7q31.3,Nutritional
1126,"Obesity, severe, susceptibility to, 601665 (3)",MC3R,155540,20q13.2,Nutritional
1126,"Obesity, susceptibility to, 300306 (3)","SLC6A14, OBX",300444,Xq23-q24,Nutritional
1126,"Obesity, susceptibility to, 601665 (3)",ADRB2,109690,5q32-q34,Nutritional
1126,"Obesity, susceptibility to, 601665 (3)",ADRB3,109691,8p12-p11.2,Nutritional
1126,"Obesity, susceptibility to, 601665 (3)",CART,602606,5q13.2,Nutritional
1126,"Obesity, susceptibility to, 601665 (3)","ENPP1, PDNP1, NPPS, M6S1, PCA1",173335,6q22-q23,Nutritional
1126,"Obesity, susceptibility to, 601665 (3)",GHRL,605353,3p26-p25,Nutritional
1126,"Obesity, susceptibility to, 601665 (3)",UCP1,113730,4q31,Nutritional
1126,"Obesity, susceptibility to, 601665 (3)",UCP2,601693,11q13,Nutritional
1126,"Obestiy with impaired prohormone processing, 600955 (3)","PCSK1, NEC1, PC1, PC3",162150,5q15-q21,Nutritional
1128,"Obsessive-compulsive disorder 1, 164230 (3)","SLC6A4, HTT, OCD1",182138,17q11.1-q12,Psychiatric
1128,"Obsessive-compulsive disorder, protection against, 164230 (3)",BDNF,113505,11p13,Psychiatric
1128,"Obsessive-compulsive disorder, susceptibility to, 164230 (3)",HTR2A,182135,13q14-q21,Psychiatric
1129,"Occipital horn syndrome, 304150 (3)","ATP7A, MNK, MK, OHS",300011,Xq12-q13,multiple
1130,"Ocular albinism, Nettleship-Falls type (3)",OA1,300500,Xp22.3,Ophthamological
1130,"Oculocutaneous albinism, type II, modifier of (3)",MC1R,155555,16q24.3,Ophthamological
1130,"Oculocutaneous albinism, type IV, 606574 (3)","MATP, AIM1",606202,5p13.3,Ophthamological
1132,"Oculodentodigital dysplasia, 164200 (3)","GJA1, CX43, ODDD, SDTY3, ODOD",121014,6q21-q23.2,Skeletal
1133,"Oculofaciocardiodental syndrome, 300166 (3)","BCOR, KIAA1575, MAA2, ANOP2",300485,Xp11.4,multiple
1135,"Oculopharyngeal muscular dystorphy, 164300 (3)","PABPN1, PABP2, PAB2",602279,14q11.2-q13,Muscular
1135,"Oculopharyngeal muscular dystrophy, autosomal recessive, 257950 (3)","PABPN1, PABP2, PAB2",602279,14q11.2-q13,Muscular
1136,"Odontohypophosphatasia, 146300 (3)","ALPL, HOPS, TNSALP",171760,1p36.1-p34,Bone
1137,"Oguchi disease-1, 258100 (3)",SAG,181031,2q37.1,Ophthamological
1137,"Oguchi disease-2, 258100 (3)","RHOK, RK, GRK1",180381,13q34,Ophthamological
1138,"Oligodendroglioma, 137800 (3)","PTEN, MMAC1",601728,10q23.31,Cancer
1139,"Oligodontia, 604625 (3)",PAX9,167416,14q12-q13,Skeletal
1140,"Oligodontia-colorectal cancer syndrome, 608615 (3)",AXIN2,604025,17q24,Cancer
1141,"Omenn syndrome, 603554 (3)","DCLRE1C, ARTEMIS, SCIDA",605988,10p,Immunological
1141,"Omenn syndrome, 603554 (3)",RAG1,179615,11p13,Immunological
1141,"Omenn syndrome, 603554 (3)",RAG2,179616,11p13,Immunological
1142,"Opitz G syndrome, type I, 300000 (3)","MID1, OGS1, BBBG1, FXY, OSX",300552,Xp22,multiple
1143,Opremazole poor metabolizer (3),"CYP2C, CYP2C19",124020,10q24.1-q24.3,Metabolic
1144,"Optic atrophy 1, 165500 (3)","OPA1, NTG, NPG",605290,3q28-q29,Ophthamological
1144,"Optic atrophy and cataract, 165300 (3)","OPA3, MGA3",606580,19q13.2-q13.3,Ophthamological
3144,"Optic nerve coloboma with renal disease, 120330 (3)",PAX2,167409,10q24.3-q25.1,multiple
5144,"Optic nerve hypoplasia/aplasia, 165550 (3)","PAX6, AN2, MGDA",607108,11p13,Ophthamological
1145,"Oral-facial-digital syndrome 1, 311200 (3)","OFD1, CXorf5",300170,Xp22.3-p22.2,Skeletal
1146,"Ornithine transcarbamylase deficiency, 311250 (3)",OTC,300461,Xp21.1,Metabolic
1147,"Orofacial cleft 6, 608864 (3)","IRF6, VWS, LPS, PIT, PPS, OFC6",607199,1q32-q41,Skeletal
1148,"Orolaryngeal cancer, multiple, (3)","CDKN2A, MTS1, P16, MLM, CMM2",600160,9p21,Cancer
1149,Oroticaciduria (3),"UMPS, OPRT",258900,3q13,Metabolic
1150,"Orthostatic intolerance, 604715 (3)","SLC6A2, NAT1, NET1",163970,16q12.2,Cardiovascular
1151,"OSMED syndrome, 215150 (3)","COL11A2, STL3, DFNA13",120290,6p21.3,Bone
1152,"Osseous heteroplasia, progressive, 166350 (3)","GNAS, GNAS1, GPSA, POH, PHP1B,
PHP1A, AHO",139320,20q13.2,Bone
1153,"Ossification of posterior longitudinal ligament of spine, 602475 (3)","ENPP1, PDNP1, NPPS, M6S1, PCA1",173335,6q22-q23,Connective tissue
1154,"Osteoarthritis, hand, susceptibility to, 607850 (3)","MATN3, EDM5, HOA",602109,2p24-p23,Connective tissue
1154,"Osteoarthritis of hip, female-specific, susceptibility to, 165720 (3)","FRZB, FRZB1, SRFP3",605083,2q31-q33,Connective tissue
1154,"Osteoarthritis, susceptibility to, 165720 (3)","ASPN, PLAP1",608135,9q21.3-q22,Connective tissue
1154,"Osteoarthrosis, 165720 (3)",COL2A1,120140,12q13.11-q13.2,Connective tissue
1156,"Osteogenesis imperfecta, 3 clinical forms, 166200, 166210, 259420 (3)",COL1A2,120160,7q22.1,Bone
1156,"Osteogenesis imperfecta, type I, 166200 (3)",COL1A1,120150,17q21.31-q22,Bone
1156,"Osteogenesis imperfecta, type II, 166210 (3)",COL1A1,120150,17q21.31-q22,Bone
1156,"Osteogenesis imperfecta, type III, 259420 (3)",COL1A1,120150,17q21.31-q22,Bone
1156,"Osteogenesis imperfecta, type IV, 166220 (3)",COL1A1,120150,17q21.31-q22,Bone
1157,"Osteolysis, familial expansile, 174810 (3)","TNFRSF11A, RANK, ODFR, OFE",603499,18q22.1,Bone
1157,"Osteolysis, idiopathic, Saudi type, 605156 (3)","MMP2, CLG4A, MONA",120360,16q13,Bone
1161,"Osteopetrosis, autosomal dominant, type I, 607634 (3)","LRP5, BMND1, LRP7, LR3, OPPG,
VBCH2",603506,11q13.4,Bone
1161,"Osteopetrosis, autosomal dominant, type II, 166600 (3)","CLCN7, CLC7, OPTA2",602727,16p13,Bone
1161,"Osteopetrosis, autosomal recessive, 259700 (3)","OSTM1, GL",607649,6q21,Bone
1161,"Osteopetrosis, recessive, 259700 (3)","CLCN7, CLC7, OPTA2",602727,16p13,Bone
1161,"Osteopetrosis, recessive, 259700 (3)","TCIRG1, TIRC7, OC116, OPTB1",604592,11q13.4-q13.5,Bone
1162,"Osteopoikilosis, 166700 (3)","LEMD3, MAN1",607844,12q14,Bone
1163,"Osteoporosis, 166710 (3)",COL1A1,120150,17q21.31-q22,Bone
1163,"Osteoporosis, 166710 (3)","LRP5, BMND1, LRP7, LR3, OPPG,
VBCH2",603506,11q13.4,Bone
1163,Osteoporosis (3),"CALCA, CALC1",114130,11p15.2-p15.1,Bone
1163,"Osteoporosis, hypophosphatemic, (3)","SLC17A2, NPT2",182309,5q35,Bone
1163,"Osteoporosis, idiopathic, 166710 (3)",COL1A2,120160,7q22.1,Bone
1163,"Osteoporosis, postmenopausal, susceptibility, 166710 (3)","CALCR, CRT",114131,7q21.3,Bone
1164,"Osteoporosis-pseudoglioma syndrome, 259770 (3)","LRP5, BMND1, LRP7, LR3, OPPG,
VBCH2",603506,11q13.4,Bone
1165,"Osteoporosis, susceptibility to, 166710 (3)",RIL,603422,5q31.1,Bone
1166,Osteosarcoma (3),"TP53, P53, LFS1",191170,17p13.1,Cancer
1166,"Osteosarcoma, somatic, 259500 (3)","CHEK2, RAD53, CHK2, CDS1, LFS2",604373,22q12.1,Cancer
1168,"Otopalatodigital syndrome, type I, 311300 (3)","FLNA, FLN1, ABPX, NHBP, OPD1,
OPD2, FMD, MNS",300017,Xq28,multiple
1168,"Otopalatodigital syndrome, type II, 304120 (3)","FLNA, FLN1, ABPX, NHBP, OPD1,
OPD2, FMD, MNS",300017,Xq28,multiple
1170,Ovarian cancer (3),"BRCA1, PSCP",113705,17q21,Cancer
1170,Ovarian cancer (3),"MSH2, COCA1, FCC1, HNPCC1",609309,2p22-p21,Cancer
1170,"Ovarian cancer, 604370 (3)",PIK3CA,171834,3q26.3,Cancer
1170,"Ovarian cancer, endometrial type (3)","MSH6, GTBP, HNPCC5",600678,2p16,Cancer
1170,"Ovarian cancer, somatic, (3)","ERBB2, NGL, NEU, HER2",164870,17q21.1,Cancer
1170,Ovarian carcinoma (3),"CDH1, UVO",192090,16q22.1,Cancer
1170,Ovarian carcinoma (3),"RRAS2, TC21",600098,11pter-p15.5,Cancer
1170,"Ovarian carcinoma, endometrioid type (3)",CTNNB1,116806,3p22-p21.3,Cancer
3171,"Ovarian dysgenesis 1, 233300 (3)","FSHR, ODG1",136435,2p21-p16,Endocrine
3171,"Ovarian dysgenesis 2, 300510 (3)","BMP15, GDF9B, ODG2",300247,Xp11.2,Endocrine
5170,"Ovarian hyperstimulation syndrome, gestational, 608115 (3)","FSHR, ODG1",136435,2p21-p16,Endocrine
7170,Ovarian sex cord tumors (3),"FSHR, ODG1",136435,2p21-p16,Cancer
1171,"Ovarioleukodystrophy, 603896 (3)",EIF2B2,606454,14q24,Neurological
1171,"Ovarioleukodystrophy, 603896 (3)",EIF2B4,606687,2p23.3,Neurological
1171,"Ovarioleukodystrophy, 603896 (3)","EIF2B5, LVWM, CACH, CLE",603945,3q27,Neurological
1172,"Pachyonychia congenita, Jackson-Lawler type, 167210 (3)","KRT17, PC2, PCHC1",148069,17q12-q21,Dermatological
1172,"Pachyonychia congenita, Jackson-Lawler type, 167210 (3)","KRT6B, PC2",148042,12q13,Dermatological
1172,"Pachyonychia congenita, Jadassohn-Lewandowsky type, 167200 (3)",KRT16,148067,17q12-q21,Dermatological
1172,"Pachyonychia congenita, Jadassohn-Lewandowsky type, 167200 (3)",KRT6A,148041,12q13,Dermatological
1173,"Paget disease, juvenile, 239000 (3)","TNFRSF11B, OPG, OCIF",602643,8q24,Bone
1173,"Paget disease of bone, 602080 (3)","SQSTM1, P62, PDB3",601530,5q35,Bone
1173,"Paget disease of bone, 602080 (3)","TNFRSF11A, RANK, ODFR, OFE",603499,18q22.1,Bone
1174,"Pallidopontonigral degeneration, 168610 (3)","MAPT, MTBT1, DDPAC, MSTD",157140,17q21.1,Neurological
1175,"Pallister-Hall syndrome, 146510 (3)","GLI3, PAPA, PAPB, ACLS",165240,7p13,multiple
1176,"Palmoplantar keratoderma, nonepidermolytic, 600962 (3)",KRT16,148067,17q12-q21,Dermatological
1176,"Palmoplantar verrucous nevus, unilateral, 144200 (3)",KRT16,148067,17q12-q21,Dermatological
3178,"Pancreatic agenesis, 260370 (3)",IPF1,600733,13q12.1,Gastrointestinal
1178,"Pancreatic cancer, 260350 (3)","ARMET, ARP",601916,3p21.1,Cancer
1178,"Pancreatic cancer, 260350 (3)","BRCA2, FANCD1",600185,13q12.3,Cancer
1178,"Pancreatic cancer, 260350 (3)","TP53, P53, LFS1",191170,17p13.1,Cancer
1178,Pancreatic cancer (3),"MADH4, DPC4, SMAD4, JIP",600993,18q21.1,Cancer
1178,"Pancreatic cancer/melanoma syndrome, 606719 (3)","CDKN2A, MTS1, P16, MLM, CMM2",600160,9p21,Cancer
1178,"Pancreatic cancer, somatic (3)","ACVR1B, ACVRLK4, ALK4",601300,12q13,Cancer
1178,"Pancreatic cancer, sporadic (3)","STK11, PJS, LKB1",602216,19p13.3,Cancer
1178,"Pancreatic carcinoma, somatic, 260350 (3)","KRAS2, RASK2",190070,12p12.1,Cancer
1178,"Pancreatic carcinoma, somatic (3)","RBBP8, RIM",604124,18q11.2,Cancer
1179,"Pancreatitis, hereditary, 167800 (3)","PRSS1, TRY1",276000,7q35,Gastrointestinal
1179,"Pancreatitis, hereditary, 167800 (3)","SPINK1, PSTI, PCTT, TATI",167790,5q32,Gastrointestinal
1179,"Pancreatitis, idiopathic (3)","CFTR, ABCC7, CF, MRP7",602421,7q31.2,Gastrointestinal
1183,Papillary serous carcinoma of the peritoneum (3),"BRCA1, PSCP",113705,17q21,Cancer
1184,"Papillon-Lefevre syndrome, 245000 (3)","CTSC, CPPI, PALS, PLS, HMS",602365,11q14.1-q14.3,multiple
1186,"Paraganglioma, familial malignant, 168000 (3)","SDHB, SDH1, SDHIP",185470,1p36.1-p35,Cancer
1186,"Paragangliomas, familial central nervous system, 168000 (3)","SDHD, PGL1",602690,11q23,Cancer
1186,"Paragangliomas, familial nonchromaffin, 1, with and without deafness, 168000 (3)","SDHD, PGL1",602690,11q23,Cancer
1186,"Paragangliomas, familial nonchromaffin, 3, 605373 (3)","SDHC, PGL3",602413,1q21,Cancer
1186,"Paraganglioma, sporadic corotid body, 168000 (3)","SDHD, PGL1",602690,11q23,Cancer
1188,"Paramyotonia congenita, 168300 (3)","SCN4A, HYPP, NAC1A",603967,17q23.1-q25.3,Muscular
1189,"Parathyroid adenoma, sporadic (3)",MEN1,131100,11q13,Cancer
1189,"Parathyroid adenoma with cystic changes, 145001 (3)","HRPT2, C1orf28",607393,1q25-q31,Cancer
1189,"Parathyroid carcinoma, 608266 (3)","HRPT2, C1orf28",607393,1q25-q31,Cancer
1190,"Parietal foramina 1, 168500 (3)","MSX2, CRS2, HOX8",123101,5q34-q35,Skeletal
1190,"Parietal foramina 2, 168500 (3)","ALX4, PFM2, FPP",605420,11p11.2,Skeletal
1190,"Parietal foramina with cleidocranial dysplasia, 168550 (3)","MSX2, CRS2, HOX8",123101,5q34-q35,Skeletal
1191,"Parkes Weber syndrome, 608355 (3)","RASA1, GAP, CMAVM, PKWS",139150,5q13.3,multiple
1192,"Parkinson disease, 168600 (3)","NR4A2, NURR1, NOT, TINUR",601828,2q22-q23,Neurological
1192,"Parkinson disease, 168600 (3)",SNCAIP,603779,5q23.1-q23.3,Neurological
1192,"Parkinson disease, 168600 (3)","TBP, SCA17",600075,6q27,Neurological
1192,"Parkinson disease 4, autosomal dominant Lewy body, 605543 (3)","SNCA, NACP, PARK1, PARK4",163890,4q21,Neurological
1192,"Parkinson disease 7, autosomal recessive early-onset, 606324 (3)","DJ1, PARK7",602533,1p36,Neurological
1192,"Parkinson disease-8, 607060 (3)","LRRK2, PARK8",609007,12q12,Neurological
1192,"Parkinson disease, early onset, 605909 (3)","PINK1, PARK6",608309,1p36,Neurological
1192,"Parkinson disease, familial, 168600 (3)","UCHL1, PARK5",191342,4p14,Neurological
1192,"Parkinson disease, familial, 168601 (3)","SNCA, NACP, PARK1, PARK4",163890,4q21,Neurological
1192,"Parkinson disease, juvenile, type 2, 600116 (3)","PRKN, PARK2, PDJ",602544,6q25.2-q27,Neurological
1192,"Parkinson disease, resistance to, 168600 (3)",DBH,609312,9q34,Neurological
1192,"Parkinson disease, susceptibility to, 168600 (3)",NDUFV2,600532,18p11.31-p11.2,Neurological
3195,Paroxysmal nocturnal hemoglobinuria (3),PIGA,311770,Xp22.1,Hematological
1195,"Paroxysmal nonkinesigenic dyskinesia, 118800 (3)","MR1, TAHCCP2, KIPP1184, BRP17,
PNKD, FPD1, PDC, DYT8",609023,2q35,Neurological
1196,"Partington syndrome, 309510 (3)","ARX, ISSX, PRTS, MRXS1, MRX36,
MRX54",300382,Xp22.13,Neurological
1198,"PCWH, 609136 (3)","SOX10, WS4",602229,22q13,Neurological
1199,"Pelger-Huet anomaly, 169400 (3)","LBR, PHA",600024,1q42.1,Hematological
1200,"Pelizaeus-Merzbacher disease, 312080 (3)","PLP1, PMD",300401,Xq22,Neurological
1201,"Pelizaeus-Merzbacher-like disease, autosomal recessive, 608804 (3)","GJA12, CX47, PMLDAR",608803,1q41-q42,Neurological
1204,"Pendred syndrome, 274600 (3)","SLC26A4, PDS, DFNB4",605646,7q31,"Ear,Nose,Throat"
1205,Perineal hypospadias (3),"AR, DHTR, TFM, SBMA, KD, SMAX1",313700,Xq11-q12,Endocrine
1206,"Periodic fever, familial, 142680 (3)","TNFRSF1A, TNFR1, TNFAR, FPF",191190,12p13.2,Immunological
1207,"Periodontitis, juvenile, 170650 (3)","CTSC, CPPI, PALS, PLS, HMS",602365,11q14.1-q14.3,"Ear,Nose,Throat"
1209,"Periventricular heterotopia with microcephaly, 608097 (3)","ARFGEF2, BIG2",605371,20q13.13,Neurological
1210,"Peroxisomal biogenesis disorder, complementation group 4 (3)","PEX6, PXAAA1, PAF2",601498,6p21.1,multiple
1210,"Peroxisomal biogenesis disorder, complementation group 6 (3)","PEX6, PXAAA1, PAF2",601498,6p21.1,multiple
1210,Peroxisome biogenesis factor 12 (3),PEX12,601758,Chr.17,multiple
3212,"Persistent hyperinsulinemic hypoglycemia of infancy, 256450 (3)","KCNJ11, BIR, PHHI",600937,11p15.1,Metabolic
1212,"Persistent Mullerian duct syndrome, type I, 261550 (3)","AMH, MIF",600957,19p13.3-p13.2,Developmental
1212,"Persistent Mullerian duct syndrome, type II, 261550 (3)","AMHR2, AMHR",600956,12q13,Developmental
1213,"Peters anomaly, 603807 (3)","PAX6, AN2, MGDA",607108,11p13,Developmental
1213,"Peters anomaly, 604229 (3)","CYP1B1, GLC3A",601771,2p22-p21,Developmental
1214,"Peutz-Jeghers syndrome, 175200 (3)","STK11, PJS, LKB1",602216,19p13.3,Cancer
1215,"Pfeiffer syndrome, 101600 (3)","FGFR1, FLT2, KAL2",136350,8p11.2-p11.1,Skeletal
1215,"Pfeiffer syndrome, 101600 (3)","FGFR2, BEK, CFD1, JWS",176943,10q26,Skeletal
1216,Phenylketonuria (3),"PAH, PKU1",261600,12q24.1,Metabolic
1216,Phenylketonuria due to dihydropteridine reductase deficiency (3),"QDPR, DHPR",261630,4p15.31,Metabolic
1216,Phenylketonuria due to PTS deficiency (3),PTS,261640,11q22.3-q23.3,Metabolic
1217,"Phenylthiocarbamide tasting, 171200 (3)","TAS2R38, T2R61, PTC",607751,7q35-q36,"Ear,Nose,Throat"
1218,"Pheochromocytoma, 171300 (3)","SDHD, PGL1",602690,11q23,Cancer
1218,"Pheochromocytoma, 171300 (3)",VHL,608537,3p26-p25,Cancer
1218,"Pheochromocytoma, extraadrenal, and cervical paraganglioma, 115310 (3)","SDHB, SDH1, SDHIP",185470,1p36.1-p35,Cancer
1220,"Phosphoglycerate dehydrogenase deficiency, 601815 (3)",PHGDH,606879,1q12,Metabolic
1221,Phosphoribosyl pyrophosphate synthetase-related gout (3),PRPS1,311850,Xq22-q24,Metabolic
1222,"Phosphorylase kinase deficiency of liver and muscle, autosomal recessive, 261750 (3)",PHKB,172490,16q12-q13,Metabolic
1223,Phosphoserine phosphatase deficiency (3),PSP,172480,7p15.2-p15.1,Metabolic
1225,"Pick disease, 172700 (3)","PSEN1, AD3",104311,14q24.3,Neurological
1226,Piebaldism (3),"KIT, PBT",164920,4q12,Dermatological
1227,"Pigmentation of hair, skin, and eyes, variation in (3)","MATP, AIM1",606202,5p13.3,Dermatological
3229,"Pigmented adrenocortical disease, primary isolated, 160980 (3)","PRKAR1A, TSE1, CNC1, CAR",188830,17q23-q24,Cancer
1229,"Pigmented paravenous chorioretinal atrophy, 172870 (3)","CRB1, RP12",604210,1q31-q32.1,Ophthamological
1230,"Pilomatricoma, 132600 (3)",CTNNB1,116806,3p22-p21.3,Cancer
1232,Pituitary ACTH-secreting adenoma (3),"GNAI2, GNAI2B, GIP",139360,3p21,Cancer
1232,Pituitary ACTH secreting adenoma (3),"GNAS, GNAS1, GPSA, POH, PHP1B,
PHP1A, AHO",139320,20q13.2,Cancer
1232,"Pituitary adenoma, nonfunctioning (3)","THRA, ERBA1, THRA1",190120,17q11.2,Cancer
3232,Pituitary anomalies with holoprosencephaly-like features (3),GLI2,165230,2q14,multiple
5232,"Pituitary hormone deficiency, combined (3)","POU1F1, PIT1",173110,3p11,Endocrine
5232,"Pituitary hormone deficiency, combined (3)",PROP1,601538,5q,Endocrine
5232,"Pituitary hormone deficiency, combined, HESX1-related, 182230 (3)","HESX1, RPX",601802,3p21.2-p21.1,Endocrine
5232,"Pituitary hormone deficiency, combined, with rigid cervical spine, 262600 (3)",LHX3,600577,9q34.3,Endocrine
7232,"Pituitary tumor, invasive (3)","PRKCA, PKCA",176960,17q22-q23.2,Cancer
1233,Placental abruption (3),NOS3,163729,7q36,Unclassified
5233,Placental steroid sulfatase deficiency (3),"STS, ARSC1, ARSC, SSDD",308100,Xp22.32,Metabolic
1234,Plasmin inhibitor deficiency (3),"PLI, SERPINF2",262850,17pter-p12,Hematological
1235,Plasminogen Tochigi disease (3),PLG,173350,6q26,Hematological
1237,Platelet-activating factor acetylhydrolase deficiency (3),"PLA2G7, PAFAH",601690,6p21.2-p12,Hematological
1237,Platelet ADP receptor defect (3),"P2RY12, P2Y12",600515,3q24-q25,Hematological
1237,"Platelet disorder, familial, with associated myeloid malignancy, 601399 (3)","RUNX1, CBFA2, AML1",151385,21q22.3,Hematological
1237,"Platelet glycoprotein IV deficiency, 608404 (3)",CD36,173510,7q11.2,Hematological
1238,"Pneumonitis, desquamative interstitial, 263000 (3)","SFTPC, SFTP2",178620,8p21,Respiratory
1239,"Pneumothorax, primary spontaneous, 173600 (3)","FLCN, BHD",607273,17p11.2,Respiratory
1241,"Polycystic kidney and hepatic disease, 263200 (3)","FCYT, PKHD1, ARPKD",606702,6p21.1-p12,Renal
1241,"Polycystic kidney disease, adult type I, 173900 (3)",PKD1,601313,16p13.3-p13.12,Renal
1241,"Polycystic kidney disease, adult, type II (3)","PKD2, PKD4",173910,4q21-q23,Renal
1241,"Polycystic kidney disease, infantile severe, with tuberous sclerosis (3)",PKDTS,600273,16p13.3,Renal
3241,"Polycystic liver disease, 174050 (3)","PRKCSH, G19P1, PCLD",177060,19p13.2-p13.1,Gastrointestinal
3241,"Polycystic liver disease, 174050 (3)",SEC63,608648,6q21,Gastrointestinal
1242,"Polycythemia, benign familial, 263400 (3)",VHL,608537,3p26-p25,Hematological
1242,"Polycythemia vera, 263300 (3)",JAK2,147796,9p24,Hematological
1243,"Polydactyly, postaxial, types A1 and B, 174200 (3)","GLI3, PAPA, PAPB, ACLS",165240,7p13,Skeletal
1243,"Polydactyly, preaxial, type IV, 174700 (3)","GLI3, PAPA, PAPB, ACLS",165240,7p13,Skeletal
1244,"Polymicrogyria, bilateral frontoparietal, 606854 (3)","GPR56, TM7XN1, BFPP",604110,16q13,Neurological
1245,"Polyposis, juvenile intestinal, 174900 (3)","BMPR1A, ACVRLK3, ALK3",601299,10q22.3,Cancer
1245,"Polyposis, juvenile intestinal, 174900 (3)","MADH4, DPC4, SMAD4, JIP",600993,18q21.1,Cancer
1246,"Popliteal pterygium syndrome, 119500 (3)","IRF6, VWS, LPS, PIT, PPS, OFC6",607199,1q32-q41,multiple
1247,"Porencephaly, 175780 (3)",COL4A1,120130,13q34,Neurological
1249,"Porphyria, acute hepatic (3)",ALAD,125270,9q34,Metabolic
1249,"Porphyria, acute intermittent (3)","HMBS, PBGD, UPS",176000,11q23.3,Metabolic
1249,"Porphyria, acute intermittent, nonerythroid variant (3)","HMBS, PBGD, UPS",176000,11q23.3,Metabolic
1249,"Porphyria, congenital erythropoietic, 263700 (3)",UROS,606938,10q25.2-q26.3,Metabolic
1249,Porphyria cutanea tarda (3),UROD,176100,1p34,Metabolic
1249,"Porphyria, hepatoerythropoietic (3)",UROD,176100,1p34,Metabolic
1249,"Porphyria variegata, 176200 (3)","HFE, HLA-H, HFE1",235200,6p21.3,Metabolic
1249,"Porphyria variegata, 176200 (3)",PPOX,600923,1q22,Metabolic
1253,"PPM-X syndrome, 300055 (3)","MECP2, RTT, PPMX, MRX16, MRX79",300005,Xq28,Neurological
1254,"Prader-Willi syndrome, 176270 (3)",NDN,602117,15q11-q13,multiple
1254,"Prader-Willi syndrome, 176270 (3)",SNRPN,182279,15q12,multiple
1256,"Precocious puberty, male, 176410 (3)",LHCGR,152790,2p21,Developmental
1257,Preeclampsia/eclampsia 4 (3),"STOX1, PEE4",609397,10q22.1,Cardiovascular
1257,"Preeclampsia, susceptibility to, 189800 (3)",EPHX1,132810,1q42.1,Cardiovascular
1257,"Preeclampsia, susceptibility to (3)","AGT, SERPINA8",106150,1q42-q43,Cardiovascular
1259,Prekallikrein deficiency (3),"KLKB1, KLK3",229000,4q35,Hematological
3260,"Premature chromosome condensation with microcephaly and mental retardation,
606858 (3)",MCPH1,607117,8p23,Neurological
1260,"Premature ovarian failure, 300511 (3)","DIAPH2, DIA, POF2",300108,Xq22,Renal
1260,"Premature ovarian failure 3, 608996 (3)","FOXL2, BPES, BPES1, PFRK, POF3",605597,3q23,Renal
1261,"Primary lateral sclerosis, juvenile, 606353 (3)","ALS2, ALSJ, PLSJ, IAHSP",606352,2q33,Neurological
1263,"Prion disease with protracted course, 606688 (3)","PRNP, PRIP",176640,20pter-p12,Neurological
1265,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, 157640 (3)","C10orf2, TWINKLE, PEO1, PEO",606075,10q24,Ophthamological
1265,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, 157640 (3)","POLG, POLG1, POLGA, PEO",174763,15q25,Ophthamological
1265,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, 157640 (3)","SLC25A4, ANT1, T1, PEO3",103220,4q35,Ophthamological
1266,Proguanil poor metabolizer (3),"CYP2C, CYP2C19",124020,10q24.1-q24.3,Metabolic
1267,"Prolactinoma, hyperparathyroidism, carcinoid syndrome (3)",MEN1,131100,11q13,Endocrine
1268,Prolidase deficiency (3),PEPD,170100,19cen-q13.11,Connective tissue
1270,"Properdin deficiency, X-linked, 312060 (3)","PFC, PFD",300383,Xp11.4-p11.23,Immunological
1271,"Propionicacidemia, 606054 (3)",PCCA,232000,13q32,Metabolic
1271,"Propionicacidemia, 606054 (3)",PCCB,232050,3q21-q22,Metabolic
1272,"Prostate cancer 1, 176807, 601518 (3)","RNASEL, RNS4, PRCA1, HPC1",180435,1q25,Cancer
1272,"Prostate cancer, 176807 (3)","BRCA2, FANCD1",600185,13q12.3,Cancer
1272,"Prostate cancer, 176807 (3)","PTEN, MMAC1",601728,10q23.31,Cancer
1272,Prostate cancer (3),"AR, DHTR, TFM, SBMA, KD, SMAX1",313700,Xq11-q12,Cancer
1272,"Prostate cancer, familial, 176807 (3)","CHEK2, RAD53, CHK2, CDS1, LFS2",604373,22q12.1,Cancer
1272,"Prostate cancer, hereditary, 176807 (3)",MSR1,153622,8p22,Cancer
1272,"Prostate cancer, progression and metastasis of, 176807 (3)","EPHB2, EPHT3, DRT, ERK",600997,1p36.1-p35,Cancer
1272,"Prostate cancer, somatic, 176807 (3)","KLF6, COPEB, BCD1, ZF9",602053,10p15,Cancer
1272,"Prostate cancer, somatic, 176807 (3)","MAD1L1, TXBP181",602686,7p22,Cancer
1272,"Prostate cancer, susceptibility to, 176807 (3)","AR, DHTR, TFM, SBMA, KD, SMAX1",313700,Xq11-q12,Cancer
1272,"Prostate cancer, susceptibility to, 176807 (3)",ATBF1,104155,16q22.3-q23.1,Cancer
1272,"Prostate cancer, susceptibility to, 176807 (3)","ELAC2, HPC2",605367,17p11,Cancer
1272,"Prostate cancer, susceptibility to, 176807 (3)",MXI1,600020,10q25,Cancer
1273,Protein S deficiency (3),PROS1,176880,3p11.1-q11.2,Hematological
1274,"Proteinuria, low molecular weight, with hypercalciuric nephrocalcinosis (3)","CLCN5, CLCK2, NPHL2, DENTS",300008,Xp11.22,Renal
1276,"Protoporphyria, erythropoietic (3)","FECH, FCE",177000,18q21.3,Metabolic
1276,"Protoporphyria, erythropoietic, recessive, with liver failure (3)","FECH, FCE",177000,18q21.3,Metabolic
1277,"Proud syndrome, 300004 (3)","ARX, ISSX, PRTS, MRXS1, MRX36,
MRX54",300382,Xp22.13,multiple
1278,"Pseudoachondroplasia, 177170 (3)","COMP, EDM1, MED, PSACH",600310,19p13.1,Skeletal
1279,"Pseudohermaphroditism, male, with gynecomastia, 264300 (3)","HSD17B3, EDH17B3",605573,9q22,Developmental
1279,"Pseudohermaphroditism, male, with Leydig cell hypoplasia (3)",LHCGR,152790,2p21,Developmental
1281,"Pseudohypoaldosteronism, type I, 264350 (3)",SCNN1A,600228,12p13,Endocrine
1281,"Pseudohypoaldosteronism, type I, 264350 (3)",SCNN1B,600760,16p13-p12,Endocrine
1281,"Pseudohypoaldosteronism, type I, 264350 (3)","SCNN1G, PHA1",600761,16p13-p12,Endocrine
1281,"Pseudohypoaldosteronism type I, autosomal dominant, 177735 (3)","NR3C2, MLR, MCR",600983,4q31.1,Endocrine
1281,Pseudohypoaldosteronism type II (3),"WNK4, PRKWNK4, PHA2B",601844,17q21-q22,Endocrine
1281,"Pseudohypoaldosteronism, type IIC, 145260 (3)","WNK1, PRKWNK1, KDP, PHA2C",605232,12p13,Endocrine
1282,"Pseudohypoparathyroidism, type Ia, 103580 (3)","GNAS, GNAS1, GPSA, POH, PHP1B,
PHP1A, AHO",139320,20q13.2,Endocrine
1282,"Pseudohypoparathyroidism, type Ib, 603233 (3)","GNAS, GNAS1, GPSA, POH, PHP1B,
PHP1A, AHO",139320,20q13.2,Endocrine
1283,"Pseudovaginal perineoscrotal hypospadias, 264600 (3)",SRD5A2,607306,2p23,Unclassified
1284,Pseudovitamin D deficiency rickets 1 (3),"CYP27B1, PDDR, VDD1",264700,12q14,Bone
1285,"Pseudoxanthoma elasticum, autosomal dominant, 177850 (3)","ABCC6, ARA, ABC34, MLP1, PXE",603234,16p13.1,Connective tissue
1285,"Pseudoxanthoma elasticum, autosomal recessive, 264800 (3)","ABCC6, ARA, ABC34, MLP1, PXE",603234,16p13.1,Connective tissue
1288,"Psoriasis, susceptibility to, 177900 (3)",PSORS6,605364,19p13,Dermatological
1288,"Psoriatic arthritis, susceptibility to, 607507 (3)","CARD15, NOD2, IBD1, CD, ACUG,
PSORAS1",605956,16q12,Dermatological
1291,"Pulmonary alveolar proteinosis, 265120 (3)",CSF2RB,138981,22q12.2-q13.1,Respiratory
1291,"Pulmonary alveolar proteinosis, 265120 (3)","SFTPC, SFTP2",178620,8p21,Respiratory
1291,"Pulmonary alveolar proteinosis, congenital, 265120 (3)","SFTPB, SFTB3",178640,2p12-p11.2,Respiratory
1291,"Pulmonary fibrosis, idiopathic, familial, 178500 (3)","SFTPC, SFTP2",178620,8p21,Respiratory
1291,"Pulmonary fibrosis, idiopathic, susceptibility to, 178500 (3)","SFTPA1, SFTP1",178630,10q22.2-q23.1,Respiratory
5291,"Pulmonary hypertension, familial primary, 178600 (3)","BMPR2, PPH1",600799,2q33,Cardiovascular
1293,"Pycnodysostosis, 265800 (3)",CTSK,601105,1q21,Skeletal
1294,"Pyloric stenosis, infantile hypertrophic, susceptibility to, 179010 (3)",NOS1,163731,12q24.2-q24.31,Developmental
1295,"Pyogenic sterile arthritis, pyoderma gangrenosum, and acne, 604416 (3)","PSTPIP1, PSTPIP, CD2BP1, PAPAS",606347,15q24-q25.1,Dermatological
1296,Pyropoikilocytosis (3),SPTA1,182860,1q21,Hematological
1297,"Pyruvate carboxylase deficiency, 266150 (3)",PC,608786,11q13.4-q13.5,Metabolic
1297,Pyruvate dehydrogenase deficiency (3),"PDHA1, PHE1A",312170,Xp22.2-p22.1,Metabolic
1297,Pyruvate dehydrogenase E1-beta deficiency (3),PDHB,179060,3p13-q23,Metabolic
1298,"Rabson-Mendenhall syndrome, 262190 (3)",INSR,147670,19p13.2,multiple
1301,"Radioulnar synostosis with amegakaryocytic thrombocytopenia, 605432 (3)","HOXA11, HOX1I",142958,7p15-p14.2,multiple
1303,"RAPADILINO syndrome, 266280 (3)","RECQL4, RTS, RECQ4",603780,8q24.3,multiple
1304,Rapid progression to AIDS from HIV1 infection (3),"CX3CR1, GPR13, V28",601470,3pter-p21,Immunological
1305,"Rapp-Hodgkin syndrome, 129400 (3)","TP73L, TP63, KET, EEC3, SHFM4, LMS,
RHS",603273,3q27,multiple
1306,Red hair/fair skin (3),MC1R,155555,16q24.3,Dermatological
1307,"Refsum disease, 266500 (3)","PEX7, RCDP1",601757,6q22-q24,Neurological
1307,"Refsum disease, 266500 (3)","PHYH, PAHX",602026,10pter-p11.2,Neurological
1307,"Refsum disease, infantile, 266510 (3)","PEX1, ZWS1",602136,7q21-q22,Neurological
1307,"Refsum disease, infantile form, 266510 (3)",PEX26,608666,22q11.21,Neurological
1307,"Refsum disease, infantile form, 266510 (3)","PXMP3, PAF1, PMP35, PEX2",170993,8q21.1,Neurological
1308,"Renal carcinoma, chromophobe, somatic, 144700 (3)","FLCN, BHD",607273,17p11.2,Cancer
1308,"Renal cell carcinoma, 144700 (3)","TRC8, RCA1, HRCA1",603046,8q24.1,Cancer
1308,"Renal cell carcinoma, clear cell, somatic, 144700 (3)",OGG1,601982,3p26.2,Cancer
1308,"Renal cell carcinoma, papillary, 1, 605074 (3)","PRCC, RCCP1",179755,1q21,Cancer
1308,"Renal cell carcinoma, papillary, 1, 605074 (3)",TFE3,314310,Xp11.22,Cancer
1308,"Renal cell carcinoma, papillary, familial and sporadic, 605074 (3)",MET,164860,7q31,Cancer
1308,"Renal cell carcinoma, somatic (3)",VHL,608537,3p26-p25,Cancer
3308,"Renal glucosuria, 233100 (3)","SLC5A2, SGLT2",182381,16p11.2,Renal
5308,"Renal hypoplasia, isolated (3)",PAX2,167409,10q24.3-q25.1,Renal
7308,"Renal tubular acidosis, distal, 179800, 602722 (3)","SLC4A1, AE1, EPB3",109270,17q21-q22,Renal
7308,"Renal tubular acidosis, distal, autosomal recessive, 602722 (3)","ATP6V0A4, ATP6N1B, VPP2, RTA1C,
RTADR",605239,7q33-q34,Renal
7308,Renal tubular acidosis-osteopetrosis syndrome (3),CA2,259730,8q22,Renal
7308,"Renal tubular acidosis, proximal, with ocular abnormalities, 604278 (3)","SLC4A4, NBC1, KNBC, SLC4A5",603345,4q21,Renal
7308,"Renal tubular acidosis with deafness, 267300 (3)","ATP6B1, VPP3",192132,2cen-q13,Renal
9308,"Renal tubular dysgenesis, 267430 (3)","ACE, DCP1, ACE1",106180,17q23,Renal
9308,"Renal tubular dysgenesis, 267430 (3)","AGTR1, AGTR1A, AT2R1",106165,3q21-q25,Renal
9308,"Renal tubular dysgenesis, 267430 (3)","AGT, SERPINA8",106150,1q42-q43,Renal
9308,"Renal tubular dysgenesis, 267430 (3)",REN,179820,1q32,Renal
1309,"Renpenning syndrome, 309500 (3)","PQBP1, NPW38, SHS, MRX55, MRXS3,
RENS1, MRXS8",300463,Xp11.23,Neurological
1311,Response to morphine-6-glucuronide (3),OPRM1,600018,6q24-q25,Neurological
1312,"Resting heart rate, 607276 (3)","ADRB1, ADRB1R, RHR",109630,10q24-q26,Cardiovascular
1314,"Restrictive dermopathy, lethal, 275210 (3)","ZMPSTE24, FACE1, STE24, MADB",606480,1p34,Dermatological
1315,"Retinal degeneration, autosomal recessive, clumped pigment type (3)","NRL, D14S46E, RP27",162080,14q11.1-q11.2,Ophthamological
1315,"Retinal degeneration, autosomal recessive, prominin-related (3)","PROM1, PROML1, AC133",604365,4p16.2-p12,Ophthamological
1315,"Retinal degeneration, late-onset, autosomal dominant, 605670 (3)","C1QTNF5, CTRP5, LORD",608752,11q23.3,Ophthamological
1315,"Retinal dystrophy, early-onset severe (3)",LRAT,604863,4q31,Ophthamological
1316,"Retinitis pigmentosa-10, 180105 (3)",IMPDH1,146690,7q31.3-q32,Ophthamological
1316,"Retinitis pigmentosa-11, 600138 (3)","PRPF31, PRP31",606419,19q13.4,Ophthamological
1316,"Retinitis pigmentosa-1, 180100 (3)","RP1, ORP1",603937,8q11-q13,Ophthamological
1316,"Retinitis pigmentosa-12, autosomal recessive, 600105 (3)","CRB1, RP12",604210,1q31-q32.1,Ophthamological
1316,"Retinitis pigmentosa-13, 600059 (3)","PRPF8, PRPC8, RP13",607300,17p13.3,Ophthamological
1316,"Retinitis pigmentosa-14, 600132 (3)","TULP1, RP14",602280,6p21.3,Ophthamological
1316,"Retinitis pigmentosa-17, 600852 (3)","CA4, RP17",114760,17q23,Ophthamological
1316,"Retinitis pigmentosa-18, 601414 (3)","HPRP3, RP18",607301,1q21.2,Ophthamological
1316,"Retinitis pigmentosa-19, 601718 (3)","ABCA4, ABCR, STGD1, FFM, RP19",601691,1p21-p13,Ophthamological
1316,Retinitis pigmentosa-20 (3),"RPE65, RP20",180069,1p31,Ophthamological
1316,Retinitis pigmentosa-2 (3),RP2,312600,Xp11.3,Ophthamological
1316,"Retinitis pigmentosa-26, 608380 (3)",CERKL,608381,2q31.2-q32.3,Ophthamological
1316,Retinitis pigmentosa-27 (3),"NRL, D14S46E, RP27",162080,14q11.1-q11.2,Ophthamological
1316,"Retinitis pigmentosa-30, 607921 (3)","FSCN2, RFSN",607643,17q25,Ophthamological
1316,"Retinitis pigmentosa-3, 300389 (3)","RPGR, RP3, CRD, RP15, COD1",312610,Xp21.1,Ophthamological
1316,"Retinitis pigmentosa-4, autosomal dominant (3)","RHO, RP4, OPN2",180380,3q21-q24,Ophthamological
1316,"Retinitis pigmentosa-7, 608133 (3)","RDS, RP7, PRPH2, PRPH, AVMD,
AOFMD",179605,6p21.1-cen,Ophthamological
1316,"Retinitis pigmentosa-9, 180104 (3)",RP9,607331,7p14.2,Ophthamological
1316,"Retinitis pigmentosa, AR, 268000 (3)",RLBP1,180090,15q26,Ophthamological
1316,"Retinitis pigmentosa, AR, without hearing loss, 268000 (3)",USH2A,608400,1q41,Ophthamological
1316,"Retinitis pigmentosa, autosomal dominant (3)",RGR,600342,10q23,Ophthamological
1316,"Retinitis pigmentosa, autosomal recessive, 268000 (3)","CNGB1, CNCG3L, CNCG2",600724,16q13,Ophthamological
1316,"Retinitis pigmentosa, autosomal recessive (3)","CNGA1, CNCG1",123825,4p12-cen,Ophthamological
1316,"Retinitis pigmentosa, autosomal recessive (3)","PDE6A, PDEA",180071,5q31.2-q34,Ophthamological
1316,"Retinitis pigmentosa, autosomal recessive (3)","PDE6B, PDEB, CSNB3",180072,4p16.3,Ophthamological
1316,"Retinitis pigmentosa, autosomal recessive (3)",RGR,600342,10q23,Ophthamological
1316,"Retinitis pigmentosa, autosomal recessive (3)","RHO, RP4, OPN2",180380,3q21-q24,Ophthamological
1316,"Retinitis pigmentosa, digenic (3)","ROM1, ROSP1",180721,11q13,Ophthamological
1316,"Retinitis pigmentosa, digenic, 608133 (3)","RDS, RP7, PRPH2, PRPH, AVMD,
AOFMD",179605,6p21.1-cen,Ophthamological
1316,"Retinitis pigmentosa, juvenile (3)","AIPL1, LCA4",604392,17p13.1,Ophthamological
1316,"Retinitis pigmentosa, late onset, 268000 (3)","NR2E3, PNR, ESCS",604485,15q23,Ophthamological
1316,"Retinitis pigmentosa, late-onset dominant, 268000 (3)","CRX, CORD2, CRD",602225,19q13.3,Ophthamological
1316,"Retinitis pigmentosa, MERTK-related, 268000 (3)",MERTK,604705,2q14.1,Ophthamological
1316,"Retinitis pigmentosa, X-linked with deafness and sinorespiratory infections, 300455 (3)","RPGR, RP3, CRD, RP15, COD1",312610,Xp21.1,Ophthamological
1316,"Retinitis pigmentosa, X-linked, with recurrent respiratory infections, 300455 (3)","RPGR, RP3, CRD, RP15, COD1",312610,Xp21.1,Ophthamological
1316,"Retinitis punctata albescens, 136880 (3)","RDS, RP7, PRPH2, PRPH, AVMD,
AOFMD",179605,6p21.1-cen,Ophthamological
1316,"Retinitis punctata albescens, 136880 (3)",RLBP1,180090,15q26,Ophthamological
1317,Retinoblastoma (3),RB1,180200,13q14.1-q14.2,Cancer
1318,"Retinol binding protein, deficiency of (3)",RBP4,180250,10q24,Ophthamological
1320,Retinoschisis (3),"RS1, XLRS1",312700,Xp22.2-p22.1,Ophthamological
1321,"Rett syndrome, 312750 (3)","MECP2, RTT, PPMX, MRX16, MRX79",300005,Xq28,Neurological
1321,"Rett syndrome, atypical, 312750 (3)","CDKL5, STK9",300203,Xp22,Neurological
1321,"Rett syndrome, preserved speech variant, 312750 (3)","MECP2, RTT, PPMX, MRX16, MRX79",300005,Xq28,Neurological
1322,"Rhabdoid predisposition syndrome, familial (3)","SMARCB1, SNF5, INI1, RDT",601607,22q11,Cancer
1322,Rhabdoid tumors (3),"SMARCB1, SNF5, INI1, RDT",601607,22q11,Cancer
1323,"Rhabdomyosarcoma, 268210 (3)","SLC22A1L, BWSCR1A, IMPT1",602631,11p15.5,Cancer
1323,"Rhabdomyosarcoma, alveolar, 268220 (3)","FOXO1A, FKHR",136533,13q14.1,Cancer
1323,"Rhabdomyosarcoma, alveolar, 268220 (3)","PAX3, WS1, HUP2, CDHS",606597,2q35,Cancer
1323,"Rhabdomyosarcoma, alveolar, 268220 (3)",PAX7,167410,1p36.2-p36.12,Cancer
1324,"Rheumatoid arthritis, progression of, 180300 (3)","IL10, CSIF",124092,1q31-q32,Connective tissue
1324,"Rheumatoid arthritis, susceptibility to, 180300 (3)","MHC2TA, C2TA",600005,16p13,Connective tissue
1324,"Rheumatoid arthritis, susceptibility to, 180300 (3)",NFKBIL1,601022,6p21.3,Connective tissue
1324,"Rheumatoid arthritis, susceptibility to, 180300 (3)","PADI4, PADI5, PAD",605347,1p36,Connective tissue
1324,"Rheumatoid arthritis, susceptibility to, 180300 (3)","PTPN8, PEP, PTPN22, LYP",600716,1p13,Connective tissue
1324,"Rheumatoid arthritis, susceptibility to, 180300 (3)","RUNX1, CBFA2, AML1",151385,21q22.3,Connective tissue
1324,"Rheumatoid arthritis, susceptibility to, 180300 (3)","SLC22A4, OCTN1",604190,5q31,Connective tissue
1324,"Rheumatoid arthritis, systemic juvenile, susceptibility to, 604302 (3)",MIF,153620,22q11.2,Connective tissue
1325,"Rhizomelic chondrodysplasia punctata, type 1, 215100 (3)","PEX7, RCDP1",601757,6q22-q24,multiple
1325,"Rhizomelic chondrodysplasia punctata, type 3, 600121 (3)","AGPS, ADHAPS",603051,2q31,multiple
1326,Rh-mod syndrome (3),"RHAG, RH50A",180297,6p21.1-p11,Hematological
1327,Rh-negative blood type (3),RHD,111680,1p36.2-p34,Hematological
1327,"Rh-null disease, amorph type (3)",RHCE,111700,1p36.2-p34,Hematological
1329,"Ribose 5-phosphate isomerase deficiency, 608611 (3)","RPIA, RPI",180430,2p11.2,Metabolic
1330,"Rickets due to defect in vitamin D 25-hydroxylation, 600081 (3)",CYP2R1,608713,11p15.2,Bone
1330,"Rickets, vitamin D-resistant, type IIA, 277440 (3)",VDR,601769,12q12-q14,Bone
1330,"Rickets, vitamin D-resistant, type IIB, 277420 (3)",VDR,601769,12q12-q14,Bone
1331,Rieger anomaly (3),"FOXC1, FKHL7, FREAC3",601090,6p25,multiple
1331,"Rieger syndrome, 180500 (3)","PITX2, IDG2, RIEG1, RGS, IGDS2",601542,4q25-q26,multiple
1332,"Ring dermoid of cornea, 180550 (3)","PITX2, IDG2, RIEG1, RGS, IGDS2",601542,4q25-q26,Ophthamological
1333,"Rippling muscle disease, 606072 (3)","CAV3, LGMD1C",601253,3p25,Muscular
1334,"Roberts syndrome, 268300 (3)",ESCO2,609353,8p21.1,Developmental
1335,"Robinow syndrome, autosomal recessive, 268310 (3)","ROR2, BDB1, BDB, NTRKR2",602337,9q22,multiple
1337,"Rokitansky-Kuster-Hauser syndrome, 277000 (3)",WNT4,603490,1p35,Developmental
1338,"Rothmund-Thomson syndrome, 268400 (3)","RECQL4, RTS, RECQ4",603780,8q24.3,multiple
1339,"Roussy-Levy syndrome, 180800 (3)","MPZ, CMT1B, CMTDI3, CHM, DSS",159440,1q22,multiple
1339,"Roussy-Levy syndrome, 180800 (3)","PMP22, CMT1A, CMT1E, DSS",601097,17p11.2,multiple
1341,"Rubenstein-Taybi syndrome, 180849 (3)","CREBBP, CBP, RSTS",600140,16p13.3,multiple
1341,"Rubinstein-Taybi syndrome, 180849 (3)",EP300,602700,22q13,multiple
1344,"Saethre-Chotzen syndrome, 101400 (3)","FGFR2, BEK, CFD1, JWS",176943,10q26,Developmental
1344,"Saethre-Chotzen syndrome, 101400 (3)","TWIST, ACS3, SCS",601622,7p21,Developmental
1344,"Saethre-Chotzen syndrome with eyelid anomalies, 101400 (3)","TWIST, ACS3, SCS",601622,7p21,Developmental
1345,Salivary adenoma (3),"HMGA2, HMGIC, BABL, LIPO",600698,12q14.3,Cancer
1346,"Salla disease, 604369 (3)","SLC17A5, SIASD, SLD",604322,6q14-q15,Metabolic
1347,"Sandhoff disease, infantile, juvenile, and adult forms, 268800 (3)",HEXB,606873,5q13,Metabolic
1348,"Sanfilippo syndrome, type A, 252900 (3)","SGSH, MPS3A, SFMD",605270,17q25.3,Metabolic
1348,"Sanfilippo syndrome, type B (3)",NAGLU,252920,17q21,Metabolic
1349,"Sarcoidosis, early-onset, 181000 (3)","CARD15, NOD2, IBD1, CD, ACUG,
PSORAS1",605956,16q12,Immunological
1349,"Sarcoidosis, susceptibility to, 181000 (3)",BTNL2,606000,6p21.3,Immunological
1349,"Sarcoidosis, susceptibility to, 181000 (3)",HLA-DR1B,142857,6p21.3,Immunological
1350,"Sarcoma, synovial (3)","SSX1, SSRC",312820,Xp11.2,Cancer
1350,"Sarcoma, synovial (3)",SSX2,300192,Xp11.2,Cancer
1352,"SARS, progression of (3)","ACE, DCP1, ACE1",106180,17q23,Immunological
1354,"Schimke immunoosseous dysplasia, 242900 (3)","SMARCAL1, HARP, SIOD",606622,2q34-q36,Connective tissue
1355,"Schindler disease, type I, 609241 (3)",NAGA,104170,22q11,Metabolic
1355,"Schindler disease, type III, 609241 (3)",NAGA,104170,22q11,Metabolic
1357,"Schizencephaly, 269160 (3)",EMX2,600035,10q26.1,Neurological
1359,"Schizoaffective disorder, susceptibility to, 181500 (3)",DISC1,605210,1q42.1,Psychiatric
1359,"Schizophrenia 5, 603175 (3)",TRAR4,608923,6q23.2,Psychiatric
1359,"Schizophrenia, chronic (3)","APP, AAA, CVAP, AD1",104760,21q21,Psychiatric
1359,"Schizophrenia, susceptibility to, 181500 (3)",COMT,116790,22q11.2,Psychiatric
1359,"Schizophrenia, susceptibility to, 181500 (3)",DISC1,605210,1q42.1,Psychiatric
1359,"Schizophrenia, susceptibility to, 181500 (3)",HTR2A,182135,13q14-q21,Psychiatric
1359,"Schizophrenia, susceptibility to, 181500 (3)","RTN4R, NOGOR",605566,22q11,Psychiatric
1359,"Schizophrenia, susceptibility to, 181500 (3)",SYN2,600755,3p25,Psychiatric
1359,"Schizophrenia, susceptibility to, 181510 (3)","EPN4, EPNR, KIAA0171, SCZD1",607265,5q33.3,Psychiatric
1359,"Schizophrenia, susceptibility to, 4 600850 (3)","PRODH, PRODH2, SCZD4",606810,22q11.2,Psychiatric
1360,"Schwannomatosis, 162091 (3)",NF2,607379,22q12.2,Cancer
1361,"Schwartz-Jampel syndrome, type 1, 255800 (3)","HSPG2, PLC, SJS, SJA, SJS1",142461,1p36.1,multiple
1362,"SCID, autosomal recessive, T-negative/B-positive type (3)","JAK3, JAKL",600173,19p13.1,Immunological
1363,"Sclerosteosis, 269500 (3)",SOST,605740,17q12-q21,Skeletal
1365,Scurvy (3),"GULOP, GULO",240400,8p21.1,Nutritional
1366,"Sea-blue histiocyte disease, 269600 (3)","APOE, AD2",107741,19q13.2,Hematological
1367,"Seasonal affective disorder, susceptibility to, 608516 (3)",HTR2A,182135,13q14-q21,Psychiatric
1368,"Sebastian syndrome, 605249 (3)","MYH9, MHA, FTNS, DFNA17",160775,22q11.2,Hematological
1369,"Seckel syndrome 1, 210600 (3)","ATR, FRP1, SCKL",601215,3q22-q24,Developmental
1370,"Segawa syndrome, recessive (3)","TH, TYH",191290,11p15.5,Neurological
1371,"Seizures, afebrile, 604233 (3)","SCN2A1, SCN2A",182390,2q23-q24.3,Neurological
1371,"Seizures, benign familial neonatal-infantile, 607745 (3)","SCN2A1, SCN2A",182390,2q23-q24.3,Neurological
1372,Selective T-cell defect (3),"ZAP70, SRK, STD",176947,2q12,Immunological
1373,"Self-healing collodion baby, 242300 (3)","TGM1, ICR2, LI1",190195,14q11.2,Dermatological
1374,"SEMD, Pakistani type (3)","PAPSS2, ATPSK2",603005,10q22-q24,Connective tissue
1375,"Senior-Loken syndrome-1, 266900 (3)","NPHP1, NPH1, SLSN1",607100,2q13,Renal
1375,"Senior-Loken syndrome 4, 606996 (3)","NPHP4, SLSN4",607215,1p36,Renal
1375,"Senior-Loken syndrome 5, 609254 (3)","IQCB1, NPHP5, KIAA0036",609237,3q21.1,Renal
1376,"Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis, 157640 (3)","POLG, POLG1, POLGA, PEO",174763,15q25,Ophthamological
1377,Sepiapterin reductase deficiency (3),SPR,182125,2p14-p12,Metabolic
1378,"Sepsis, susceptibility to (3)","CASP12, CASP12P1",608633,11q22.3,Immunological
1378,"Septic shock, susceptibility to (3)","TNF, TNFA",191160,6p21.3,Immunological
1380,"Septooptic dysplasia, 182230 (3)","HESX1, RPX",601802,3p21.2-p21.1,multiple
1381,"Sertoli cell-only syndrome, susceptibility to, 305700 (3)",USP26,300309,Xq26.2,Renal
1383,"Severe combined immunodeficiency, Athabascan type, 602450 (3)","DCLRE1C, ARTEMIS, SCIDA",605988,10p,Immunological
1383,"Severe combined immunodeficiency, B cell-negative, 601457 (3)",RAG1,179615,11p13,Immunological
1383,"Severe combined immunodeficiency, B cell-negative, 601457 (3)",RAG2,179616,11p13,Immunological
1383,"Severe combined immunodeficiency due to ADA deficiency, 102700 (3)",ADA,608958,20q13.11,Immunological
1383,Severe combined immunodeficiency due to PTPRC deficiency (3),"PTPRC, CD45, LCA",151460,1q31-q32,Immunological
1383,"Severe combined immunodeficiency, T-cell negative, B-cell/natural killer cell-positive
type, 600802 (3)",IL7R,146661,5p13,Immunological
1383,"Severe combined immunodeficiency, T-negative/B-positive type, 600802 (3)","CD3D, T3D",186790,11q23,Immunological
1383,"Severe combined immunodeficiency, X-linked, 300400 (3)","IL2RG, SCIDX1, SCIDX, IMD4",308380,Xq13,Immunological
1384,"Sex reversal, XY, with adrenal failure (3)","FTZF1, FTZ1, SF1",184757,9q33,Unclassified
1385,Sezary syndrome (3),BCL10,603517,1p22,Cancer
1386,"Shah-Waardenburg syndrome, 277580 (3)",EDN3,131242,20q13.2-q13.3,multiple
1387,"Short stature, autosomal dominant, with normal serum growth hormone binding protein
(3)",GHR,600946,5p13-p12,Skeletal
1387,"Short stature, idiopathic (3)",GHR,600946,5p13-p12,Skeletal
1387,"Short stature, idiopathic familial, 604271 (3)","SHOX, GCFX, SS, PHOG",312865,Xpter-p22.32,Skeletal
1387,"Short stature, idiopathic familial, 604271 (3)",SHOXY,400020,Ypter-p11.2,Skeletal
1387,"Short stature, pituitary and cerebellar defects, and small sella turcica, 606606 (3)",LHX4,602146,1q25,Skeletal
1388,"Shprintzen-Goldberg syndrome, 182212 (3)","FBN1, MFS1, WMS",134797,15q21.1,multiple
1389,"Shwachman-Diamond syndrome, 260400 (3)","SBDS, SDS",607444,7q11,multiple
1391,"Sialic acid storage disorder, infantile, 269920 (3)","SLC17A5, SIASD, SLD",604322,6q14-q15,Metabolic
1391,"Sialidosis, type I, 256550 (3)","NEU1, NEU, SIAL1",608272,6p21.3,Metabolic
1391,"Sialidosis, type II, 256550 (3)","NEU1, NEU, SIAL1",608272,6p21.3,Metabolic
1392,"Sialuria, 269921 (3)","GNE, GLCNE, IBM2, DMRV, NM",603824,9p12-p11,Metabolic
1393,Sickle cell anemia (3),HBB,141900,11p15.5,Hematological
1394,"Sick sinus syndrome, 608567 (3)","SCN5A, LQT3, IVF, HB1, SSS1",600163,3p21,Cardiovascular
1396,"Silver spastic paraplegia syndrome, 270685 (3)","BSCL2, SPG17",606158,11q13,Neurological
1397,"Simpson-Golabi-Behmel syndrome, type 1, 312870 (3)","GPC3, SDYS, SGBS1",300037,Xq26,multiple
1398,"Sitosterolemia, 210250 (3)",ABCG5,605459,2p21,Metabolic
1398,"Sitosterolemia, 210250 (3)",ABCG8,605460,2p21,Metabolic
1399,Situs ambiguus (3),NODAL,601265,Chr.10,Developmental
1399,"Situs inversus viscerum, 270100 (3)","DNAH11, DNAHC11",603339,Chr.7,Developmental
1400,"Sjogren-Larsson syndrome, 270200 (3)","ALDH3A2, ALDH10, SLS, FALDH",609523,17p11.2,Metabolic
1401,"Skin fragility-woolly hair syndrome, 607655 (3)","DSP, KPPS2, PPKS2",125647,6p24,Dermatological
1403,Slow acetylation (3),"NAT2, AAC2",243400,8p23.1-p21.3,Metabolic
1404,"Slowed nerve conduction velocity, AD, 608236 (3)","ARHGEF10, KIAA0294",608136,8p23,Neurological
1406,"Small patella syndrome, 147891 (3)",TBX4,601719,17q21-q22,Skeletal
1408,"SMED Strudwick type, 184250 (3)",COL2A1,120140,12q13.11-q13.2,Skeletal
1409,"Smith-Fineman-Myers syndrome, 309580 (3)","ATRX, XH2, XNP, MRXS3, SHS",300032,Xq13,multiple
1410,"Smith-Lemli-Opitz syndrome, 270400 (3)","DHCR7, SLOS",602858,11q12-q13,multiple
1411,"Smith-Magenis syndrome, 182290 (3)","RAI1, SMCR, SMS",607642,17p11.2,multiple
1412,"Smith-McCort dysplasia, 607326 (3)","DYM, FLJ90130, DMC, SMC",607461,18q12-q21.1,Skeletal
1414,"Solitary median maxillary central incisor, 147250 (3)","SHH, HPE3, HLP3, SMMCI",600725,7q36,Skeletal
1415,Somatotrophinoma (3),"GNAS, GNAS1, GPSA, POH, PHP1B,
PHP1A, AHO",139320,20q13.2,Endocrine
1416,"Sorsby fundus dystrophy, 136900 (3)","TIMP3, SFD",188826,22q12.1-q13.2,Ophthamological
1417,"Sotos syndrome, 117550 (3)","NSD1, ARA267, STO",606681,5q35,Developmental
1418,"Spastic ataxia, Charlevoix-Saguenay type, 270550 (3)","SACS, ARSACS",604490,13q12,Neurological
1418,"Spastic paralysis, infantile onset ascending, 607225 (3)","ALS2, ALSJ, PLSJ, IAHSP",606352,2q33,Neurological
1418,"Spastic paraplegia 10, 604187 (3)","KIF5A, NKHC, SPG10",602821,12q13,Neurological
1418,"Spastic paraplegia-13, 605280 (3)","HSPD1, SPG13, HSP60",118190,2q33.1,Neurological
1418,"Spastic paraplegia-2, 312920 (3)","PLP1, PMD",300401,Xq22,Neurological
1418,"Spastic paraplegia-3A, 182600 (3)",SPG3A,606439,14q11-q21,Neurological
1418,"Spastic paraplegia-4, 182601 (3)","SPG4, SPAST",604277,2p22-p21,Neurological
1418,"Spastic paraplegia-6, 600363 (3)","NIPA1, SPG6",608145,15q11.1,Neurological
1418,"Spastic paraplegia-7, 607259 (3)","PGN, SPG7, CMAR, CAR",602783,16q24.3,Neurological
3419,"Specific granule deficiency, 245480 (3)","CEBPE, CRP1",600749,14q11.2,Immunological
1419,"Speech-language disorder-1, 602081 (3)","FOXP2, SPCH1, TNRC10, CAGH44",605317,7q31,Neurological
1422,"Spermatogenic failure, susceptibility to (3)","DAZL, DAZH, SPGYLA",601486,3p24,Renal
1423,Spherocytosis-1 (3),SPTB,182870,14q22-q23.2,Hematological
1423,Spherocytosis-2 (3),"ANK1, SPH2",182900,8p11.2,Hematological
1423,"Spherocytosis, hereditary (3)","SLC4A1, AE1, EPB3",109270,17q21-q22,Hematological
1423,"Spherocytosis, hereditary, Japanese type (3)",EPB42,177070,15q15,Hematological
1423,"Spherocytosis, recessive (3)",SPTA1,182860,1q21,Hematological
1425,"Spina bifida, 601634 (3)","MTHFD, MTHFC",172460,14q24,Developmental
1425,"Spina bifida, risk of, 601634, 182940 (3)",MTR,156570,1q43,Developmental
1425,"Spina bifida, risk of, 601634, 182940 (3)",MTRR,602568,5p15.3-p15.2,Developmental
1426,"Spinal and bulbar muscular atrophy of Kennedy, 313200 (3)","AR, DHTR, TFM, SBMA, KD, SMAX1",313700,Xq11-q12,Muscular
1426,"Spinal muscrular atrophy, late-onset, Finkel type, 182980 (3)","VAPB, VAPC, ALS8",605704,20q13.3,Muscular
1426,"Spinal muscular atrophy-1, 253300 (3)","SMN1, SMA1, SMA2, SMA3, SMA4",600354,5q12.2-q13.3,Muscular
1426,"Spinal muscular atrophy-2, 253550 (3)","SMN1, SMA1, SMA2, SMA3, SMA4",600354,5q12.2-q13.3,Muscular
1426,"Spinal muscular atrophy-3, 253400 (3)","SMN1, SMA1, SMA2, SMA3, SMA4",600354,5q12.2-q13.3,Muscular
1426,"Spinal muscular atrophy-4, 271150 (3)","SMN1, SMA1, SMA2, SMA3, SMA4",600354,5q12.2-q13.3,Muscular
1426,"Spinal muscular atrophy, distal, type V, 600794 (3)","BSCL2, SPG17",606158,11q13,Muscular
1426,"Spinal muscular atrophy, distal, type V, 600794 (3)","GARS, SMAD1, CMT2D",600287,7p15,Muscular
1426,"Spinal muscular atrophy, juvenile (3)",HEXB,606873,5q13,Muscular
1426,"Spinal muscular atrophy with respiratory distress, 604320 (3)","IGHMBP2, SMUBP2, CATF1, SMARD1",600502,11q13.2-q13.4,Muscular
1428,Spinocerebellar ataxia-10 (3),"ATXN10, SCA10",603516,22q13,Neurological
1428,"Spinocerebellar ataxia-1, 164400 (3)","ATXN1, ATX1, SCA1",601556,6p23,Neurological
1428,"Spinocerebellar ataxia 12, 604326 (3)",PPP2R2B,604325,5q31-q33,Neurological
1428,"Spinocerebellar ataxia 14, 605361 (3)","PRKCG, PKCC, PKCG, SCA14",176980,19q13.4,Neurological
1428,"Spinocerebellar ataxia 17, 607136 (3)","TBP, SCA17",600075,6q27,Neurological
1428,"Spinocerebellar ataxia-2, 183090 (3)","ATXN2, ATX2, SCA2",601517,12q24,Neurological
1428,Spinocerebellar ataxia 25 (3),SCA25,608703,2p21-p13,Neurological
1428,"Spinocerebellar ataxia-27, 609307 (3)","FGF14, FHF4, SCA27",601515,13q34,Neurological
1428,"Spinocerebellar ataxia 4, pure Japanese type, 117210 (3)",PLEKHG4,609526,16q22.1,Neurological
1428,"Spinocerebellar ataxia-6, 183086 (3)","CACNA1A, CACNL1A4, SCA6",601011,19p13,Neurological
1428,"Spinocerebellar ataxia-7, 164500 (3)","ATXN7, SCA7, OPCA3",607640,3p21.1-p12,Neurological
1428,"Spinocerebellar ataxia 8, 608768 (3)",SCA8,603680,13q21,Neurological
1428,"Spinocerebellar ataxia, autosomal recessive with axonal neuropathy, 607250 (3)",TDP1,607198,14q31-q32,Neurological
1430,"Split hand/foot malformation, type 3, 600095 (3)","SHFM3, DAC",608071,10q24,Skeletal
1430,"Split-hand/foot malformation, type 4, 605289 (3)","TP73L, TP63, KET, EEC3, SHFM4, LMS,
RHS",603273,3q27,Skeletal
1432,"Spondylocarpotarsal synostosis syndrome, 272460 (3)","FLNB, SCT, AOI",603381,3p14.3,Skeletal
1433,"Spondylocostal dysostosis, autosomal recessive, 1, 277300 (3)","DLL3, SCDO1",602768,19q13,Skeletal
1433,"Spondylocostal dysostosis, autosomal recessive 2, 608681 (3)",MESP2,605195,15q26.1,Skeletal
1435,"Spondyloepimetaphyseal dysplasia, 608728 (3)","MATN3, EDM5, HOA",602109,2p24-p23,Skeletal
1435,"Spondyloepiphyseal dysplasia, Kimberley type, 608361 (3)","AGC1, CSPG1, MSK16, SEDK",155760,15q26.1,Skeletal
1435,"Spondyloepiphyseal dysplasia, Omani type, 608637 (3)","CHST3, C6ST, C6ST1",603799,10q22.1,Skeletal
1435,"Spondyloepiphyseal dysplasia tarda, 313400 (3)","SEDL, SEDT",300202,Xp22.2-p22.1,Skeletal
1435,"Spondyloepiphyseal dysplasia tarda with progressive arthropathy, 208230 (3)","WISP3, PPAC, PPD",603400,6q22-q23,Skeletal
1436,"Spondylometaphyseal dysplasia, Japanese type (3)",COL10A1,120110,6q21-q22.3,Skeletal
1437,"Squamous cell carcinoma, burn scar-related, somatic (3)","TNFRSF6, APT1, FAS, CD95, ALPS1A",134637,10q24.1,Cancer
1437,"Squamous cell carcinoma, head and neck, 601400 (3)",ING1,601566,13q34,Cancer
1437,"Squamous cell carcinoma, head and neck, 601400 (3)","TNFRSF10B, DR5, TRAILR2",603612,8p22-p21,Cancer
1438,"Stapes ankylosis syndrome without symphalangism, 184460 (3)","NOG, SYM1, SYNS1",602991,17q22,multiple
1439,"Stargardt disease-1, 248200 (3)","ABCA4, ABCR, STGD1, FFM, RP19",601691,1p21-p13,Ophthamological
1439,"Stargardt disease 3, 600110 (3)","ELOVL4, ADMD, STGD2, STGD3",605512,6q14,Ophthamological
1440,"Startle disease, autosomal recessive (3)","GLRA1, STHE",138491,5q32,Neurological
1440,"Startle disease/hyperekplexia, autosomal dominant, 149400 (3)","GLRA1, STHE",138491,5q32,Neurological
1441,"STAT1 deficiency, complete (3)",STAT1,600555,2q32.2-q32.3,Unclassified
1442,"Statins, attenuated cholesterol lowering by (3)",HMGCR,142910,5q13.3-q14,Metabolic
1444,"Steatocystoma multiplex, 184500 (3)","KRT17, PC2, PCHC1",148069,17q12-q21,Dermatological
1445,Stem-cell leukemia/lymphoma syndrome (3),"ZNF198, SCLL, RAMP, FIM",602221,13q11-q12,Cancer
1446,"Stevens-Johnson syndrome, carbamazepine-induced, susceptibility to, 608579 (3)",HLA-B,142830,6p21.3,Dermatological
1447,"Stickler syndrome, type I, 108300 (3)",COL2A1,120140,12q13.11-q13.2,multiple
1447,"Stickler syndrome, type II, 604841 (3)","COL11A1, STL2",120280,1p21,multiple
1447,"Stickler syndrome, type III, 184840 (3)","COL11A2, STL3, DFNA13",120290,6p21.3,multiple
1449,"Stomach cancer, 137215 (3)","KRAS2, RASK2",190070,12p12.1,Cancer
1454,"Stroke, susceptibility to, 1, 606799 (3)","PDE4D, DPDE3, STRK1",600129,5q12,Cardiovascular
1454,"Stroke, susceptibility to, 601367 (3)","ALOX5AP, FLAP",603700,13q12,Cardiovascular
1455,"Stuve-Wiedemann syndrome/Schwartz-Jampel type 2 syndrome, 601559 (3)","LIFR, STWS, SWS, SJS2",151443,5p13.1,multiple
1456,"Subcortical laminal heteropia, X-linked, 300067 (3)","DCX, DBCN, LISX",300121,Xq22.3-q23,Neurological
1456,Subcortical laminar heterotopia (3),"PAFAH1B1, LIS1",601545,17p13.3,Neurological
1457,Succinic semialdehyde dehydrogenase deficiency (3),SSADH,271980,6p22,Metabolic
1458,Sucrose intolerance (3),SI,222900,3q25-q26,Metabolic
1459,"Sudden infant death with dysgenesis of the testes syndrome, 608800 (3)","TSPYL1, TSPYL, SIDDT",604714,6q22-q23,Unclassified
1460,"Sulfite oxidase deficiency, 272300 (3)",SUOX,606887,Chr.12,Metabolic
1461,"Superoxide dismutase, elevated extracellular (3)",SOD3,185490,4p15.3-p15.1,Unclassified
1462,"Supranuclear palsy, progressive, 601104 (3)","MAPT, MTBT1, DDPAC, MSTD",157140,17q21.1,Neurological
1462,"Supranuclear palsy, progressive atypical, 260540 (3)","MAPT, MTBT1, DDPAC, MSTD",157140,17q21.1,Neurological
1463,"Supravalvar aortic stenosis, 185500 (3)",ELN,130160,7q11.2,Cardiovascular
1464,"Surfactant deficiency, neonatal, 267450 (3)","ABCA3, ABC3",601615,16p13.3,Respiratory
1464,Surfactant protein C deficiency (3),"SFTPC, SFTP2",178620,8p21,Respiratory
1465,"Sutherland-Haan syndrome-like, 300465 (3)","ATRX, XH2, XNP, MRXS3, SHS",300032,Xq13,multiple
1466,Sweat chloride elevation without CF (3),"CFTR, ABCC7, CF, MRP7",602421,7q31.2,Unclassified
1467,"Symphalangism, proximal, 185800 (3)","NOG, SYM1, SYNS1",602991,17q22,Skeletal
1468,"Syndactyly, type III, 186100 (3)","GJA1, CX43, ODDD, SDTY3, ODOD",121014,6q21-q23.2,Skeletal
1469,"Synostoses syndrome, multiple, 1, 186500 (3)","NOG, SYM1, SYNS1",602991,17q22,multiple
1470,"Synpolydactyly, 3/3'4, associated with metacarpal and metatarsal synostoses, 608180
(3)",FBLN1,135820,22q13.3,Skeletal
1470,"Synpolydactyly, type II, 186000 (3)","HOXD13, HOX4I, SPD",142989,2q31-q32,Skeletal
1470,"Synpolydactyly with foot anomalies, 186000 (3)","HOXD13, HOX4I, SPD",142989,2q31-q32,Skeletal
1471,"Systemic lupus erythematosus, susceptibility, 152700 (3)","TNFSF6, APT1LG1, FASL",134638,1q23,Immunological
1471,"Systemic lupus erythematosus, susceptibility to, 152700 (3)","DNASE1, DNL1",125505,16p13.3,Immunological
1471,"Systemic lupus erythematosus, susceptibility to, 152700 (3)","PTPN8, PEP, PTPN22, LYP",600716,1p13,Immunological
1471,"Systemic lupus erythematosus, susceptibility to, 2, 605218, 152700 (3)","PDCD1, SLEB2",600244,2q37.3,Immunological
1472,"Tall stature, susceptibility to (3)",MCM6,601806,2q21,Skeletal
1473,"Tangier disease, 205400 (3)","ABCA1, ABC1, HDLDT1, TGD",600046,9q22-q31,Metabolic
1475,"Tarsal-carpal coalition syndrome, 186570 (3)","NOG, SYM1, SYNS1",602991,17q22,Skeletal
1476,Tauopathy and respiratory failure (3),"MAPT, MTBT1, DDPAC, MSTD",157140,17q21.1,Neurological
1477,"Tay-Sachs disease, 272800 (3)","HEXA, TSD",606869,15q23-q24,Metabolic
1478,T-cell acute lymphoblastic leukemia (3),BAX,600040,19q13.3-q13.4,Cancer
3478,"T-cell immunodeficiency, congenital alopecia, and nail dystrophy (3)",WHN,600838,17q11-q12,Immunological
1478,"T-cell prolymphocytic leukemia, sporadic (3)","ATM, ATA, AT1",607585,11q22.3,Cancer
1480,"Temperature-sensitive apoptosis, cellular (3)",DAD1,600243,14q11-q12,Unclassified
1482,"Tetra-amelia, autosomal recessive, 273395 (3)","WNT3, INT4",165330,17q21,multiple
1483,"Tetralogy of Fallot, 187500 (3)","JAG1, AGS, AHD",601920,20p12,Cardiovascular
1483,"Tetralogy of Fallot, 187500 (3)","ZFPM2, FOG2",603693,8q23,Cardiovascular
1483,"Tetrology of Fallot, 187500 (3)","NKX2E, CSX",600584,5q34,Cardiovascular
1486,"Thalassemia, alpha- (3)",HBA2,141850,16pter-p13.3,Hematological
1486,"Thalassemia-beta, dominant inclusion-body, 603902 (3)",HBB,141900,11p15.5,Hematological
1486,"Thalassemia, delta- (3)",HBD,142000,11p15.5,Hematological
1486,Thalassemia due to Hb Lepore (3),HBD,142000,11p15.5,Hematological
1486,"Thalassemia, Hispanic gamma-delta-beta (3)",LCRB,152424,11p15.5,Hematological
1486,"Thalassemias, alpha- (3)",HBA1,141800,16pter-p13.3,Hematological
1486,"Thalassemias, beta- (3)",HBB,141900,11p15.5,Hematological
1490,"Thanatophoric dysplasia, types I and II, 187600 (3)","FGFR3, ACH",134934,4p16.3,Skeletal
1491,"Thiamine-responsive megaloblastic anemia syndrome, 249270 (3)","SLC19A2, THTR1",603941,1q23.3,Hematological
1493,"Thrombocythemia, essential, 187950 (3)",JAK2,147796,9p24,Hematological
1493,"Thrombocythemia, essential, 187950 (3)","THPO, MGDF, MPLLG, TPO",600044,3q26.3-q27,Hematological
1494,"Thrombocytopenia-2, 188000 (3)","FLJ14813, THC2",608221,10p12.1,Hematological
1494,"Thrombocytopenia, congenital amegakaryocytic, 604498 (3)","MPL, TPOR, MPLV",159530,1p34,Hematological
1494,"Thrombocytopenia, X-linked, 313900 (3)","WAS, IMD2, THC",300392,Xp11.23-p11.22,Hematological
1494,"Thrombocytopenia, X-linked, intermittent, 313900 (3)","WAS, IMD2, THC",300392,Xp11.23-p11.22,Hematological
1494,Thromboembolism susceptibility due to factor V Leiden (3),F5,227400,1q23,Hematological
1497,Thrombophilia due to factor V Liverpool (3),F5,227400,1q23,Hematological
1497,Thrombophilia due to heparin cofactor II deficiency (3),"HCF2, HC2, SERPIND1",142360,22q11,Hematological
1497,Thrombophilia due to HRG deficiency (3),HRG,142640,3q27,Hematological
1497,Thrombophilia due to protein C deficiency (3),PROC,176860,2q13-q14,Hematological
1497,Thrombophilia due to thrombomodulin defect (3),"THBD, THRM",188040,20p11.2,Hematological
1497,"Thrombophilia, dysfibrinogenemic (3)",FGB,134830,4q28,Hematological
1497,"Thrombophilia, dysfibrinogenemic (3)",FGG,134850,4q28,Hematological
1497,"Thrombosis, hyperhomocysteinemic (3)",CBS,236200,21q22.3,Hematological
1497,"Thrombotic thrombocytopenic purpura, familial, 274150 (3)","ADAMTS13, VWFCP, TTP",604134,9q34,Hematological
1494,"Thrombycytosis, susceptibility to, 187950 (3)","MPL, TPOR, MPLV",159530,1p34,Hematological
1502,Thymine-uraciluria (3),"DPYD, DPD",274270,1p22,Metabolic
1503,"Thyroid adenoma, hyperfunctioning (3)",TSHR,603372,14q31,Cancer
1503,Thyroid carcinoma (3),"TP53, P53, LFS1",191170,17p13.1,Cancer
1503,"Thyroid carcinoma, follicular, 188470 (3)","MINPP1, HIPER1",605391,10q23,Cancer
1503,"Thyroid carcinoma, follicular, 188470 (3)","PTEN, MMAC1",601728,10q23.31,Cancer
1503,"Thyroid carcinoma, follicular, somatic, 188470 (3)",HRAS,190020,11p15.5,Cancer
1503,"Thyroid carcinoma, papillary, 188550 (3)","GOLGA5, RFG5, PTC5",606918,14q,Cancer
1503,"Thyroid carcinoma, papillary, 188550 (3)","NCOA4, ELE1, PTC3",601984,10q11.2,Cancer
1503,"Thyroid carcinoma, papillary, 188550 (3)","PCM1, PTC4",600299,8p22-p21.3,Cancer
1503,"Thyroid carcinoma, papillary, 188550 (3)","PRKAR1A, TSE1, CNC1, CAR",188830,17q23-q24,Cancer
1503,"Thyroid carcinoma, papillary, 188550 (3)","TIF1G, RFG7, PTC7",605769,1p13,Cancer
1503,"Thyroid carcinoma, papillary, 188550 (3)","TRIM24, TIF1, TIF1A, PTC6",603406,7q32-q34,Cancer
3503,"Thyroid hormone organification defect IIA, 274500 (3)","TPO, TPX",606765,2p25,Endocrine
3503,"Thyroid hormone resistance, 188570 (3)","THRB, ERBA2, THR1",190160,3p24.3,Endocrine
3503,"Thyroid hormone resistance, autosomal recessive, 274300 (3)","THRB, ERBA2, THR1",190160,3p24.3,Endocrine
1504,"Thyrotoxic periodic paralysis, susceptibility to, 188580 (3)","CACNA1S, CACNL1A3, CCHL1A3",114208,1q32,Endocrine
1505,"Thyrotropin-releasing hormone resistance, generalized (3)",TRHR,188545,8q23,Endocrine
1506,Thyroxine-binding globulin deficiency (3),TBG,314200,Xq22.2,Hematological
1508,"Tietz syndrome, 103500 (3)","MITF, WS2A",156845,3p14.1-p12.3,multiple
1509,"Timothy syndrome, 601005 (3)","CACNA1C, CACNL1A1, CCHL1A1, TS",114205,12p13.3,multiple
1510,"Toenail dystrophy, isolated, 607523 (3)",COL7A1,120120,3p21.3,Dermatological
1511,Tolbutamide poor metabolizer (3),CYP2C9,601130,10q24,Unclassified
3512,"Total iodide organification defect, 274500 (3)","TPO, TPX",606765,2p25,Endocrine
1514,"Townes-Brocks branchiootorenal-like syndrome, 107480 (3)","SALL1, HSAL1, TBS",602218,16q12.1,multiple
1514,"Townes-Brocks syndrome, 107480 (3)","SALL1, HSAL1, TBS",602218,16q12.1,multiple
1515,"Transaldolase deficiency, 606003 (3)",TALDO1,602063,11p15.5-p15.4,Metabolic
1516,Transcobalamin II deficiency (3),"TCN2, TC2",275350,22q11.2-qter,Hematological
1518,"Transient bullous of the newborn, 131705 (3)",COL7A1,120120,3p21.3,Dermatological
1519,"Transposition of great arteries, dextro-looped, 217095 (3)","CFC1, CRYPTIC, HTX2",605194,2q21.1,Developmental
1519,"Transposition of the great arteries, dextro-looped, 608808 (3)","THRAP2, PROSIT240, TRAP240L,
KIAA1025",608771,12q24,Developmental
1520,"Treacher Collins mandibulofacial dysostosis, 154500 (3)","TCOF1, MFD1",606847,5q32-q33.1,Developmental
1521,"Tremor, familial essential, 2, 602134 (3)","HS1BP3, FLJ14249, ETM2",609359,2p24.1,Neurological
1522,"Trichodontoosseous syndrome, 190320 (3)","DLX3, TDO",600525,17q21.3-q22,multiple
1524,"Trichorhinophalangeal syndrome, type I, 190350 (3)",TRPS1,604386,8q24.12,Developmental
1524,"Trichorhinophalangeal syndrome, type III, 190351 (3)",TRPS1,604386,8q24.12,Developmental
1525,Trichothiodystrophy (3),"ERCC3, XPB",133510,2q21,Dermatological
1525,"Trichothiodystrophy, 601675 (3)","ERCC2, EM9",126340,19q13.2-q13.3,Dermatological
1525,"Trichothiodystrophy, complementation group A, 601675 (3)","TGF2H5, TTDA, TFB5, C6orf175",608780,6p25.3,Dermatological
1525,"Trichothiodystrophy, nonphotosensitive 1, 234050 (3)","TTDN1, C7orf11, ABHS",609188,7p14,Dermatological
1526,"Trifunctional protein deficiency, type 1 (3)","HADHA, MTPA",600890,2p23,Metabolic
1526,"Trifunctional protein deficiency, type II (3)",HADHB,143450,2p23,Metabolic
1528,"Trismus-pseudocomptodactyly syndrome, 158300 (3)",MYH8,160741,17p13.1,multiple
1529,"Tropical calcific pancreatitis, 608189 (3)","SPINK1, PSTI, PCTT, TATI",167790,5q32,Gastrointestinal
1530,"Troyer syndrome, 275900 (3)",SPG20,607111,13q12.3,Neurological
1534,"TSC2 angiomyolipomas, renal, modifier of, 191100 (3)",IFNG,147570,12q14,multiple
1533,"Tuberculosis, susceptibility to (3)",IFNGR1,107470,6q23-q24,Respiratory
1533,"Tuberculosis, susceptibility to, 607948 (3)",IFNG,147570,12q14,Respiratory
1534,"Tuberous sclerosis-1, 191100 (3)","TSC1, LAM",605284,9q34,multiple
1534,"Tuberous sclerosis-2, 191100 (3)","TSC2, LAM",191092,16p13.3,multiple
1536,"Turcot syndrome, 276300 (3)","APC, GS, FPC",175100,5q21-q22,Cancer
1536,"Turcot syndrome with glioblastoma, 276300 (3)","MLH1, COCA2, HNPCC2",120436,3p21.3,Cancer
1536,"Turcot syndrome with glioblastoma, 276300 (3)","PMS2, PMSL2, HNPCC4",600259,7p22,Cancer
1538,"Twinning, dizygotic, 276400 (3)","FSHR, ODG1",136435,2p21-p16,Unclassified
1540,"Tyrosinemia, type I (3)",FAH,276700,15q23-q25,Metabolic
1540,"Tyrosinemia, type II (3)",TAT,276600,16q22.1-q22.3,Metabolic
1540,"Tyrosinemia, type III (3)",HPD,276710,12q24-qter,Metabolic
1542,"Ullrich congenital muscular dystrophy, 254090 (3)","COL6A1, OPLL",120220,21q22.3,Muscular
1542,"Ullrich congenital muscular dystrophy, 254090 (3)",COL6A3,120250,2q37,Muscular
1542,"Ullrich scleroatonic muscular dystrophy, 254090 (3)",COL6A2,120240,21q22.3,Muscular
1543,"Ulnar-mammary syndrome, 181450 (3)",TBX3,601621,12q24.1,multiple
1544,"Unipolar depression, susceptibility to, 608516 (3)","TPH2, NTPH",607478,12q21.1,Psychiatric
1545,"Unna-Thost disease, nonepidermolytic, 600962 (3)",KRT1,139350,12q13,Dermatological
1550,"Urolithiasis, 2,8-dihydroxyadenine (3)",APRT,102600,16q24.3,Metabolic
1550,"Urolithiasis, hypophosphatemic (3)","SLC17A2, NPT2",182309,5q35,Metabolic
1551,"Usher syndrome, type 1B (3)","MYO7A, USH1B, DFNB2, DFNA11",276903,11q13.5,multiple
1551,"Usher syndrome, type 1C, 276904 (3)","USH1C, DFNB18",605242,11p15.1,multiple
1551,"Usher syndrome, type 1D, 601067 (3)","CDH23, USH1D",605516,10q21-q22,multiple
1551,"Usher syndrome, type 1F, 602083 (3)","PCDH15, DFNB23",605514,10q21-q22,multiple
1551,"Usher syndrome, type 1G, 606943 (3)","SANS, USH1G",607696,17q24-q25,multiple
1551,"Usher syndrome, type 2A, 276901 (3)",USH2A,608400,1q41,multiple
1551,"Usher syndrome, type 3, 276902 (3)","USH3A, USH3",606397,3q21-q25,multiple
1551,"Usher syndrome, type IIC, 605472 (3)","MASS1, VLGR1, KIAA0686, FEB4,
USH2C",602851,5q14,multiple
1552,Uterine leiomyoma (3),"HMGA2, HMGIC, BABL, LIPO",600698,12q14.3,Cancer
1553,"UV-induced skin damage, vulnerability to (3)",MC1R,155555,16q24.3,Dermatological
1554,"van Buchem disease, type 2, 607636 (3)","LRP5, BMND1, LRP7, LR3, OPPG,
VBCH2",603506,11q13.4,Unclassified
3554,"van der Woude syndrome, 119300 (3)","IRF6, VWS, LPS, PIT, PPS, OFC6",607199,1q32-q41,Developmental
1555,"VATER association with hydrocephalus, 276950 (3)","PTEN, MMAC1",601728,10q23.31,multiple
1556,"Velocardiofacial syndrome, 192430 (3)","TBX1, DGS, CTHM, CAFS, TGA, DORV,
VCFS, DGCR",602054,22q11.2,multiple
1557,"Venous malformations, multiple cutaneous and mucosal, 600195 (3)","TEK, TIE2, VMCM",600221,9p21,Cardiovascular
1557,"Venous thrombosis, susceptibility to (3)","SERPINA10, ZPI",605271,14q32.1,Cardiovascular
3558,"Ventricular fibrillation, idiopathic, 603829 (3)","SCN5A, LQT3, IVF, HB1, SSS1",600163,3p21,Cardiovascular
1558,"Ventricular tachycardia, idiopathic, 192605 (3)","GNAI2, GNAI2B, GIP",139360,3p21,Cardiovascular
1558,"Ventricular tachycardia, stress-induced polymorphic, 604772 (3)",CASQ2,114251,1p13.3-p11,Cardiovascular
1558,"Ventricular tachycardia, stress-induced polymorphic, 604772 (3)","RYR2, VTSIP",180902,1q42.1-q43,Cardiovascular
1559,"Vertical talus, congenital, 192950 (3)","HOXD10, HOX4D",142984,2q31-q32,Skeletal
1562,"Viral infections, recurrent (3)","FCGR3A, CD16, IGFR3",146740,1q23,Immunological
1562,"Viral infection, susceptibility to (3)","OAS1, OIAS",164350,12q24.2,Immunological
1563,"Virilization, maternal and fetal, from placental aromatase deficiency (3)","CYP19A1, CYP19, ARO",107910,15q21.1,Developmental
1565,"Vitamin K-dependent clotting factors, combined deficiency of, 2, 607473 (3)","VKORC1, VKOR, VKCFD2, FLJ00289",608547,16p11.2,Hematological
1565,"Vitamin K-dependent coagulation defect, 277450 (3)",GGCX,137167,2p12,Hematological
1566,"Vitelliform macular dystrophy, adult-onset, 608161 (3)",VMD2,607854,11q13,Ophthamological
1570,"VLCAD deficiency, 201475 (3)","ACADVL, VLCAD",609575,17p13,Metabolic
1571,"Vohwinkel syndrome, 124500 (3)","GJB2, CX26, DFNB1, PPK, DFNA3, KID,
HID",121011,13q11-q12,multiple
1571,"Vohwinkel syndrome with ichthyosis, 604117 (3)",LOR,152445,1q21,multiple
1572,"von Hippel-Lindau disease, modification of, 193300 (3)","CCND1, PRAD1, BCL1",168461,11q13,Cancer
1572,"von Hippel-Lindau syndrome, 193300 (3)",VHL,608537,3p26-p25,Cancer
3572,von Willebrand disease (3),"VWF, F8VWF",193400,12p13.3,Hematological
1573,"Waardenburg-Shah syndrome, 277580 (3)","EDNRB, HSCR2, ABCDS",131244,13q22,multiple
1573,"Waardenburg-Shah syndrome, 277580 (3)","SOX10, WS4",602229,22q13,multiple
1574,"Waardenburg syndrome/albinism, digenic, 103470 (3)",TYR,606933,11q14-q21,multiple
1574,"Waardenburg syndrome/ocular albinism, digenic, 103470 (3)","MITF, WS2A",156845,3p14.1-p12.3,multiple
1574,"Waardenburg syndrome, type I, 193500 (3)","PAX3, WS1, HUP2, CDHS",606597,2q35,multiple
1574,"Waardenburg syndrome, type IIA, 193510 (3)","MITF, WS2A",156845,3p14.1-p12.3,multiple
1574,"Waardenburg syndrome, type III, 148820 (3)","PAX3, WS1, HUP2, CDHS",606597,2q35,multiple
1574,"Waardenburg syndrome, typ IID, 608890 (3)","SNAI2, SLUG, WS2D",602150,8q11,multiple
1575,"Wagner syndrome, 143200 (3)",COL2A1,120140,12q13.11-q13.2,Ophthamological
1576,"WAGR syndrome, 194072 (3)",WT1,607102,11p13,multiple
1578,"Walker-Warburg syndrome, 236670 (3)",FCMD,607440,9q31,multiple
1578,"Walker-Warburg syndrome, 236670 (3)",POMT1,607423,9q34.1,multiple
1578,"Warburg micro syndrome 1, 600118 (3)","RAB3GAP, WARBM1, P130",602536,2q21.3,multiple
1580,"Warfarin resistance, 122700 (3)","VKORC1, VKOR, VKCFD2, FLJ00289",608547,16p11.2,Hematological
1580,"Warfarin sensitivity, 122700 (3)",CYP2C9,601130,10q24,Hematological
1580,Warfarin sensitivity (3),"F9, HEMB",306900,Xq27.1-q27.2,Hematological
1581,"Watson syndrome, 193520 (3)","NF1, VRNF, WSS, NFNS",162200,17q11.2,Cancer
1582,"Weaver syndrome, 277590 (3)","NSD1, ARA267, STO",606681,5q35,Developmental
1583,Wegener-like granulomatosis (3),"TAP2, ABCB3, PSF2, RING11",170261,6p21.3,Immunological
1585,"Weill-Marchesani syndrome, dominant, 608328 (3)","FBN1, MFS1, WMS",134797,15q21.1,Connective tissue
1585,"Weill-Marchesani syndrome, recessive, 277600 (3)","ADAMTS10, WMS",608990,19p13.3-p13.2,Connective tissue
1586,"Weissenbacher-Zweymuller syndrome, 277610 (3)","COL11A2, STL3, DFNA13",120290,6p21.3,Connective tissue
1588,"Werner syndrome, 277700 (3)","RECQL2, RECQ3, WRN",604611,8p12-p11.2,multiple
1589,"Wernicke-Korsakoff syndrome, susceptibility to, 277730 (3)",TKT,606781,3p14.3,Metabolic
1590,"Weyers acrodental dysostosis, 193530 (3)",EVC,604831,4p16,Skeletal
1591,"WHIM syndrome, 193670 (3)","CXCR4, D2S201E, NPY3R, WHIM",162643,2q21,Immunological
1592,"White sponge nevus, 193900 (3)",KRT13,148065,17q21-q22,Connective tissue
1592,"White sponge nevus, 193900 (3)","KRT4, CYK4",123940,12q13,Connective tissue
1594,"Williams-Beuren syndrome, 194050 (3)",ELN,130160,7q11.2,multiple
1595,"Wilms tumor, 194070 (3)","BRCA2, FANCD1",600185,13q12.3,Cancer
1595,"Wilms tumor, somatic, 194070 (3)","GPC3, SDYS, SGBS1",300037,Xq26,Cancer
1595,"Wilms tumor susceptibility-5, 601583 (3)","POU6F2, WTSL, WT5",609062,7p14-p13,Cancer
1595,"Wilms tumor, type 1, 194070 (3)",WT1,607102,11p13,Cancer
1596,"Wilson disease, 277900 (3)","ATP7B, WND",606882,13q14.3-q21.1,Metabolic
1598,"Wiskott-Aldrich syndrome, 301000 (3)","WAS, IMD2, THC",300392,Xp11.23-p11.22,Immunological
1599,"Witkop syndrome, 189500 (3)","MSX1, HOX7, HYD1, OFC5",142983,4p16.1,Developmental
1600,"Wolcott-Rallison syndrome, 226980 (3)","EIF2AK3, PEK, PERK, WRS",604032,2p12,Bone
1601,"Wolff-Parkinson-White syndrome, 194200 (3)","PRKAG2, WPWS",602743,7q36,Cardiovascular
1603,"Wolfram syndrome, 222300 (3)","WFS1, WFRS, WFS, DFNA6",606201,4p16.1,Metabolic
1604,Wolman disease (3),LIPA,278000,10q24-q25,Metabolic
1607,"Xanthinuria, type I, 278300 (3)",XDH,607633,2p23-p22,Metabolic
1608,"Xeroderma pigmentosum, group A (3)",XPA,278700,9q22.3,Dermatological
1608,"Xeroderma pigmentosum, group B (3)","ERCC3, XPB",133510,2q21,Dermatological
1608,"Xeroderma pigmentosum, group C (3)","XPC, XPCC",278720,3p25,Dermatological
1608,"Xeroderma pigmentosum, group D, 278730 (3)","ERCC2, EM9",126340,19q13.2-q13.3,Dermatological
1608,"Xeroderma pigmentosum, group E, DDB-negative subtype, 278740 (3)",DDB2,600811,11p12-p11,Dermatological
1608,"Xeroderma pigmentosum, group F, 278760 (3)","ERCC4, XPF",133520,16p13.3-p13.13,Dermatological
1608,"Xeroderma pigmentosum, group G, 278780 (3)","ERCC5, XPG",133530,13q33,Dermatological
1608,"Xeroderma pigmentosum, variant type, 278750 (3)","POLH, XPV",603968,6p21.1-p12,Dermatological
1610,"X-inactivation, familial skewed, 300087 (3)","XIC, XCE, XIST, SXI1",314670,Xq13.2,Unclassified
1611,"XLA and isolated growth hormone deficiency, 307200 (3)","BTK, AGMX1, IMD1, XLA, AT",300300,Xq21.3-q22,Immunological
1613,"Yellow nail syndrome, 153300 (3)","FOXC2, FKHL14, MFH1",602402,16q24.3,Immunological
1614,"Yemenite deaf-blind hypopigmentation syndrome, 601706 (3)","SOX10, WS4",602229,22q13,multiple
1615,"Zellweger syndrome-1, 214100 (3)","PEX1, ZWS1",602136,7q21-q22,multiple
1615,"Zellweger syndrome, 214100 (3)","PEX10, NALD",602859,Chr.1,multiple
1615,"Zellweger syndrome, 214100 (3)","PEX13, ZWS, NALD",601789,2p15,multiple
1615,"Zellweger syndrome, 214100 (3)",PEX14,601791,1p36.2,multiple
1615,"Zellweger syndrome, 214100 (3)",PEX26,608666,22q11.21,multiple
1615,"Zellweger syndrome, 214100 (3)","PXF, HK33, D1S2223E, PEX19",600279,1q22,multiple
1615,"Zellweger syndrome, 214100 (3)","PXR1, PEX5, PTS1R",600414,12p13.3,multiple
1615,Zellweger syndrome-2 (3),"ABCD3, PXMP1, PMP70",170995,1p22-p21,multiple
1615,Zellweger syndrome-3 (3),"PXMP3, PAF1, PMP35, PEX2",170993,8q21.1,multiple
1615,"Zellweger syndrome, complementation group 9 (3)",PEX16,603360,11p12-p11.2,multiple
1615,"Zellweger syndrome, complementation group G, 214100 (3)",PEX3,603164,6q23-q24,multiple
1617,"Zlotogora-Ogur syndrome, 225000 (3)","HVEC, PVRL1, PVRR1, PRR1",600644,11q23-q24,multiple
